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Abstract 
 
Human induced pluripotent stem cells (hiPSC) have the potential to provide patient 
and disease specific cells for research and act as therapeutic agents in unlimited 
supply.  To translate lab-scale research toward clinical applications we need to reduce 
variability from complex differentiation protocols which often include xenogeneic 
components.  A move toward more defined culture systems will improve predictability 
and process control as well as reduce risks of exposure to animal pathogens.  Cell 
therapy development, also requires flexibility in scalability as cell numbers for 
therapies vary greatly between disease indications.  Improved control over the 
microenvironment at the lab scale would offer more defined parameters amenable to 
scale up with better flexibility, reduced waste and more precision. 
This thesis describes the use of forced aggregation to improve the initiation of 
differentiation combined with culture in pre-validated and scalable, 24 microwell 
plates on shaking platforms, for stem cell differentiation toward retinal lineages.  
Using an established hiPSC line (MSU001) we show using forced aggregation to form 
embryoid bodies (EBs) promotes efficient initiation of differentiation.  We next 
determined 2 EB sizes (5K and 10K cells/EB) which improved initiation of retinal 
differentiation compared to scraped EBs as demonstrated by >3fold increase in 
expression of early eye field transcription factor Rax at day 3 of culture.  The 5K and 
10K EBs also facilitated the adaption of an adherent protocol for retinal differentiation 
to an orbital shaken suspension culture system.  Size controlled EBs also enabled the 
selection of a permissive shaking speed (120rpm) suitable for orbital shaken culture for  
initiating retinal differentiation with 5K and 10K EBs.  Furthermore orbital shaken 
culture enabled elimination of the undefined xenogeneic ingredients of Matrigel, from 
the culture system.   
This thesis demonstrates that combining size control for hiPSC derived EBs and orbital 
shaken culture is a feasible method for the initiation of retinal differentiation.  By 
facilitating removal of xenogeneic materials from the culture system; the combination 
of orbital shaken culture with size controlled EBs may be of value to other complex 
stem cell differentiation systems to improve the initiation of differentiation whilst 
providing the potential for scalability. 
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Chapter 1:  Introduction 
1.1 The emergence of pluripotent stem cells 
The origins of the term ‘stem cells’ in the scientific literature can be credited to an 18th 
Century Zoologist Ernst Häckel, who first described the concept of ‘stamzelle’ in 1868 
which gave rise to the English translation of ‘stem cell’.  In his work Häckel describes 
morphogenesis as a concise recapitulation of phylogeny where unicellular units give 
rise to multicellular organisms, describing stem cells as naïve, undifferentiated cells 
able to give rise to all other cell types of the body (Haeckel 1868).  Almost a century 
passed between the publication of Haeckel’s concepts and a demonstration of the 
potential use of stem cells in medicine by James Till and Ernest McCulloch in 1963.  
Till & McCulloch showed bone marrow cells donated to irradiated recipient mice, 
formed clonal colonies of erythroid and myeloid cells matched to the donor mice to 
repopulate their haematopoietic systems (Becker, A.J. McCulloch, E.A. Till 1963).  
Their work set the foundations of our understanding of the haematopoietic system, 
which depends on populations of stem cells that possess the ability to self-renew and 
give rise to differentiated (blood) cells (Becker, A.J. McCulloch, E.A. Till 1963).   
Stem cell’s potential to aid repair in the body was demonstrated in the 60’s, but 
decades passed before there was substantial evidence of their pluripotent potential – 
the capacity to develop into virtually any specialised cell type in the body.  
Pluripotency was first demonstrated in mouse embryonic stem cells (mESC) by their 
ability to participate in the normal embryogenesis of chimeric animals and form 
teratocarcinomas (Papaioannou et al. 1975; Stevens 1970).  Soon after, in 1981 
pluripotent mouse embryonic stem cells, isolated from in vitro cultures of mouse 
blastocysts, were established and propagated in vitro cultures by Evans and Kauffman  
(Evans & Kauffman 1981).  The mESC displayed normal karyotypes and proved their 
pluripotent status in vivo, in inoculated mice and in vitro; with the capacity to 
differentiate into tumours consisting of derivatives of all 3 germ layers (ectoderm, 
mesoderm and endoderm) responsible for giving rise to all cells in the body (Evans & 
Kauffman 1981).  Subsequent advances made in the understanding of mammalian 
development were made possible by the ability to culture and genetically manipulate 
mESC derived mouse embryos, as models of mammalian development and tools to 
study gene expression (Bradley et al. 1984).  
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1.2 Human embryonic stem cells 
 
Murine studies paved the way for the first human embryonic stem cell (hESC) 
derivation in the 90’s.  Human embryonic stem cells were first extracted from the inner 
cell mass of donated in vitro fertilization (IVF) embryos cultured to the blastocyst 
stage (Thomson et al. 1998).  The resulting stem cells were co-cultured on mouse 
embryonic fibroblasts (MEF) and exhibited the same characteristics of pluripotency as 
their murine counterparts (Thomson et al. 1995).  hESC exhibit pluripotency through 
their ability for prolonged undifferentiated proliferation in vitro, the potential to 
differentiate into all 3 embryonic germ layers in embryoid bodies and through teratoma 
induction on injection into severe-combined immunodeficient (SCID) beige mice 
(Thomson et al. 1998).   
The clonal derivation of new stem cell lines from H9 stem cells, which were 
propagated in continuous culture for over 6 months, proved the ability of hESC to 
maintain pluripotency and their property of self-renewal whilst maintaining normal 
karyotype over long periods (Amit et al. 2000).  The hESC derivative lines showed the 
same properties of pluripotency as their parental line, demonstrating true potential for 
scalability.  Thus securing the idea that hESC derivatives deserve practical 
consideration for future clinical applications.  In order for hESC research to gain 
continued support the defining properties of stem cells required detailed 
characterisation and elucidation of the underlying molecular mechanisms.  To this aim, 
the discovery of key genetic markers for stage specific early differentiation of hESC 
helped track differentiation from pluripotency to the three germ layers and have been 
important in enabling research to follow cells at different stages of development 
(Itskovitz-Eldor et al. 2000).  
Attempts to unravel the key factors and pathways responsible for driving self-renewal, 
pluripotency and differentiation have benefitted from global transcriptional profiling 
techniques.  The key involvement of ligands, receptors and secreted inhibitors of the 
FGF, TGFβ/BMP and canonical Wnt pathways for the maintenance of pluripotency 
were identified by transcriptional profiling studies which found 918 genes enriched in 
pluripotent hESC, these pathways have subsequently been shown to be responsible for 
retaining pluripotent states in hESC (Sato et al. 2003; Vallier & Pedersen 2005; Xu et 
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al. 2009; Vallier et al. 2009).  Pharmacological inhibitors has also played an important 
role in identifying key components of signalling pathways involved in maintaining 
pluripotency.  The potent inhibitor of Glycogen Synthase Kinase  (GSK-3), 6-
bromoindirubin-3’-oxime (BIO) also demonstrates the importance of the Wnt pathway 
in maintaining self-renewal and pluripotency for both hESC and mESC; through BIO’s 
ability to control pluripotency by reversible activation of the Wnt pathway (Sato et al. 
2004).   
With the discovery of chemical inhibitors such as BIO, the removal of animal 
components from hESC cultures has become a popular concern and goal as research 
edges toward the goal of clinical application.  It is the difficulty in precisely 
quantifying the effects animal components have on mechanisms governing 
pluripotency and differentiation, which have spurred research efforts to oust MEFs and 
other xenogeneic factors from stem cell maintenance and differentiation protocols 
(Amit et al. 2004).  Early attempts to create animal-free hESC cultures succeeded in 
reducing the risk of exposure to animal pathogens by firstly removing dependency on 
animal derived serum (Amit et al. 2000).  Removal of mouse embryonic fibroblast 
feeder layers from the hESC cultures followed soon after (Amit et al. 2004).   Together 
developments in removing animal components offer an opportunity for providing more 
defined micro-environment for stem cell culture, to enable better process control and 
reproducibility.   
There is however a lack of consensus over optimal culture conditions (Table 1.1) and 
these have prompted efforts to standardise embryonic stem cell culture procedures 
starting with better characterisation of stem cell lines.  ‘The International Stem Cell 
Initiative’ was set up to collate data from 17 laboratories across the globe, in an effort 
to  characterize 59 human embryonic stem cell lines (Adewumi et al. 2007).  The 
resulting data allowed researchers to delineate differences in pluripotent cells due to 
inherent genetic variation as opposed to artefacts from variable culture conditions 
(Allegrucci & Young 2007).  Whether this data was used in the creation of the first 
truly chemically defined culture mediums (CDM) for hESCs is unknown but the 
advent of CDMs would surely have helped deduce the key factors responsible for 
pluripotency (Vallier & Pedersen 2008).   
20 
 
 
Table 1.1 Components of conventional culture highlighting motivating factors for the 
development of chemically defined medium (Valamehr et al. 2011).   
 
1.3 The emergence of induced pluripotent stem cells 
Human induced pluripotent stem cells (hiPSC) are human embryonic stem cell-like 
cells  created through reprogramming somatic cells, by driving them to artificially 
express the key factors responsible for a cell’s pluripotent state, as defined by 
Thomson’s seminal work on hESC (Takahashi & Yamanaka 2006; Takahashi et al. 
2007; Thomson et al. 1998).  The emergence of IPSC has, often and reasonably, been 
linked to seminal research on nuclear transfer by Briggs and King from 1952.  They 
showed it was possible to use enucleated eggs for re-nucleation with embryonic cell 
nuclei, to support tadpole development in the amphibian Rana Pipiens (Briggs and 
King, 1952).  This early work lead to the experiments of Professor John B. Gurdon 
who subsequently demonstrated the reversible nature of somatic cell specialisation 
(Gurdon, 1962) in xenopus, so laying the foundations for the later establishment of 
human induced pluripotent stem cells (Takahashi & Yamanaka 2006; Takahashi et al. 
2007). 
The development of nuclear transfer techniques lead to the famously successful 
nuclear transfer of somatic cells into viable oocytes to create Dolly The Sheep in 1996 
(Campbell 1996).  Attempts to apply the approach in humans lead to the successful 
production of human totipotent cells through transfer of somatic cell nuclei from 
human adult thymocytes into enucleated human embryos (Tada et al. 2001).  While 
these cells exhibited great similarities to hESCs,  somatic cell nuclear transfer 
techniques relied on human oocytes and the means of acquiring them by donation were 
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ethically objectionable in the least and morally unacceptable at worst (Meyer 2008; 
Tada et al. 2001).   
To avoid ethical controversy the scientific community has responded by intensifying 
research into alternative approaches to achieve pluripotent status from adult somatic 
cells.  The first iPSCs were obtained from adult mouse fibroblasts by overexpressing 4 
key transcription factors with DNA integrating retroviral vectors for octamer-binding 
transcription factor 4 (OCT4), sex determining region Y box 2 (SOX2), 
myelocytomatosis viral oncogene homologue (c-MYC) and Kruppel-like factor 4 
(KLF4) (Takahashi & Yamanaka 2006).  In 2007, Shinya Yamanaka showed for the 
first time that it was also possible to reprogram human somatic cells using DNA 
integrating retroviral vectors to overexpress the same four reprogramming factors 
(OCT4, SOX2, c-MYC and KLF4) now referred to as the Yamanaka four factors 
(Takahashi et al. 2007). The establishment of human induced pluripotent cells won 
The Nobel Prize in Physiology or Medicine, awarded jointly to Professors John B. 
Gurdon and Shinya Yamanaka in 2012.  By providing an alternate adult source of 
pluripotent cells, human iPSCs eliminate dependence on the ethically objectionable 
use of human embryos to derive pluripotent stem cells (Meyer 2008).  Human IPSCs 
promise to provide a potentially infinite source of patient and disease specific cells for 
disease modelling, drug discovery and cellular therapeutics, without the risks of 
immune rejection associated with allogeneic ESC derived cells. 
 
1.4 IPS derivation and culture refinement   
The functional equivalence of IPSCs to hESCs was successfully achieved by 
elucidating the similarities in their mechanisms for maintaining pluripotency and 
controlling differentiation under defined culture conditions (Vallier et al. 2009).  
Research promoting standardisation of stem cell culture supported these efforts with 
the development of a more refined stem cell culture medium in 2011, designed to 
facilitate clinical application of IPS cells.  The commercially available ‘E8’ medium 
system (Life Technologies) is free of animal components and is chemically defined, 
comprising of just 8 essential components (Chen et al. 2011).  Such developments play 
an essential role in the advancement of future therapeutics, especially as international 
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regulatory guidelines governing cellular therapeutics have begun to merge.  
Documents for international guidelines such as the PAS 83 and PAS 93 which try to 
harmonize European and American frameworks together are particularly helpful in 
facilitating international collaborations to accelerate the translation of stem cell 
research to clinical scenarios.  It is likely that regulations may prohibit the use of 
xenogeneic materials in the future as they already recommend the use of defined 
culture mediums where possible (PAS 83 & PAS 93).  Since they offer greater 
visibility over the impact of external factors on the behaviour of stem cells, defined 
culture mediums are an important consideration for any stem cell based research with 
potential clinical applicability (Casaroli-marano & Vilarrodona 2014). 
 
1.4.1 Evolution of integration-free IPSC reprogramming methods 
The first IPSC derivation relied on retroviral transduction of somatic cells which 
required the use of multiple individual viral vectors at high load to deliver the 4 factors 
and resulted in multiple integrations across the genomes of successfully reprogrammed 
cells (Sommer 2009).  The inherent risk of teratoma formation from retroviral 
integration into mammalian DNA and low reprogramming efficiency of (10-4) 
encouraged the development of better reprogramming methods to minimise or avoid 
genomic modifications to the host genome and produce safer, potentially therapeutic 
cells (Takahashi et al. 2007; Zhou & Freed 2009; Tada et al. 2001; Lai et al. 2011).   
The use of lentiviruses to generate IPSCs gained popularity for the ability to transfect 
proliferating cells in addition to non-dividing cells, which increased their 
reprogramming  efficiency by 10-fold compared to retroviruses (Sommer 2009).  The 
most commonly used lentiviral system is the single cassette reprogramming vector, 
engineered with a Cre-Lox mediated transgene excision mechanism, to enable 
clearance of integrated sequences from successfully generated IPSCs (Soldner et al. 
2009).  The humanised version of the vector ‘STEMCCA’ has reprogramming 
efficiencies between 0.1-1.5% (Somers 2010) but as a lentiviral system, still involves 
the risks of genomic integration and insertional mutagenesis (Walia et al. 2012).   
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1.4.2 Non-integrating virus IPSC reprogramming 
Adenoviral vectors expressing c-Myc, Klf-4, Sox2 and Oct4 have been used to 
successfully reprogram human somatic cells without transgene integration (Stadtfeld et 
al. 2008).  The system has also been used to produce IPS cells which were further 
differentiated to produce dopaminergic neurons (Zhou & Freed 2009).  However, 
adeno viral vector based reprogramming is less popular, most likely to be due to 
reportedly very low efficiencies of reprogramming and the requirement for multiple 
infections (Zhou & Freed 2009).  
The Sendai virus, a negative sense single stranded RNA virus, offers an added 
advantage that it does not enter the nucleus and is therefore unable to integrate into the 
host genome (Faísca & Desmecht 2007). Sendai virus vectors therefore have become a 
popular approach to induce expression of exogenous pluripotency genes as RNA 
transcripts in somatic cells and produce transgene free IPS cells (Fusaki et al. 2009).  
Since its establishment in 2009, the Sendai virus vector method has been modified to 
include temperature-sensitive mutations in the virus to facilitate viral clearance post 
reprogramming by altering culture temperature (390C) (Ban et al. 2011).   
 
1.4.3 Non-viral reprogramming 
Non-viral mechanisms for reprogramming include the host factor independent 
PiggyBac (PB) and Sleeping Beauty (SB) transposition methods.  These transposons  
introduce doxycycline inducible transcription factors in PB or SB transposons that are 
self-excised post reprogramming, by the inducible expression of transposase enzymes 
(VandenDriessche et al. 2009; Woltjen 2009).  Advances in recombinant transposase 
design, have also shown modification of PB transposition activity can be used to  
reduce the risk of damage to the host genome from potential PB transposon re-
mobilisation (Meir et al. 2013).  Despite efforts to make transposon based techniques 
safer, they still entail risks of genomic recombination and insertional mutagenesis 
making them less attractive than integration free methods (Warren et al. 2010). 
Direct delivery of reprogramming proteins has also been a successful method of 
reprograming as demonstrated in mouse fibroblasts (Kim et al. 2009) and human 
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fibroblasts (Zhou et al. 2009).  Challenges associated with producing sufficient 
quantities of bioactive proteins with long enough half-lives, able to cross the plasma 
membrane for efficient reprogramming, make this a troublesome method that requires 
further development (Lai et al. 2011). 
The evolution of non-viral and non-integrating techniques have also given rise to a 
method of reprogramming by transient overexpression of episomal plasmids encoding 
the reprogramming factors, but the low efficiency of reprogramming has made this less 
popular than other techniques (Okita et al. 2011).  Similarly, reprogramming by 
mRNA transfection of the Yamanaka factors has shown great promise as a non-
integrating, non-mutagenic method in which synthetic mRNAs complexed with 
cationic compounds to stimulate uptake by endocytosis are also able to inhibit innate 
anti-viral immune responses (Warren et al. 2010).  Transient overexpression of 
episomal plasmids has been used to improve reprogramming efficiencies of human 
fibroblasts from 1.4% in 20 days to 4.4%.  This was achieved by culturing the cells at  
5% O2 with medium containing the histone deacetylase inhibitor, valproic acid, the 
original four reprogramming factors and additional reprogramming factor Lin28 
(Warren et al. 2010; Yu et al. 2007).  There major different techniques for 
reprogramming in use have varying degrees of efficiency and inherent risks of 
integration as summarised in Table 1.2. 
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Vector Method 
Genomic 
Integration Factors(d) 
Reprogramming 
efficiency in 
human 
fibroblasts(e) Reference 
Virus Retroviral + OSKM ++++ 
Takahashi  
2007 
 
Lentiviral + OSKM +++ Yu 2007 
 
Adenoviral - (a) OSKM + Zhou  2009 
 
Sendai virus - (b) OSKM ++++ Fusaki  2009 
DNA Episomal Plasmid - (a) OSKMNLT + Yu 2009 
 
Transposon - (a,c) OSKM ++ 
Woltjen 2009 
& Kaji 2009 
 
Minicircle - (a) OSNL + Jia 2010 
RNA RNA - OSKM +++ Warren 2010 
Protein 
Cell transparent 
protein - OSKM + Kim 2009 
 
Table 1.2 Comparison of methods for induction of pluripotency to highlight genomic integration risks 
relative to reprogramming efficiencies.  Adapted from (Okita & Yamanaka 2011)  
(a) Absence of genomics integration should be experimentally determined. 
(b) Absence of virus genome should be experimentally determined. 
(c) Transposon vector integration into genome is reversible. 
(d) O: OCT3/4; S: SOX2; K: KLF; M: C-MYC; N: NANOG; L: LIN28; T: SV40-large T antigen 
(e) + <0.001%; ++ <0.01%; +++ <0.1%; ++++ >0.1% 
 
1.5 hiPSC Characterisation 
While both hESC and hiPSC cells have the potential for unlimited proliferation and 
differentiation to produce cells for therapeutic use in vast quantities, only hiPSC can be 
used for autografts or to mass produce recipient Human Leukocyte Antigen (HLA) 
matched therapies to minimise the risk of an immune response and reduce the 
requirement for immunosuppression (Ilic & Stephenson 2013).  Considering this 
potential benefit to medicine and despite a lack of consensus over standards for hiPSC 
characterization, IPS cell banks are emerging around the world.  Most famously, 
Yamanaka has plans to accrue 75 hiPSC lines to provide sufficiently close-matched-
HLA haplotypes for 80% of the Japanese population (Cyranoski 2012).   
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Without a unified and comprehensive reference for characterisation that each cell bank 
must adhere to, most researchers seek compliance with guidelines set by local 
governing bodies such as the Food and Drugs Administration (USA) or the European 
Medicines Agency.  In 2010 the International Stem Cell Banking Initiative (ISCBI) 
was created to compile and collate a report stating the case and necessity for 
standardised characterisation of stem cells (Crook et al. 2010).  Several stem cell banks 
were involved in the project globally (Table 1.3) but the success of the ISCBI has yet 
to be ascertained.  The lack of consensus in the methods for characterisation of 
pluripotent stem cells, has surprisingly not restricted the approval of clinical trials 
using cell therapeutics derived from hESCs/iPSCs and these are currently required to 
comply with regulations for clinically compliant biologics (Devito et al. 2014). 
 
 
Table 1.3 International stem cell banks in the International Stem Cell Banking Initiative 
(ISCBI) adapted  from (Crook et al. 2010). 
 
To date one of the closest practical solutions for harmonizing pluripotent stem cell 
characterisation attempts is a novel gene expression real time PCR assay, the ‘TaqMan 
hPSC Scorecard’ (Life Technologies).  The scorecard compares 94 qPCR assays per 
sample to a reference set of functionally validated hESC and IPSC lines to detect 
genomic signatures of self-renewal and differentiation (Fergus et al. 2014).  This 
approach will push progress towards understanding the genetic changes induced during 
reprogramming and routine culture.  Though it does not detect epigenetic changes.  
Combining a qPCR approach with DNA methylation analyses and medium-resolution 
array-comparative genomic hybridization would help bring more resolution to the 
characterisation of pluripotency at the genetic and epigenetic levels closer to 
standardisation for hESC and hiPSC (Ilic & Stephenson 2013).   
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The altered epigenetic or genomic states unique to each hiPS or hES cell line which 
affect their differentiation propensities and have the potential to impact their safety for 
clinical application (Osafune et al. 2008).   
To help address these concerns the use of genome-wide reference maps of DNA 
methylation and gene expression derived from comparisons across 20 hES and 12 hiPS 
cell lines could be used to facilitate better characterisation of pluripotent cells 
according to their propensities to differentiate into each of the germ layers (Bock et al. 
2011).  Such an approach would help ensure directed differentiation techniques use the 
most relevant cell line for their target cell type and reduce cell line specific variability 
(Pal et al. 2009).  Genome-wide reference maps could pave the way for an 
internationally recognised consensus to aid standardised characterisation of pluripotent 
stem cells at the genetic and epigenetic levels.  Standardisation in this way, may be 
useful to ensure pluripotent cells intended for directed fate specification toward 
therapeutic cell types, begin differentiation from a common well characterised start 
point (Buta et al. 2013).   
Genetic reference maps may also help to predictively identify inherent cell line 
specific differentiation biases to enable the selection of suitable cell lines to ultimately 
improve reproducibility, reduce risk and increase process and product knowledge in 
stem cell differentiation dependent bioprocesses.  In the absence of a set of genetic 
reference maps, the first stage of stem cell differentiation, study of the embryoid body 
stage also provides a method to characterise stem cell lines according to differentiation 
propensities (Moon et al. 2011) 
  
1.6 Stem cell differentiation with embryoid bodies 
 
Stem cell differentiation processes are susceptible to variability from many sources in 
addition to that conferred by the individual cell lines selected for expansion and fate 
specification.  A major source of variability in stem cell differentiation protocols 
comes from the first stage of initiating differentiation, the embryoid body (EB) 
formation stage (Doetschman et al. 1985; Rungarunlert et al. 2009).  Both mouse and 
human ESC as well as fibroblast derived IPSC undergo spontaneous differentiation 
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when cultured in suspension without anti-differentiation factors, to form three 
dimensional aggregates or EBs, that follow patterns of development reminiscent of 
early embryogenesis (Keller 1995; Thomson et al. 1998; Itskovitz-Eldor et al. 2000; 
Takahashi et al. 2007; Takahashi & Yamanaka 2006; Doetschman et al. 1985).     
The transformation of pluripotent stem cells begins with trophoectoderm formation, 
followed by primitive endoderm specification progressing to definitive embryonic 
tissue formation at the later stage of gastrulation, to give rise to each of the three germ 
layers; the predecessors of all human adult tissues (Keller 2005; Hua & Sidhu 2008).  
Fine changes in the temporal balance of TGFβ/Activin/Nodal and BMP within EBs 
are responsible for orchestrating the transgression from pluripotency through 
differentiation toward each of three germ layers ectoderm, mesoderm and endoderm 
(Vallier et al. 2009; Hong et al. 2011; Zhang et al. 2008).  The germ layer cell 
populations are dynamic in their nature as evidenced by their heterogeneous marker 
expression which has resulted in an alternate nomenclature to encompass these 
characteristics with the terms ‘primitive ectoderm-like’ cells, ‘mesendoderm-like’ 
cells and ‘extra-embryonic endoderm-like’ cells (Kopper et al. 2010).   
The formation of EBs in vitro presents the challenge of identifying the influence of 
EB formation techniques on differentiation propensity with large discrepancies 
between EBs cultured in static versus hydrodynamic environments (Yirme et al. 
2008).  Different EB formation techniques show that the relationship between EB 
size and differentiation toward specific cell lineages exists albeit cell-line specific  
(Hwang et al. 2009).   
 
1.6.1 EB formation size control 
 
The techniques available for EB formation have developed greatly since the original 
method of simply scraping stem cell colonies for suspension culture (Thomson et al. 
1998)(Figure 1.1).  Early attempts to control EB size include seeding stem cells in 
micromass culture conditions in 24 well tissue culture plates, hydrophilic petriperm 
dishes,  semisolid mediums such as methylcellulose or hanging drops of medium 
followed by suspension culture in static or orbital bacterial shaken bacterial grade 
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cultures dishes (Doetschman et al. 1985; Dang et al. 2002).  For human stem cells, 
using volume controlled drops of medium to culture precise numbers of stem cells for 
EB formation improved EB size reproducibility at the cost of laborious manual 
handling and limitations to small EB sizes more suited to mouse EB culture (Dang et 
al. 2002).  EBs have also been formed reproducibly in agarose hydrogel capsules 
(Dang et al. 2004).   
Yirme’s work showed expansion of hEBs can be improved using dynamic culture 
conditions.  Compared to 4-fold expansion of hEBs in static culture conditions, fold 
expansion in Erlenmeyer flasks was reported at ~5-fold, whilst glass boll bulb shaped 
impeller spinners showed ~6.25 fold hEB expansion levels.  In contrast paddle 
impeller flasks and stirred tank bioreactors had diminished capacities to propagate EBs 
due to higher percentages of apoptosis which brought their fold expansion levels to 
below 3-fold (Yirme et al. 2008).  Other reports have also showed stirred tank 
bioreactors to provide 10-fold increases in neural differentiation using hESCs (Serra et 
al. 2009).  Stirred tank lateral vessels (STLV) and high aspect ratio vessels (HARV) 
have also been reported to improve yields of EBs 3-fold in comparison to static 
cultures (Gerecht-Nir et al. 2004). 
Although improved yields are indeed possible with the use of bioreactors the large 
volumes required can be prohibitively costly and so research into smaller scale 
hydrodynamic cultures have yielded important findings.  In particular the work 
Carpenedo et al showed rotary suspension culture on orbital rotary shakers can provide 
a 20-fold improvement in cell numbers incorporated into EBs compared to static 
conditions (Carpenedo et al. 2007).  Comparing scalable EB production systems 
considering spinner flasks, stirred tank bioreactors and slow turning lateral culture 
vessels, seeded with EBs formed as stem cell clumps or single cells in suspension has 
also demonstrated that adding pre-formed EBs to hydrodynamic environments offers 
the most homogenous scalable production systems (Kurosawa 2007).  
To produce reproducible sized EBs from human pluripotent stem cells it is now 
possible to utilise cost-effective equipment such as ultra-low attachment V-bottom 96-
well plates, seeded with precise numbers of stem cells for size-controlled EBs (Sakai et 
al. 2011). Though cost-effective, the use of low attachment 96-well plates, confines 
experiments to 96 EBs per plate and therefore has a relatively large footprint which 
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can be prohibitive for higher throughput studies.  To date the most popular method for 
EB production builds on this simple technique, by the microfabrication of precisely 
sized and shaped microwells from cell-repellent, poly (ethylene glycol) (PEG) (Karp et 
al. 2007).  Microwells offer the possibility to produce thousands of uniform sized EBs 
in a reproducible fashion, to support higher throughput investigations into the initiation 
of differentiation from EBs  in controlled microenvironments  (Karp et al. 2007).   The 
technology for producing large numbers of EBs was developed for commercial 
availability as Aggrewell Plates (Stemcell Technologies) and has been proven using 
hESCs to form spatially and temporally synchronised EBs (Ungrin et al. 2008) which 
enable the reproducible production of size-controlled EBs discussed further in Chapter 
3. 
 
 
Figure 1.1 Common methods for EB formation adapted from (Kurosawa 2007). 
 
 
1.6.2 Differentiation biases and the role of size control in EBs 
 
Inherent differences between cell lines for germ layer biases, have also been 
demonstrated in HUES-9 and HUES-7 cell lines, which show different propensities to 
develop neuroectodermal tissue and mesoderm/ endodermal specification respectively 
(Pal et al. 2009).  Independently derived pluripotent stem cell lines can also have 
unique differentiation properties due to hESC cell derivation or IPSC reprogramming 
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techniques but the mechanisms responsible for these are not yet fully understood.  In 
addition to biases from cell derivation or cell line specific variability, the size of EBs 
also impacts their differentiation profile and several studies have demonstrated the 
introduction of developmental biases for specific germ layer lineages through 
controlled modulation of EB size (Bauwens et al. 2008; Côme et al. 2008a; Choi et al. 
2010).  
Although EB differentiation can be influenced by modulation of the microenvironment 
or physical parameters such as EB size, there is no established ideal ratio for EB size to 
germ layer bias which is independent of cell line variability or the heterogeneity within 
stem cell culture techniques or colonies of the same cell line (Lim et al. 2011; 
Bauwens et al. 2008).  The influence of EB size on germ layer specification can be 
dependent on the ratio of endoderm-gene-expressing to neuroectoderm-gene-
expressing cells in the parent hESC colonies used to make them (Bauwens et al. 2008).     
Nutrient mass transfer rates, availability of soluble factors along concentration 
gradients and oxygen diffusion to inner cells, are all affected by EB size and are 
contributing factors in influencing differentiation.  The difference in internal oxygen 
concentrations between EBs of different sizes has been demonstrated by  showing, 
EBs with diameters of 200µm can have 50% higher oxygen concentrations in their 
centres than EBs with diameters of 400µm (Van Winkle et al. 2012).   EB size also 
influences early fate specification and the ability to form homogenous populations of 
cells in each of the germ layers (Carpenedo et al. 2007).   
By manipulating EB size it has also been possible to accelerate differentiation with one 
study reporting a 2-fold increase in the yield of target endothelial cells as a result of 
tight control over EB size (Moon et al. 2014).  In the same report EB size control was 
also used as a tool to counteract inherent cell line specific differentiation propensities; 
in 2 cell lines (H9 and CHA15) by finding unique optimal EB sizes for the same 
differentiation protocol for each cell line (Moon et al. 2014).  The control of EB size 
has been shown to be important in helping to establish reproducible and reliable 
systems for stem cell expansion as well as in differentiation processes to therapeutic 
cell types such as β cells and retinal cells (Hwang et al. 2008; Yanai et al. 2013; 
Mfopou et al. 2010).   
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The potential influence of EB size is therefore an important factor to consider in 
attempts to influence differentiation (Andres M. Bratt-Leal, Richard L. Carpenedo 
2009).  Rotary orbital suspension culture methods have been used as a tool for 
investigating the impact of EB size in murine EBs; altering orbital shaking speeds 
impacts both EB size and differentiation profiles (Sargent et al. 2010).  The ability to 
control EB size through orbital shaking also facilitated fundamental studies analysing 
the hydrodynamic environment after removing the influence of EB size by keeping 
them constant (Kinney et al. 2012).  The individual and combined effects of EB size 
and orbital shaking on differentiation are discussed in more detail in chapters 4 and 5.   
 
1.7 The case for orbitally shaking culture systems for retinal 
differentiation 
 
Adherent or planar monolayer cultures are still the most commonly used platforms for 
stem cell differentiation cultures due to the ease of use of 2D tissue culture plastics.  
Though 2D tissue culture plastics are established well characterised culture systems, 
cell culture in them lacks mixing and is prone to the accumulation of soluble factor 
gradients in specific locations within the culture.  Extracellular matrices, co-culture 
techniques and synthetic scaffolds can be used to build stem cell niches able to 
immobilise exogenous factors, but without mixing the formation of concentration 
gradients of these and other nutrients is inevitable (Hazeltine et al. 2013). 
Suspension protocols for retinal differentiation were first demonstrated by Dutt et al. 
2003.  Their work differentiated a human retinal progenitor (KGLDMSM) and an 
epithelium cell line (D407) on Laminin coated Cytodex 3 micocarrier beads 
(Parmacia) in a NASA developed lateral rotating wall bioreactor to produce 
photoreceptor-like cells (Dutt et al. 2003).  The same group also found retinal 
progenitor cell lines co-cultured with a retinal progenitor epithelial (RPE) cell line 
(D407) could be induced to differentiate into Nrl+ photoreceptors in a 3D rotary 
culture, with conical flasks on a shaker at 90rpm in 10 days demonstrating the 
feasibility of retinal differentiation in dynamic cultures (Dutt & Cao 2009).   
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The first report of EB culture on orbital shakers was described by (Carpenedo et al. 
2007) who showed orbital shaking of mouse EBs in bacterial grade culture dishes on 
orbital rotary shakers between at rotational frequencies of 25, 40 and 55 rpm provided 
a hydrodynamic environment which improved the homogeneity of EB size, shape and 
gene expression.  Improved efficiency of stem cell expansion as well as EB formation 
compared to hanging drop techniques were also reported.  Though the orbital diameter 
and fluid flow regimes are not reported the authors described a 20-fold increases in 
numbers of cells incorporated into EBs compared to static cultures and found EB 
differentiation toward germ layers was accelerated (particularly for endoderm) and 
more homogeneous (Carpenedo et al. 2007).   
A comparison of controlled-size EBs cultured within different hydrodynamic 
environments has also been demonstrated to produce clinically relevant quantities of 
mesodermal derived cardiac cells from hESCs (Niebruegge et al. 2009).  Comparing 
EB cultures on static dishes with EBs cultured in dynamic systems (orbitally shaken 
dishes – with ultra-low attachment plates on a Rotomix shaker at 50rpm, roller bottles 
on a Barnstead rotisserie system, stirred suspension cultures in DasGip cell-ferm pro 
spinners systems with a glass bulb spinner and culture within a bellco spinner fitted 
with a paddle spinner) the authors demonstrated cardiomyocyte generation was higher 
in dynamic systems.  The best improvement was found in glass bulb equipped spinner 
system (5 fold ± 2.8) (Niebruegge et al. 2009) but it is unclear how the orbital shaken 
experiments were optimised and the flow regime within them was not reported. 
A more detailed impact of varying the hydrodynamic environment is presented by 
(Sargent et al. 2010) where rotary orbital suspension culture of mESC derived EBs was 
demonstrated to influence EB cellular organisation, morphology, kinetic profile of 
gene expression and derivative cell types from differentiation.  The authors formed 
EBs from single cell suspensions on an orbital shaker (orbital diameter 0.19mm, fluid 
height 1.27mm, vessel diameter 100mm – bacterial grade polystyrene dishes) and 
varied shaking speeds between 20 and 60rpm for 7 days of culture.  The computational 
fluid dynamics approaches employed allowed characterize the EB distribution patterns 
with varying shaking speeds and the corresponding shear stresses produced by the 
hydrodynamic environments created (Sargent et al. 2010).  Their analysis of the shear 
stress by CFD showed these increased with increasing rotary speeds and were highest 
at the edges (< 11dyn/cm2) of the vessel but also showed at higher speeds the EBs 
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tended to occupy regions closer to the centre of the well and didn’t experience shear 
rates above 2.5 dyn/cm2 suggesting higher shaking frequencies could have been 
tolerated (Sargent et al. 2010).  
The work of (Sargent et al. 2010) was further developed with a systematic analysis of 
differentiating forced aggregation formed EBs of uniform size, in different orbitally 
shaken hydrodynamic environments (25, 45 and 65rpm) over a 14 day culture period.  
The authors describe the impact of mixing conditions on EB morphogenesis and found 
morphological biases developed according to the rotary speeds used, namely 
agglomeration at 25rpm, while 45 and 65rpm cultures maintained EBs as individual 
entities.  However, only subtle variations between their gene expression profiles were 
observed which could be attributed to the different shaking regimes for example  
differential temporal expression of mesodermal marker Nkx2.5 between the 45 and 
65rpm peaked at days 7 and 14 respectively (Kinney et al. 2012).  These results while 
conducted in mouse EBs show that different shaking regimes can indeed influence EB 
differentiation when EB size is removed as a factor. 
More recently suspension stem cell culture techniques have developed alongside new 
differentiation protocols, such as the static suspension culture method used to 
differentiate mESC into self-forming optic cups, as developed by the Sasai lab (Eiraku 
et al. 2011).  The same approach was also successful in producing hESC derived self-
forming optic cups (Nakano et al. 2012) and hiPSC initiated optic cup derived 
functional photoreceptors (Zhong et al. 2015).  Unlike Dutt’s protocol the Eiraku, 
Nakano and Zhong experiments were all carried out under static conditions and may 
benefit from the introduction of orbital shaken culture to improve scalability and 
reproducibility.  In summary the orbital shaken and retinal cell differentiation 
experiments discussed above demonstrate the feasibility of introducing dynamic 
suspension environments to these cultures.  In particular with the advent of suspension 
protocols yielding self-forming optic cup derived photoreceptors there is a need to 
develop reliable bioprocesses to cater for research in this field and potential therapeutic 
cell manufacturing processes.  It follows then that a demonstration of the feasibility of 
differentiating retinal cells in a dynamic culture system with potential for scale such as 
the orbital shaking microwell system, is required and forms the inspiration for the 
work in this report.   
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1.8 Engineering and flow characteristics of shaken microwell 
systems  
 
In order to appreciate the background of the impact of orbital shaking in the cultures 
discussed in this thesis, an understanding of the behaviour of liquids or flow dynamics 
within shaken microwell systems as well as an overview of the engineering 
characterisation of microwell bioreactors used for the culture system would be 
beneficial.  Consequently the following section aims to provide an overview of the 
fundamental principles involved in terms of the engineering of shaken microwell 
systems and the flow dynamics within them. 
Bioreactors are commonly used for high throughput screening and bioprocess 
development in mammalian cultures and include shaking tanks, flasks or microtitre 
plates with nominal volumes from litres to microliters.  Of these bioreactors, microwell 
plates offer multiple uniform wells for parallel experiments at low volumes that can 
inform process design strategies and are found in formats with 24, 28, 96, 384 and 
even 1536 wells (Sigma Aldrich).  The reduced volumes offered by microwell plates 
are necessary to lower material and labour costs from conventional scale culture 
options which are impractical for process development (Girard et al. 2001). 
Microwell bioreactors allow for speedier process development times and are 
commonly used for process optimization and screening with shaking platforms instead 
of mechanically stirred bioreactors which have comparatively reduced scope for 
parallelization typically being capable of running between only 4 and 48 experiments 
together (Puskeiler et al. 2005; Gill et al. 2008).  Microwell plates can also be readily 
incorporated into automation systems to deliver important process design 
considerations at the lab-scale making them a useful choice for developing new and 
optimising existing bioprocesses (Lye et al. 2003; Micheletti & Lye 2006).  An added 
advantage for microwell platform cultures is their ability to readily incorporate 
complex operating strategies including liquid handling and for pH control as described 
for microwell fermentations of S. erythraea CA340 (Elmahdi et al. 2003).  The 
implementation of automation for microwell culture and differentiation of mouse 
embryonic stem cells also highlights their potential utility for high throughput stem 
cell process development applications (Hussain et al. 2013).   
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The fundamental principles underpinning the suitability of shaken microplates for stem 
cell culture bioprocess development, can be described by engineering characterisation 
of their environment, which can be used for selecting optimal culture conditions.  The 
engineering characteristics considered below include oxygen transfer, power input, 
phase of operation, hydromechanical stress and mixing regimes (Klöckner & Büchs 
2012).   
Oxygen transfer 
Sufficient oxygen mass transfer between the gas and the liquid phase at the surface of 
the culture medium is required for the cells in culture systems to be supported for cell 
survival and growth.  The oxygen transfer rate OTR (mM L-1 h-1) between the gas and 
liquid phase is usually defined as: 
𝑂𝑇𝑅 = 𝑘𝐿𝑎 (𝐶𝐿
∗ − 𝐶𝐿) =  𝑘𝐿𝑎 (𝑝𝑂2 . 𝐿𝑂2 −  𝐶𝐿 )       (1) 
Where kL (m/s) is the mass transfer coefficient, a is the volume specific transfer area 
(making 𝑘𝐿𝑎 the volumetric gas liquid mass transfer coefficient). 𝐶𝐿
∗ and 𝐶𝐿 are the 
oxygen concentration in the saturated gas-liquid interface and the bulk phase 
respectively, 𝐿𝑂2 is the oxygen solubility of the culture medium and 𝑝𝑂2the oxygen 
partial pressure in the headspace of the culture vessel (Klöckner & Büchs 2012). From 
the above equation when the 𝑝𝑂2in the headspace is equal to that of air (0.2095 bar), 
for maximum OTR, 𝐶𝐿 can be considered as = 0 to give: 
𝑂𝑇𝑅𝑚𝑎𝑥 =  𝑘𝐿𝑎 . 𝑝𝑂2 . 𝐿𝑂2     (2) 
In this equation 𝑘𝐿𝑎 is fundamental and changes for different vessel geometries as well 
as with differing material properties of the vessel and the operating parameters such as 
fill volumes, shaking diameter and shaking frequency.  Using a model sulphite 
oxidation system (Hermann et al. 2003) were able to characterize oxygen transfer in a 
single well of a 96-well microwell plate.  By studying different shaking frequencies 
(up to 1000l/min) with different shaking diameters (3-50 mm) and filling volumes 
(140-200μl) they found that (OTRmax) is primarily influenced by the specific mass 
transfer area (a) in round-shaped wells.  The mass transfer area (a) or the liquid surface 
was also found to be influenced by the surface properties of the vessel material and by 
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the interfacial tension of the medium which could be modulated by altering the shaking 
intensity by changing the shaking diameter.  The group also demonstrated that for a 
single well of a standard flat bottom round 96-well plate, in order to improve OTRmax it 
is first necessary to provide sufficient centrifugal force to the system to break the 
surface tension of the medium.  To cause any liquid movement shaking frequencies 
must exceed a critical value (ncrit) which can be determined by equation (3) (Hermann 
et al. 2003): 
𝑛𝑐𝑟𝑖𝑡 =  √
𝜎 .  𝐷𝑤
4 .𝜋 .𝑉𝐿 .𝜌𝐿.𝑑𝑂
       (3) 
where 𝑛𝑐𝑟𝑖𝑡 is the shaking frequency, 𝜎 (N/m) is the surface tension, 𝐷𝑤 (m) is the well 
diameter, 𝑉𝐿 (m
3) is the vessel fill volume and 𝜌𝐿 (Kg/m
3) is the density of the liquid.  
The observations of a complete lack of liquid movement below the 𝑛𝑐𝑟𝑖𝑡 is specific to 
the properties of microwell plates and do not hold true for larger vessels such as shake 
flasks where the surface properties of the flasks have been shown not to influence 
power consumption in the system (Buchs et al. 2000).  Additionally the reliability of 
equation 5 was questioned when  application of formula (3) to the geometries of 24-
well plates provided an 𝑛𝑐𝑟𝑖𝑡= 23rpm while the experimentally determined range 
reported was determined to be between 120-300rpm (Barrett et al. 2010).    
Alternative approaches for 𝑘𝐿𝑎 calculations for microbial fermentation cultures in 24, 
96 and 384 microwell plates were presented by (Doig et al. 2005) which eliminated the 
requirement for volume specific correlations by utilising Buckingham’s 𝜋 theorem and 
dimensionless groups to calculate 𝑘𝐿𝑎.  The group also showed that although kLa 
values may be calculated at acceptable values for a given system, insufficient mixing 
can still lead to oxygen deficient regions at the microwell base highlighting the 
requirement for mixing after oxygen enters the gas-liquid interface.  Though the work 
described by  (Doig et al. 2005) was carried out in a microbial system, similar insights 
on the development of nutrient gradients within bioreactors described by (Lara et al. 
2006) highlighted the potential threat these gradients can cause to cells in culture and 
emphasized the importance of sufficient mixing. 
Power input and flow characterisation 
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In shaking cultures the power input influences the fluid flow and therefore mass 
transfer and mixing which make up the hydrodynamic environment (Klöckner & 
Büchs 2012).  Power is usually described as the non-dimensional power number and as 
a function of the Reynolds number which describes whether the fluid flow is in or out-
of-phase (ie. when the fluid either does or does not follow the movement of the 
shaking platform respectively) a description which was first demonstrated by (Buchs et 
al. 2000).  The authors correlated power input and Reynolds number through 
measurement of power consumption from torque and shaking frequency measurements 
in Erlenmyer flasks.  Coupled with a visualisation platform, the data showed fluid flow 
patterns at different operating parameters for vessel size, fill volume, viscosity, 
shaking frequency and shaking diameter (Buchs et al. 2000).  The results produced a 
method to demonstrate that at a particular rotational frequency N, the liquid within the 
vessel is out-of-phase and therefore prone to diminished volumetric power 
consumption and subsequent gas/liquid mass transfer.  A non-dimensional phase 
number Ph was also derived by (Buchs et al. 2000) to identify the two phases and is a 
function of the orbital to flask diameter ratio do/d and the film Reynolds number Ref, 
and the axial Froude number Fra (a dimensionless number describing the ratio of flow 
inertia to the external field at the axis of rotation): 
  𝑃ℎ =
𝑑𝑜
𝑑
 (1 + 3𝑙𝑜𝑔10  (𝑅𝑒𝑓))       (4) 
According to this equation in-phase conditions should occur if Ph > 1.26 but only for 
high shaking frequencies with Fra >0.4 where only a minority of the liquid would be in 
contact with the base of the vessel (Buchs et al. 2000).  To investigate the power 
consumption in cylindrical shaken bioreactors (Klöckner et al. 2012) showed that 
using Buckingham 𝜋 theorem approaches it was possible to calculate the relationship 
between the Newton number Ne and  Reynolds number Re=𝑁𝑑𝑖
2/𝑣, Froude number 
𝐹𝑟 =  𝑁2𝑑𝑖/𝑔, Volume number 𝑉𝑙/𝑑
3 and orbital to cylinder diameter ratio 𝑑𝑜/𝑑𝑖: 
  
𝑁𝑒 = 9 𝑅𝑒−0.17 (
𝑁2𝑑𝑖
𝑔
)
0.42
(
𝑉𝑙
𝑑𝑖
3)
0.44
(
𝑑𝑜
𝑑𝑖
)
0.42
     (5) 
where 𝑑𝑖 = cylinder inner diameter (m), 𝑔 = gravitational acceleration (ms
-2) and 𝑉𝑙 = 
fill volume.  The above relationship enabled the conclusion that the power number is 
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influenced by the orbital to cylinder diameter ratio 𝑑𝑜/𝑑𝑖 in cylindrical vessels but not 
Erlenmyer flasks where the conical shape prevents fluid inclination reducing the 
wetted area while the opposite is true for cylindrical vessels (Klöckner et al. 2012).  
The authors also determined a new formula for the critical shaking speed Ncrit, specific 
to cylindrical bioreactors (equation 6) to identify when centrifugal acceleration is 
higher than the inertial forces within the liquid to enable liquid movement.   
𝑁𝑐 =  
1
𝑑𝑖
2 √0.28𝑉𝐿𝑔      (6) 
To address the fact that high Froude numbers used in (Buchs et al. 2000) are not 
typically associated with mammalian cultures (Weheliye et al. 2012a) performed a 
pioneering  characterisation of fluid flow mechanics at low Froude numbers Fra < 0.4 
in cylindrical bioreactors to derive a flow scaling law independent of the power law 
correlations relying instead on dimensionless physical parameters.  The effect on flow 
dynamics was observed when varying shaken cylindrical bioreactors with inner 
diameter di = 10cm and 13cm and fluid heights h = 3-7cm, orbital diameters do = 1.5-
5cm and shaker speeds N = 60-140 rpm, by interpreting phase resolved particle image 
velocimetry (PIV) with free surface measurements (Weheliye et al. 2012a).  The 
authors described in detail how in-phase, out-of-phase and transitional flow can be 
characterised mostly by observing two counter-rotating vortices near the free surface 
for ∆h/h < (do/di)0.5.  At the critical wave amplitude (∆h/hc) = (do/di)0.5, the vortices 
were observed to increase in size to reach the base of the wells and as rotational speed  
increases these vortices gradually subside to the walls of the vessel before 
disappearing, at which point incipient flow transition leads to an out-of-phase flow 
regime (Weheliye et al. 2012a).   
For in-phase flow characterisation, when the Froude number (defined with the 
characteristic length as the orbital diameter as in equation (7)) Frdo < 0.15 the report 
showed in-phase flow can be approximated from the visualisation of a free surface 
inclined eliptic disc where the longer axis length is in continuously aligned with the 
direction of the gravitational and centrifugal accelerations due to the moving shaker 
(Rodriguez et al. 2013; Ducci, A; Weheliye 2014).   
    
𝐹𝑟 = (
2(𝜋𝑁)2𝑑
𝑔
)    (7) 
40 
 
With increasing rotational speeds N and Frdo, approximation of the free surface is no 
longer possible as the surface takes on complicated three dimensional shapes which 
stray from the scaling law derived by the group.  The scaling law determined from the 
in-phase observations using measurements which showed the inclination of the free 
surface ∆h was proportional to the Froude number as seen in equation (8) below: 
∆ℎ
𝑑𝑖
=  𝑎𝑜 (
2(𝜋𝑁)2𝑑
𝑔
)        (8) 
where the constant of proportionality ao depends on the properties of the fluid and  
deemed to be 1.4 for water (Weheliye et al. 2012a).  This scaling law was further 
developed to account for deviations from in-phase flow operations, to include 
situations with increased rotational speeds N or higher Fr numbers.  Under such 
conditions the toroidal vortices from in-phase operation transition from horizontal to 
an extended vertical toroidal vortex, which reaches the bottom of the vessel close to 
the wall at the shortest side of the free surface and moves around the cylinder axis 
signalling the end of the transition to out-of-phase operation.  (Weheliye et al. 2012a) 
proposed that the flow transition could be predetermined for when h/di > (do/di)
0.5 or 
h/di < (do/di)
0.5 using with the two following equations (9) and (10). 
   
ℎ
𝑑𝑖
= 𝑎𝑜  (
𝑑𝑖
𝑑0
)
0.5
𝐹𝑟𝑑𝑜   (9)    
          𝑎𝑜𝐹𝑟𝑑𝑖 = 1                     (10) 
Equation (9) above for predicting flow regimes was implemental in the work of this 
report, only approximate values were possible due to differences in the inner diameters 
between the vessels and a do/di > 0.6 in this report compared to a do/di between 0.2 and 
0.5 in (Weheliye et al. 2012a) detailed in (Chapter 4.3).  Considering the likely flow 
regimes through theoretical calculations helped select and understand permissive 
shaking frequencies for orbital shaken EB cultures in this report.   
 
1.9 The eye and in vitro retinogenesis as a biological model to 
investigate stem cell differentiation  
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Among the multitude of therapeutic cell types under intense research in stem cell 
labs all over the world, retinal cell generation has been a focal point for several 
reasons.  Apart from the worthy cause and possibility of restoring vision to the 
blind, research on the ocular environment benefits from the advantage of the eye 
being an immunologically privileged site due to its immunosuppressive and anti-
inflammatory properties (Billingham & Boswell 1952).  Ocular immune privilege 
was discovered by transplanting skin grafts into rabbit corneas; to observe no 
immune responses were elicited, provided vascularisation did not occur and led to 
the coining of the term ‘immunologically privileged’ (Billingham & Boswell 1952).  
The later discovery of the phenomenon of anterior-chamber-associated-immune-
deviation (ACAID), a system of active immune regulation with help from 
suppressor T cells, provided further support to secure the ocular environments’ 
status as ‘immune-privileged’(Waldrep & Kaplan 1983).  The eye, is not however a 
perfect system and is still susceptible to auto-immune diseases such as uveitis and 
sympathetic opthalmia, but their rare incidence is evidence for the case of the eye as 
a model system for intervention (Niederkorn & Wang 2005).   
Other factors which contribute to making the eye a particularly suitable organ for 
study and intervention, include its well characterised and evolutionarily conserved 
mechanism of development, its relatively simple structure and the availability of 
cell-specific markers for its constituent cell populations (Gamm & Meyer 2010).  
Importantly, the eye is non-essential to life has ease of surgical accessibility for 
graft characterisation and ablation or removal of problematic cells, tissues or grafts 
making it particularly suitability as a model system for regenerative medicine 
interventions (Heavner & Pevny 2012). 
The majority of inherited retinal disorders and age-related macular degeneration 
(AMD) (one of the leading causes of blindness in the world), share a key feature - the 
ultimate loss of photoreceptors preceding impaired vision even though their aetiologies 
are different (Pearson 2014).  The loss of light sensitive photoreceptors in Retinitis 
Pigmentosa (RP) and Age-Related Macular Degeneration (AMD) cause untreatable 
blindness in their sufferers (Boucherie et al. 2012).  In particular, AMD has been 
designated a priority eye disease as the third leading cause of visual impairment 
worldwide, associated with a blindness prevalence of 8.7%  it is the leading cause of 
blindness in industrial countries (WHO Priority Report, 2015).   
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To date, clinically available treatment options for patients are both limited and unable 
to restore vision.  In contrast, research efforts exploring photoreceptor generation and 
transplantation as a potentially viable treatment option, provide great hope for all 
retinal degenerations (Pearson 2014).  Pioneering proof of principle studies 
demonstrating the integration of hESC derived NRL positive photoreceptors into 
mouse retinae have paved the way for a growing body of researchers now dedicated 
to developing cellular therapeutics for retinal disorders (MacLaren et al. 2006; West 
et al. 2012; Gonzalez-Cordero et al. 2013).  The in vitro differentiation of retinal 
cells from pluripotent stem cells recapitulates the in vivo biological developmental 
processes (Meyer et al. 2009).  An appreciation of the developmental processes 
involved in retinogenesis would therefore be beneficial to understand the parallels 
drawn between the in vitro and in vivo stages of differentiation in the literature on 
retinal cell derivation.  
 
1.9.1 Retinogenesis and photoreceptor development 
 
One of the first reports on vertebrate eye development was published in 1885 and 
localised the beginning of eye development to the anterior medullary grooves in early 
stages of embryonic development (Sharp 1885).  More comprehensive research to 
describe and illustrate development of the vertebrate eye was reported 110 years ago; 
from a collection of direct observations made in the developing Chick embryo they 
provided the first illustrations of the medullary groove and its folds which, over 48 
hours, give rise to the bilateral formation of optic cups (Gradon J.T, 1905).  Decades 
later, a report dedicated to understanding the development of the human eye made the 
first direct observations from the largest collection of human foetuses at the time to 
provide an analysis correlating eye development with embryo length and gestation 
period (Mann I.C, 1928). 
Thousands of researchers have since contributed to the growing number of 
publications attempting to elucidate mechanisms underpinning development of the 
human eye and retinogenesis.  A PubMed search for ‘retinal development’ at the time 
of print returned 22,485 results, making it one of the most studied systems of the 
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human body.  As a result our understanding of eye development has grown rapidly.  
Although all the mechanisms involved retinogenesis are yet to be fully identified and 
understood, many key components or factors directing fate along retinal fates have 
been discovered and are included as exogenous supplements in retinal differentiation 
protocols (Table 1.5).  The current protocols are often complex and efforts to simplify 
them are already underway.  These have led to exciting discoveries using the 
propensity of stem cells to self-form neural retina and retinal pigment epithelium from 
PSCs with minimal external inputs (Eiraku et al., 2011 ; Nakano et al., 2012 ; 
Boucherie et al., 2012 ; Reichman et al., 2014).   
To appreciate the advances which led to the accumulation of differentiation protocols 
directing retinogenesis, a brief description of the main events during retinal 
development follows.  To contextualize in vitro retinal differentiation protocols with in 
vivo processes, to help identify some of the underlying mechanisms and provide the 
rationale for chosen cell markers which feature in the experiments of this report in the 
following chapters. 
Stringent processes of cell discrimination and spatio-temporally defined lineage 
commitments during early development at the onset of organogenesis, are responsible 
for the structural organization of cells into tissues and organs (Lancaster & Knoblich 
2014).  In eye development, finely orchestrated signalling cascades are recruited by the 
anterior neural ectoderm to initiate formation of the medial anterior neural plate, the 
primordium of the forebrain and also the location of the eye field or eye primordium 
(Li et al. 1997).  This eye field forms two bilateral depressions which are known as the 
optic cup primordia (Li et al. 1997; Wilson & Houart 2004).   
The anterior neural ectoderm, responsible for beginning the signalling cascades to 
promote retinal development does so through expression of transcription factors Sex 
Determining Region Y-Box 2 (Sox2) and Orthodenticle Homeobox 2 (Otx2), which 
activate other transcription factors: Retina and Anterior Neural Fold Homeobox (Rax) 
expression and mark the ventral forebrain the prospective eye field;  Rax, in turn 
stimulates expression of the early eye field transcription factors (EFTFs), Sine Oculis 
Homeobox Homolog 3 (Six3), Paired Box Protein 6 (Pax6) and Lim Homeobox 
Protein (Lhx2) (Heavner & Pevny 2012).  The Rax mediated transcription factors, act 
as markers for the early eye field, initiate and orchestrate signalling cascades to specify 
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optic vesicle patterning, during optic vesicle formation from which the optic cup 
primordia are formed.  Retinal progenitor cells here are segregated according to their 
future morphogenic potentials (Heavner & Pevny 2012; Fuhrmann 2010).  Figure 1.2 
shows the complexity of the multi-layered transcriptional control mechanisms 
involved during retinogenesis in normal development (A) and in popularly used retinal 
differentiation protocols (C). 
In vivo, ocular development requires the optic vesicles, made up of retinal stem cells, 
to evaginate and contact the surface ectoderm to begin formation of the lens placode 
(LP) (Heavner & Pevny 2012).  In vitro, however it has also been possible for optic 
vesicles to form the optic cup in the absence of surface ectoderm (Eiraku et al. 2012).  
In contrast in  vivo,  the  optic vesicles begin to invaginate to form optic cups after 
contact with the surface ectoderm (Jayakody et al. 2015).  Before optic cup 
morphogenesis is complete, retinal stem cells within the optic vesicles are 
compartmentalised to provide the presumptive neural retina, retinal pigment 
epithelium and the optic stalk (Heavner & Pevny 2012).   
The invagination of the distal portion of the optic cup provides its double walled 
structure, through simultaneous invagination of the lens placode with the optic vesicle 
(Eiraku et al. 2011).  The resulting optic cup consists of the inner (neurosensory neural 
retina) and outer (pigmented - early retinal pigmented epithelium) layers of the  retina 
(Heavner & Pevny 2012; Kwan 2014).  As an extension of the brain from early 
morphogenesis, the retina is a part of the central nervous system and is the highly 
specialized neural tissue responsible for vision (Tian et al. 2015).  The retina 
consists of 6 cell classes, 5 types of neurons and one major glial cell type the Müller 
cells; arranged into three cellular layers separated by two synaptic layers (inner and 
outer plexiform) in which visual information is analysed in parallel before leaving 
the eye (Dowling 2009).  Further classification of the cells reveals the 5 neuronal 
cell types consist of 3 classifications of cone photoreceptors and one rod 
photoreceptor; 2 types of horizontal cells, 13 bipolar cells, >29 amacrine cells and > 
20 types of retinal ganglion cells which project to the brain via the optic nerve (Tian 
et al. 2015).   
In the developed eye, image acquisition from visual cues begin with the rod and 
cone photoreceptors that first capture photons on their pigmented outer segments to 
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initiate a series of chemical reactions that result in electrical signals which spread 
through >20 neural circuits in the retina before transmission to the brain via the 
retinal ganglion cells (Osakada & Takahashi 2015).  Photoreceptors are primary 
light processing sensory cells essential to vision and are also among the first cells 
damaged during initial degenerative stages of retinal dystrophies such as retinitis 
pigmentosa and age-related macular degeneration(Nowak 2006).  During the early 
stages of degeneration, there is selective sacrifice of first order neurons such as 
photoreceptors, which safeguards the complex neural circuits responsible for higher-
order visual processing, but it is ultimately the malfunction and loss of 
photoreceptors which is responsible for loss of vision (Osakada & Takahashi 2015; 
Curcio et al. 1996).   
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Figure 1.2 (A) Structural features of the developing retina.  (B) Transcriptional control of 
early eye and photoreceptor development and the developmental cascade of genes involved in 
early eye and photoreceptor development.  (C) Key components of major retinal differentiation 
protocols, adapted from (Jayakody et al. 2015). 
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1.10 Cues for directed differentiation of pluripotent stem cells into 
retinal cells 
1.10.1 The importance of the extracellular microenvironment  
 
The evolutionarily conserved mechanisms governing stem cell differentiation are 
responsive to cues from cytoskeletal and extracellular matrix modelling and 
remodelling, physical, physiochemical environmental cues such as temperature, pH, 
oxygen tension and inter and intra-cellular signalling cascades in both paracrine and 
endocrine mechanisms (Kinney & McDevitt 2013; Serra et al. 2012; Azarin & Palecek 
2010).  Stem cell researchers targeting therapeutic cell derivation, aim to generate 
large populations of in vitro differentiated cells for humanised disease models or as 
potential therapeutic transplants.  In the case of retinal cell differentiation protocols,  
evidence for the trend toward research directed at producing larger amounts of cells 
comes from the increasing number of reports citing differentiation efficiencies and cell 
yields(Ikeda et al. 2005; Lamba et al. 2006; Hirami et al. 2009; Lamba et al. 2009; 
Fridley et al. 2010; Meyer et al. 2009; Meyer et al. 2012; Mellough et al. 2012; 
Nakano et al. 2012; Boucherie et al. 2012; Tucker et al. 2013). 
Currently stem cell differentiation protocols use laboratory specific protocols which 
are subject to operator and cell line specific variabilities.  The protocols are further 
complexed by the unique methods for measuring successful differentiation in each 
report.  Difficulties in measuring differentiated populations, arises from a lack of 
sufficient unique and comprehensive biomarkers to represent different stages of 
differentiation effectively and the variability in reported markers.  Without definitive 
markers for referencing various stages of differentiation, protocols are not directly 
comparable making it difficult for regulatory bodies to create a gold standard for 
reporting efficiencies of differentiation.  As a result comparing individual protocols 
and their reported efficiencies of differentiation effectively is still a challenge.   
Maximising differentiation efficiencies and cell yields from directed differentiation 
protocols (discussed further in Chapter 1) is nonetheless a key focus of research, as is 
the study of the roles of the principle components of the microenvironment (depicted 
in Table 1.5).  Academic and industrial interest in the interactions between the 
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parameters of the microenvironment and their impact on stem cell differentiation have 
grown into a research field essential to industrialisation of cell therapies (Manuscript et 
al. 2010; Hazeltine et al. 2013; Hernandez et al. 2011; Christiane & Moens 2013; 
Kinney & McDevitt 2013; Bae et al. 2011; Veraitch et al. 2008).   
For stem cell derived retinal cell generation protocol research, the large number of 
methods use different cell culture techniques in both planar and/or suspension 
culture, some with defined culture medium components, others reliant on 
xenogeneic and undefined materials (Table 1.5).  The majority of retinal 
differentiation protocols use combinations of multiple exogenous factors, at 
different times, for unique durations and in different concentrations, in order to 
recapitulate in vivo cues for retinogenesis in vitro (Table 1.5).  The lack of a 
standardised protocol is likely due to the early stage of research in this field and it 
represents a key challenge to the development of reproducible strategies, amenable 
to development for industrial scale production of retinal cells.  The challenge will 
require a multifactorial approach, prompting research into the unique impact of 
microenvironmental factors. 
The microenvironment can be manipulated by changing the culture surface with 
extracellular matrix or other substrate coatings on tissue culture plastics, to provide 
mechanical support for differentiating cells and a surface for the attachment of 
signalling molecules and exogenous factors which create the stem cell niche (Meng et 
al. 2014).  Another strategy to modulate the microenvironment, involves the use of 
substrates with physiologically relevant Young’s Modulus’ to influence germ layer 
specification in differentiating EBs (Earls et al. 2013).  In addition, UV/Ozone 
radiation of tissue culture plastics has also been shown to enhance expansion of 
pluripotent cells 3-fold in a chemically defined and xeno-free culture system (Saha et 
al. 2011).  Creating hydrophobic culture environments on culture surfaces is also 
implemented to prevent surface attachment with PDMS coating to promote formation 
of size specific EBs (100-300µm) (Valamehr et al. 2008).   
Investigations into other microenvironmental factors during cell processing in stem 
cell cultures include inoculation seeding densities (Fridley et al. 2010; Yirme et al. 
2008; Veraitch et al. 2008), pH (Wilson & McDevitt 2012; Li & Marbán 2010), 
temperature (Veraitch et al. 2008; Ban et al. 2011), hydrodynamic forces (Kinney et al. 
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2012; Fridley et al. 2014; Cimetta et al. 2009) and centrifugal forces (Veraitch et al. 
2008; Ungrin et al. 2008).  Figure 1.3 illustrates the impact of microenvironmental  
factors providing a summary of the evidence which supports the requirement to 
improve control over these parameters.  Understanding the influence of these factors 
on stem cell cultures will facilitates their utility in improving culture conditions for 
stem differentiation protocols.   
 
 
Figure 1.3 Environmental cues and bioprocessing factors impacting pluripotent stem cell 
decisions - adapted from (Serra et al. 2012). 
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1.10.2 The role extracellular matrix in protocols for retinogenesis 
 
The traditional approach for directed differentiation of pluripotent stem cells has been 
to use exogenous morphogens in 2-dimensional culture systems with the addition of 
soluble factors and morphogens to the medium as well as a coating on the culture 
surface to recapitulate endogenous matrices with variable degrees of control.  In 
differentiation protocols reliant on an EB stage for development, the formation of an 
outer basement membrane layer around the EBs, modulates their microenvironment.  
The basement membrane limits the diffusive capability of soluble factors such as 
cytokines, growth factors, vitamins and other small molecules used to induce 
differentiation and produces extracellular matrix (Sachlos & Auguste 2008).   
For retinal development and optic cup morphogenesis, the complex cellular dynamics 
and molecular mechanisms involved, have been reported in context of the roles 
extracellular matrix substrates collagen IV, fibronectin and laminin hold to show their 
functional requirement (Kwan 2014).  Using the optically accessible zebra fish model, 
the functional requirement of laminin has been determined to be necessary at both the 
early stage of evagination and later again for invagination during optic cup 
morphogenesis.  Similarly the role of fibronectin was deemed functionally required at 
both lens placode formation and invagination (Figure 1.4)(Kwan 2014).   
The affirmed functional requirement of extracellular matrix during morphogenesis has 
resulted in the widespread use of commercially available Matrigel, an FDA approved 
but undefined matrix substrate included in many protocols for retinal differentiation to 
date (Table1.4).  Associated risks of xenogeneic contamination and a lack of 
knowledge of the concentrations of ingredients within Matrigel, are largely overlooked 
but have prompted the wider use of defined synthetic and human recombinant protein 
based alternatives such as collagen IV, laminin and fibronectin, to reduce process 
variability due to batch differences and risks of contamination with xenogeneic 
pollutants (Rodin et al. 2010; Heng et al. 2012).   
The advantage of removing undefined ingredients, includes conferring the ability to 
measure the true impact of simple micro-environmental factors by removing the 
uncertain influence of unquantified factors.  This was demonstrated in an interesting 
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report where two defined alternative substrates to Matrigel, Laminin and Vitronectin 
were used to investigate the expansion of hESCs in 2-dimensional (2-D) tissue culture 
plastic versus 3-dimensional (3-D) culture on polystyrene microcarriers (Heng et al., 
2012).  By removing uncharacterised influences from unknown ingredients in Matrigel 
they discovered the impact of changing physical parameters, showing 3-D culture 
performed better than 2-D culture for hESC expansion.  In the study, both Laminin and 
Vitronectin surface coatings promoted an 8.5 fold increase in cell yields for 3-D 
cultures as compared to planar or 2-D cultures  (Heng et al., 2012).  Defined substrates 
such as Laminin and Vitronectin will promote the development of stem cell 
differentiation protocols with clinical relevance and the advantage of better suitability 
for translation to scalable, reproducible and standardized culture systems (Serra et al. 
2012).   
 
 
 
 
Figure 1.4 Overview of optic cup morphogenesis and extracellular matrix components. “The 
optic vesicle undergoes a series of dramatic shape changes to form the optic cup: it first 
evaginates from the brain neuroepithelium, makes close contact with pre-lens ectoderm as the 
lens placode forms, then invaginates with the lens to form the optic cup. Laminin, fibronectin, 
and collagen IV are all present throughout optic cup morphogenesis; when listed in red, it has 
been demonstrated to be functionally required during that stage of optic cup formation. Inset: 
Closer view of retina-lens interface at the end of optic cup morphogenesis. Note that ECM is 
present not just at the retina- lens interface, but also surrounding the eye and lens structures 
throughout optic cup morphogenesis” (Kwan 2014). 
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1.10.3 The role of growth factors and morphogens in retinogenesis 
 
The framework of our understanding into the role of growth factors during cell 
specification in embryogenesis stems from fundamental studies in 1924 when 
Spearman and Goldman showed diffusible substances from salamander embryonic 
dorsal blastpore cells from one (un-pigmented) Salamander could direct the fate of 
surrounding tissues, on transplantation to another (pigmented) salamander embryo 
(Spearman & Goldman 1924).  Decades later, mouse embryonic carcinoma cells 
were found to recapitulate pre-implantation development in simple basal medium, 
independent of exogenous cues (Heath & Rees 1985).  The same group also showed 
embryonic growth could also be accelerated on increased exposure to insulin-like-
growth-factor (IGF), which could regulate both the development of the mouse 
embryo, as well as its own expression, through feedback loops between germ layer 
cells and their differentiated derivatives (Heath & Rees 1985).   
IGF-1: Signalling molecules such as IGF-1 have since been incorporated as key 
elements of differentiation protocols to generate therapeutic cell types including 
retinal cells.  The role of IGF-1 in retinal morphogenesis has been demonstrated by 
injecting IGF-1 mRNAs into Xenopus embryos, an act which causes the formation of 
ectopic eyes with neural retinae (Coppola et al. 2009).  Experiments in IGF-1-/-- null 
mice have shown its essential role in optic nerve development resulting from 
disruptive structural modifications to the first synapses of the retinal pathway 
(Rodriguez-de la Rosa et al. 2012).   The importance of insulin signalling in 
photoreceptor development was also shown by disruptions to the IGF-1 signalling 
pathway; in mice lacking the insulin receptor substrate 2, a 50% reduction in 
photoreceptor populations is observed by two weeks and near total knockout of 
photoreceptors by 16 months (Yi et al. 2005).  The supplementation of IGF-1 to stem 
cell differentiation cultures has been demonstrated to improve the yields of retinal 
progenitor cells (Lund et al. 2006; Lamba et al. 2006). 
FGF family: Many members of the FGF family of signalling molecules have been 
implicated for roles in retinal differentiation.  The early expression of FGF8 has roles 
in directing patterning of the embryonic head and can induce optic vesicle regression 
expression is induced before the developing optic cup makes first contact with the 
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surface ectoderm and transient expression of FGF 1,2,8 and 9 in the RPE are all able to 
convert RPE to neural retina (Mellough et al. 2014; Pittack et al. 1997).  IGF1 
supplementation to the medium has been shown to augment the production of retinal 
progenitor cells from hESCs and iPSCs (Lamba et al. 2006; Lamba et al. 2010).   
Hedgehog family agonists:  Sonic hedgehog (Shh) agonists act on the evolutionarily 
conserved hedgehog pathway essential to normal embryonic development.  Acting in 
concentration and time dependent mechanisms they have roles spanning cell survival, 
proliferation and cell fate determination and also feature in many retinal differentiation 
protocols (Table 1.4).  Shh agonists are used for their ability to influence the formation 
of separate optic cups, their impact on developing neural retina from ventral RPE and 
optic stalk and their ability to promote photoreceptor cell production and 
differentiation (Mellough et al. 2014; Beachy et al. 2010). 
Transforming growth factor β (TGFβ) & Bone morphogenic protein (BMP): The 
TGFβ/ BMP superfamily of signalling molecules direct cell growth, developmental 
processes, differentiation and morphogenesis (Horbelt et al. 2012).  A key member of 
the family involved specifically in retinal differentiation Activin A features in many 
retinal differentiation protocols as it has also been shown to promote photoreceptor 
formation from progenitor cells by its overexpression in day 18 rat retinal cultures 
(Davis et al. 2000).  For retinal differentiation, BMP4 has a specifically determined 
role for dorsoventral patterning of the optic cup and its inhibition can prompt initial 
differentiation from pluripotent cells whilst directing anterior neural specification 
(Hirami et al. 2009; Mellough et al. 2012).   
Wnt family: Similar to BMP inhibition Wnt inhibition by molecules such as DKK-1 
and Lefty-A helps initiate early stages of hESC differentiation and directs cells toward 
anterior neural specification (Ikeda et al. 2005; Hirami et al. 2009; Mellough et al. 
2012).   
Notch Signalling: Notch signalling is also part of the evolutionarily conserved multi 
signalling-pathway network which regulates cell fate specification during 
development.  Notch signalling operates through contact dependent or juxtacrine 
signalling in cell to cell or cell to extracellular matrix contact, mediated by 
transmembrane ligand-receptor crosstalk during development and beyond into 
adulthood for tissue homeostasis (Andersson & Lendahl 2014).  Notch signalling is 
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inhibited in early retinal differentiation programmes to promote retinal progenitor cell 
development and later to direct retinal progenitor cells to photoreceptor differentiation 
(Hirami et al. 2009; Zheng et al. 2010; Eiraku et al. 2011; Nakano et al. 2012). 
Retinoic acid and taurine: The role of retinoic acid has been described as a powerful 
morphogen capable of promoting neuronal differentiation (Kumar et al. 2007; 
Genaro et al. 2013).  Its expression during early retinal development at the optic cup 
formation stage and later during RPE is recapitulated in differentiation protocols for 
RPE and for later stages of photoreceptor generation protocols to promote the 
conversion of retinal progenitors into photoreceptors (Kelley et al. 1994).  The role of 
Taurine is similar to that of retinoic acid but more selective by specifically inducing 
retinal progenitors to develop into rod photoreceptors (Genaro et al. 2013; Hyatt et al. 
1996; Militante & Lombardini 2002) 
The major retinal differentiation protocols use molecules to modulate the signalling 
pathways described above but the molecules used vary between protocols as do the 
timelines required to express retinal cell specific markers and a comparison of the key 
retinal differentiation protocols is presented in Table 1.4.  The amount of variation 
between retinal differentiation protocols serves as a reminder of the early stage of the 
field and as evidence for the inherent robust adaptability of retinal differentiation 
pathways to be able to effect retinal differentiation under so many different conditions.   
Our incomplete understanding of the molecular mechanisms governing retinal 
differentiation is beginning to be addressed using novel tools for single cell 
transcriptional profiling.  In particular the development of a genome-wide single cell 
transcriptional profiling technique called ‘Dropseq’ has been able to profile the 
transcriptional variation between single cells from murine retinae to classify them  into 
39 transcriptionally separate populations in agreement with previously known markers 
for retinal cell populations (Macosko et al. 2015).  Such developments may help 
investigate subtle differences due to as yet uncharacterised variations in the 
transcriptome which could lead to the discovery of more complete or novel signalling 
pathways and molecular mechanisms governing retinal cell function as well as new 
more specific markers for finer stages of retinal differentiation.  
Fortunately, current gaps in our knowledge of molecular control systems in place for 
retinal differentiation have not hindered our progress toward generating retinal cells 
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from pluripotent stem cells in vitro (Lamba et al. 2006; Meyer et al. 2009; Mellough et 
al. 2012).  It may be the high degree of evolutionary conservation in eye development 
mechanisms, which has facilitated our progress through extensive experimental 
research (Zuber et al. 2003).  Evolutionary conservation of the major retinal 
differentiation pathways does not exclude differences in underlying mechanisms, 
factors involved, timings and pathways induced for cell specialization and 
development between species (Finlay 2008).  Yet despite the many layers of control or 
maybe because of them, it is possible for optic cup like structures to self-organise from 
mouse and human stem cell aggregates (Sasai et al. 2012).  The demonstration of the 
ability of hESC and hiPSC cells to ‘self-direct’ differentiation into retinal cells 
(Eiraku et al. 2008; Nakano et al. 2012) was a landmark achievement and involved 
EB culture in suspension albeit with the inclusion of Matrigel in the medium 
combined with relatively few other additional morphogens (see Table 1.4).     
The development of finer control over the conditions required for retinal 
differentiation is dependent on improved understanding of the biological processes 
involved.  Practical improvements over differentiation can be cultivated through 
operating in a smaller design space with fewer variables.  This would promote the 
development of optimal culture conditions at a faster pace for ultimate translation 
into reproducible, reliable processes.  These are required before standardisation, 
automation and practical and eventual clinical applicability.  Though we have 
limited understanding of simple factors affecting retinal differentiation such as the 
influence of light, temperature or pH, stirring or shaking these are being addressed 
through studies much like this one, with the aims of uncovering mechanisms 
governing retinal cell differentiation which may be harnessed to improve our 
chances of creating readily available therapeutic cell types to address errant cells in 
retinal diseases such as RP and AMD. 
The discovery that hESC and hiPSC cells can self-direct their differentiation into 
retinal cells with minimal external prompts presents an exciting proposition from a 
bioprocessing perspective (Nakano et al. 2012; Eiraku et al. 2011).  With fewer 
external inputs required for retinal differentiation there is an opportunity to 
investigate the remaining culture parameters free from avoidable complications 
arising from unnecessary components in the system.  Studying fewer variables to 
improve understanding of processes governing retinal differentiation may offer 
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improved understanding of the differentiation process.  Discovery and optimisation 
of new culture techniques able to affect retinal differentiation may also help 
translate laboratory research protocols into reproducible, reliable processes 
amenable to standardisation and automation for manufacture of cells as therapies or 
disease models at scale.   
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Table 1.4 A comparison of key retinal differentiation protocols showing exogenous molecules 
used to induce target retinal cell type and the number of culture days required to express retinal 
markers where reported. 
 
 
1.11 Project Aims & Objectives 
Overall Aims 
This thesis aims to test whether improving process control in a commonly used retinal 
differentiation protocol can improve the initiation of induced pluripotent stem cell 
differentiation toward retinal lineages when compared to a standard adherent culture 
protocol (Lamba et al. 2006).  The influence of EB size will be assessed to determine 
suitable EB sizes with which to initiate retinal differentiation.  Furthermore it was 
hypothesized that the initiation of retinal differentiation with controlled sized hiPSC 
derived EBs could withstand and benefit from culture in shaken 24-standard round 
well plates.  We tested whether there was an influence of EB size on the initiation of 
retinal differentiation in orbital shaken cultures compared to static controls.  We also 
tested the hypothesis that orbital shaken culture could be implemental in reducing the 
requirement for Matrigel, a major source of undefined exogenous factors, from the 
culture medium.  Furthermore, we investigated the impact of orbital shaking on the 
speed of initiating retinal differentiation for 2 different EB sizes to determine 
permissive shaking speeds and EB size combinations for the MSU001 IPSC line (see 
Figure 1.5 for outline of approach).    
 
Objectives 
Chapter 3: Stem cell aggregation efficiency and size control 
The objectives of this chapter are to characterize EB formation by traditional 
scraping techniques as compared to forced aggregation.  A fundamental approach of 
measuring the cell viability and cell losses between the different techniques helps to 
clarify the impact of each method on the efficiency of EB formation.  To assess the 
impact of each aggregation method on EB formation size, we used the commonly 
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used and rapidly assessable parameter of EB diameter to measure EB size.  The 
pluripotent nature of early EBs and their initiation of differentiation was assessed 
using immunostaining and quantitative polymerase chain reaction assay approaches.  
Chapter 4: Establishing a potentially scalable, orbital shaken culture protocol 
to initiate retinal differentiation 
Having established a more reproducible method for uniform EB formation, a range of 
EB sizes were investigated for their suitability to orbital shaken culture at different 
shaking speeds, without the addition of any ECM substrates.  After identifying suitable 
EB sizes and shaking speeds for culture in orbital shaken conditions, different size EBs 
were analysed for their ability to initiate retinal differentiation using a popular 
differentiation protocol (Lamba et al. 2006).  The impact of varying input EB size on 
the initiation of retinal differentiation in orbital shaken cultures was measured by 
QPCR and helped identify 2 EB sizes amenable to orbital shaken retinal differentiation 
culture. 
Chapter 5:  The impact of controlled size EBs and orbital shaking on the 
progression of retinal differentiation over 21 days in a Matrigel-free culture 
Having examined the ability of EBs formed by forced aggregation to differentiate 
toward retinal fates in orbital shaken cultures, in the absence of Matrigel 
supplementation; the experiments described in this chapter tested whether this culture 
system was suitable for extended culture periods up to 21 days.  In order to 
characterise the impact of orbital shaking culture on progression through retinal 
differentiation we used gene expression analyses to illustrate the effects on retinal 
marker expression for 2 different sized EB cultures over the culture period. 
Chapter 6: Orbital shaken culture of a feeder free cell line for retinal 
differentiation 
In this final chapter the focus turned to testing whether the newly established orbital 
shaken culture system for retinal differentiation was applicable to another cell line.  
We tested if the onset of retinal differentiation was replicated using a feeder free 
hiPSC and gene expression analyses.  
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Figure 1.5 Overview of the experimental approach.  HiPSC were cultured and routinely 
passaged at a ratio of 1:3.  Cells for use in experiments were taken from the same passage 
number and used to form EBs by scraped or forced aggregation.  EBs were cultured in pro 
retinal differentiation medium for 3 days before being split into 2 experiment streams, for either 
adherent (control) or orbital shaken cultures.  Both the control adherent and shaken culture 
systems were based on the Lamba 2006 protocol for retinal cell generation (see section 2.3).  
One modification was made to the Lamba 2006 protocol for adherent cultures: the use of 
uniform size EBs.  In shaken cultures, additional modifications were the introduction of orbital 
shaking culture in 24 standard round well plates and the removal of Matrigel. 
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2.0 Materials and Methods 
 
2.1 Pluripotent stem cell culture and maintenance 
2.1.1 Mouse feeder cell dependent pluripotent stem cell - maintenance  
 
An induced pluripotent stem (IPS) MSU001 cell line derived from human foetal 
fibroblasts was used for the majority of the experiments.  These IPS cells were 
routinely co-cultured on mytomycin C (Sigma-Aldrich) inactivated mouse embryonic 
fibroblasts in culture medium containing KnockOut Dulbecco’s modified Eagle’s 
medium (KnockOut DMEM) (Gibco), supplemented with 20% knockout serum 
replacement (KOSR) (Gibco), 1% minimum essential medium non-essential amino 
acids (MEM NEAA) (Gibco), 2mM L-Glutamine (Gibco), 0.1mM ß-mercaptoethanol 
(Gibco), and 10 ng/ml bFGF (R&D Systems).  IPS medium was replaced daily except 
the day after passage.  Cells were cultured in T25 flasks containing feeder cells at a 
confluency of 230-250K cells per flask.  IPS cells were used between passages 56- 80.   
 
2.1.2 Thawing pluripotent cells from liquid Nitrogen storage 
 
Vials of pluripotent cells from liquid nitrogen storage were placed in a water bath at 
37oC to thaw for up to 2 minutes.  On disappearance of ice from the cryovial, the vials 
were transferred to a tissue culture hood where the cell suspension was aspirated into a 
10ml pipette containing 8ml of pre-warmed pluripotent stem cell culture medium.  The 
cells were transferred to a centrifuge tube and centrifuged for 3 minutes at 1200rpm 
before the supernatant was removed and cells re-suspended in pre-warmed culture 
medium.  The cell suspension was finally transferred to appropriate culture vessels.  
The mouse feeder dependent pluripotent stem cells (MSU001-IPS) were transferred 
with 5-7ml of medium to pre-prepared flasks containing feeder cells at a density of 
230-250K cells per T25 flask.  Feeder free pluripotent stem cells (BJ-IPS) in E8 
medium (Invitrogen) were transferred to T25 flasks pre-coated with VTN (Invitrogen) 
for an hour in advance.    
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2.1.3 Mouse embryonic fibroblast and feeder cell isolation and 
preparation  
 
Mouse embryonic fibroblasts (MEFs) from CF1 mouse embryos were isolated at day 
13.  Heads and internal organs were first removed from the tissue using sterilised 
tweezers and scissors before washing with PBS and digesting using 0.05% 
Trypsin/EDTA (Gibco-Invitrogen).  The tissue was then finely minced before the 
addition of more Trypsin/EDTA and transfer to an incubator at 37oC for 5-10 minutes.  
The digestion reaction was quenched using MEF medium containing Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% (v/v) foetal bovine serum 
and 1% (v/v) non-essential amino acid (NEAA) (all Gibco-Invitrogen).  The mixture 
was transferred to a centrifuge tube to settle before removal of the supernatant and re-
suspension in fresh MEF medium.  After centrifugation at 1000rpm for 3-5 minutes the 
supernatant was discarded and the pellet re-suspended in more MEF medium and 
transferred to a T75 flask (NUNC, Easy Flasks, Thermo-Fischer Scientific) and 
returned to the incubator at 370C.  The MEFs were expanded for two population 
doublings before being designated passage zero (P0).  At P0 the cells were harvested 
using Trypsin/EDTA, and re-suspended in cryopreservation medium (40% MEF 
medium, 50% FBS and 10% DMSO (Sigma-Aldrich)) before being frozen in liquid 
nitrogen.    
 
P0 MEFs from liquid Nitrogen were used between P1 and 6 and were maintained in 
mouse embryonic fibroblast (MEF) medium.  The frozen vials were placed in a water 
bath at 37oC for less than 2 minutes before being re-suspended in MEF medium.  The 
cells were then centrifuged at 1200rpm for 3 minutes before removal of the supernatant 
and re-suspended in fresh MEF medium before plating into T75 flasks.  The MEFs 
were passaged every 3 days using 0.25% Trypsin/EDTA and split at a ratio of 1:4 – 
1:2.   
 
Before MEFs could be used as feeders they were inactivated with mytomycin-C (1 
mg/mL)  and re-suspended in MEF medium before being seeded on gelatinised T25 
flasks (0.1% Porcine gelatine (Sigma-Aldrich) at a confluency of 250K per flask.  
Inactivated MEFs or Feeders were prepared a day before passaging IPS cells onto them 
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and were kept in MEF medium until 30 minutes before passaging the following day, 
when MEF medium was replaced with IPS cell medium.  IPS cell medium composed 
of Dulbecco’s modified Eagle’s medium (DMEM from Invitrogen) supplemented with 
20% knockout serum replacement (KSR), 2mM non-essential amino acids and 2mM 
L-glutamine (Invitrogen Life Sciences); 0.1mM b-mercapethanol (Sigma) and 10ng/ml 
human recombinant basic fibroblast growth factor (bFGF - R&D systems). 
 
2.1.4 Mouse feeder cell dependent pluripotent stem cell - passaging  
 
Confluent flasks of IPS cells were passaged at a ratio of 1:2 or 1:3 on reaching 70-80% 
confluence.  Spent IPS cell culture medium was first replaced with 6mls of fresh 
medium at least an hour in advance.  Undifferentiated IPS colonies were mechanically 
scraped from the flasks using sterile Pasteur pipettes (Starlabs) under a phase contrast 
dissecting microscope.  Stem cell colony clumps suspended in the medium were 
pipetted out onto fresh T25 feeder flasks.  Feeder flasks were seeded with 230-250K 
MEF cells 24 hours in advance and were primed for stem cell addition by addition of 
IPS medium 30 minutes prior to use.  
 
2.1.5 BJ IPS cell line maintenance in fully defined feeder free culture 
conditions 
 
The BJ induced pluripotent stem cell (iPSC) line was generated from human foreskin 
fibroblasts. BJ IPS were created by Sendai virus vector transfection Yamanaka’s 
reprogramming factors in expression cassettes (Takahashi et al. 2007).  The 
transformed cells have a normal male karyotype (National Centre for Global Health, 
Tokyo).  These cells were maintained on Essential 8 Medium (Invitrogen) developed 
by Jamie Thomson’s Lab (Chen et al. 2011) on Vitronectin VTN-N (Invitrogen) 
coated T25 flasks.  Medium was replaced daily except the day after passage. 
 
2.1.6 BJ IPS cell passaging 
 
Cells were typically passaged every 3-4 days when they reached 70-80% confluency.  
E8 medium was aspirated from the culture vessel and discarded before washing with 
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PBS without Calcium or Magnesium.  To dislodge the cells 2ml of 0.5mM solution of 
EDTA in PBS without Calcium or Magnesium was used.  Following a 5-8 minutes 
incubation at room temperature the EDTA was aspirated and E8 medium was added to 
the flasks and gently titurated.  The suspended IPS colony clumps were transferred into 
new VTN-N coated T25 flasks at a split ratio of 1:4-6 depending on the cell density.  
For all other assays and differentiation protocols the cells were treated in exactly the 
same way as the MSU001 cell line. 
 
 
2.2 Aggregation of stem cells and aggregate/EB processing 
2.2.1 Manual scraped EB formation  
 
IPS cells were harvested from their T25 flasks when they reached between 70-80% 
confluency by manual scraping.  Spent medium was replaced with 3mls of EB 
formation medium (knockout-DMEM, 34, 10% KSR, 2mM L Glutamine, 2mM L 
nonessential amino acids (all from Invitrogen) supplemented with the appropriate 
concentrations of retinal induction growth factors (see section on retinal differentiation 
below).  The suspended scraped cell clumps, were transferred to low attachment 
bacterial grade culture dishes (3cm diameter) and placed in an incubator at 37oC and 
5% CO2 for 3 days.  The dishes were shaken once a day to prevent mass clumping of 
the aggregates.  
 
2.2.2 Forced aggregation of pluripotent stem cells using Aggrewells 
 
To form uniform sized stem cell aggregates, Aggrewell plates (Stemcell Technologies) 
were used in accordance with the manufacturer’s instructions.  Briefly, medium from 
T25 flasks containing IPS cells was discarded and replaced with 3mls of Dulbecco’s 
phosphate buffered saline (PBS) to wash.  On removal of the PBS 2mls/T25 of gentle 
enzymatic dissociation reagent Tryple (Invitrogen) was added to each flask and 
incubated for 10 minutes at 37oC.  At the end of the incubation flasks were tapped on 
the bench to dislodge cells before 5 ml of IPS medium was used to quench and 
neutralise the dissociation enzyme.  The cell suspension was subsequently passed 
65 
 
through a 40um cell strainer (BD) before being centrifuged at 300G for 2 minutes.  
Post centrifugation the supernatant was discarded and the cell pellet re-suspended in 
2mls of EB formation medium supplemented with 1ng/ml of Rho Kinase Inhibitor 
(ROKi).  In order to count cells in the concentrated suspension with a haemocytometer, 
the suspension was first diluted by a factor of 10.  A sample of 10ul of the cell 
suspension was mixed in a vial containing 80ul of IPS medium and 10ul of Trypan 
blue before 10ul of the mixture was introduced to a chamber of the haemocytometer 
and counted.  An average of three cell counts was used for the final measurement of 
cell concentration.  The appropriate volume of cells was finally distributed into 
Aggrewell plate wells containing 500ul of EBMr and the total volume of each well 
was made up to 2mls with the addition of an appropriate volume of more EBMr.  The 
Aggrewell plates were placed in an incubator at 370C and 5% CO2 for 24 hours. 
 
2.2.3 Harvesting stem cell aggregate/ EBs from Aggrewells 
 
After 24 hours stem cell aggregates were dislodged from the Aggrewells by gentle 
tituration using a 5ml pipette.  Suspended aggregates were then transferred to a 10ml 
centrifuge tube and allowed to settle before the medium containing ROKi was replaced 
with EB formation medium without ROKi.  The new suspension was finally 
transferred to low attachment 3cm bacterial grade dishes and aggregates were returned 
to an incubator at 37oC for 3 days. 
 
2.3 Retinal differentiation  
 
Whether the stem cell aggregates were formed by manual scraping or by forced 
aggregation the newly formed stem cell aggregates were harvested by gentle tituration 
using a 5ml pipette and transferred to a 10ml centrifuge tube to settle.  The aggregates 
settled to the bottom of the centrifuge within 5 minutes and the supernatant was 
aspirated and replaced with phase 1 (P1) retinal induction medium (Lamba et al. 2006) 
containing DMEM/F12 (Gibco), supplemented with 1ng/ml (R&D Systems), 5ng/ml 
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IGF-1 (Miltenyi Biotec), 1ng/ml dkk1 (System Biosciences), 10% knockout serum-
replacement (KOSR) (Gibco), 1% N2 supplement (Gibco), and 1% L-Glutamine 
(Gibco).  The freshly suspended aggregates were finally transferred to low attachment 
bacterial grade dishes (ᴓ300mm, Sterilin) and returned to the incubator for 3 days.  
Aggregate dishes were shaken (twice left to right and twice up and down) daily to 
avoid mass clumping.   
 
On day 3 the aggregates were harvested from the dishes by aspiration with a 5ml 
pipette and collected into 10ml centrifuge tubes for settling.  The spent medium was 
replaced with phase 2 (P2) retinal differentiation medium (Osakada et al. 2009) in 
summary: DMEM/F12 (Gibco), supplemented with 10ng/ml noggin (R&D® Systems), 
10ng/ml IGF-1 (Miltenyi Biotec), 10ng/ml dkk1 (System Biosciences®), 1% N2 
supplement (Gibco), 5ng/ml B27 supplement (Gibco), 5ng/ml bFGF (R&D Systems), 
and 1% L-Glutamine (Gibco).   
 
Depending on whether the differentiations were assigned for completion in suspension 
or in an adherent system (see 4.3.1 and 4.3.2), the aggregates were transferred to the 
appropriate vessels and medium was replaced every 2 days until day 15 and then as 
necessary to avoid the medium turning too yellow over the 31 days. 
 
2.3.1 Attached differentiation of EBs on Matrigel 
 
Attached culture of EBs was carried out in 24 well tissue culture plates (Nunc).  Plates 
were first coated with reduced growth factor Matrigel (BD).  Coating the wells 
required the surfaces to be completely submerged in Matrigel for an hour’s incubation 
at room temperature.  After incubation the Matrigel was removed and the wells 
hydrated with 250ul of P2 medium.  Finally using sterile Pasteur pipettes 30-40 
aggregates were transferred under a dissecting microscope to each well.  Tissue culture 
plates were returned to an incubator at 37oC for the remainder of the culture period 
with medium changes every day until day 15 and as required thereafter to avoid the 
medium becoming too yellow. 
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2.3.2 Orbital shaken culture of EBS for retinal differentiation without 
Matrigel 
 
Day 3 EBs designated for orbital shaken differentiation culture were transferred to 
ultra-low attachment 24 well culture plates, dimensions of an individual well were: 
height=17.40mm, top internal diameter = 16.26mm and bottom internal diameter = 
15.62mm (Corning).  For each experiment 30-40 aggregates were transferred into each 
well and additional P2 medium added to make up the total volume to 500ul per well.  
No Matrigel was added to these plates and they were placed on a shaker with orbital 
diameter 10mm on an IKA KS 260 Shaker (IKA) set at 120rpm in an incubator at 370C 
for the remainder of their differentiation with ~90% medium changes every 2 days  
until day 15 and then 50% medium changes daily up to day 31. 
  
 
2.4 Analytical techniques for retinal differentiation  
2.4.1 Cell counts for suspension cells and cells from EB digests 
 
Aggregates formed by scraped or forced aggregation after 24 hours, were transferred to 
a 10ml centrifuge tube and allowed to settle for 5-10 minutes.  The supernatants 
containing unincorporated cells were transferred to fresh centrifuge tubes and kept 
aside for counting alongside cells from digested EBs at the end of the protocol.  The 
settled EBs were resuspended in 5ml PBS to wash and centrifuged before the PBS was 
aspirated and replaced with 1ml of Tryple (pre-warmed to 37oC) and the tubes 
transferred to a water bath at 37oC to activate the Tyrple for EB digestion.  To aid EB 
digestion samples were also manually titurated using 200μl Gilson pipettes, for the 3 
minutes duration in the water bath.  The single cell suspensions from digested EBs 
containing Tryple were quenched using 3mls of IPS medium before being counted in 
parallel with the supernatant containing single cells separated at the start of the 
procedure.  The live and dead cell portions of all cell samples were counted using the 
Trypan Blue exclusion method on a Vi-Cell counter (Beckman Coulter).  
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For dense aggregates from later time points (10 days+) 100ug/ml DNAase I (Sigma) 
and 5mM MgCl2 in PBS were also added to the Tryple for the digestion reaction.  In 
addition the samples needed tituration whilst in the water bath at 370C to obtain break 
up EBs into suspension.   
 
2.4.2 EB size calculations using Image J software 
Variation in EB size over time (24 hours, day 3, day 10 and day 15) was assessed by 
calculating the average sizes of EBs (n=100) formed by scraping or forced 
aggregation.  For the 1K EBs analysed at 24 and 48 hours not assigned for EB 
digestion, the full volumes of the cultures containing the EBs were transferred to 10ml 
centrifuge tubes as above and the supernatant containing unincorporated cells in 
suspension transferred to another centrifuge tube for counting separately.  The EBs 
were subsequently resuspended in 3ml of medium and gently titurated using a 5ml 
pipette to mix before sampling.  Samples of 100μl of suspended EBs were taken and 
distributed into 10 wells of black-walled, flat bottom 96-well plates.  EBs were left to 
settle for 5 mins before being counted or imaged by light microscopy (Nikon 
epifluorescence Eclipse 2000 inverted microscope) for calculating EB sizes as 
described below.   
For 5K and 10K EBs at days 3, 10 and 15 cultured in suspension, the EBs were 
allowed to settle to the bottom of their culture wells (5 mins) before being imaged by 
light microscopy (Nikon epifluorescence Eclipse 2000 inverted microscope).  Image J 
software was used to take 3 pixel length measurements per EB for all EB sizes from 
the micrographs (transverse, dorsoventral and diagonal).  The pixel length 
measurements were converted to μm lengths in the software using image size 
parameters to reference known distances (Table 1.5).  Finally averages of 3 
measurements per EB (n ≥ 100) were calculated to represent the size of each EB.   
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Figure 2.1 Representative micrographs to show EB size measurement method.  The 3 
yellow lines per EB illustrate the 3 typical measurements (transverse, dorsoventral and 
diagonal) taken for each settled EB in the same plane to calculate an average 
representing the EB’s size.  Images are of 10K EBs at day 15 of orbital shaken retinal 
differentiation culture (10x magnification and scale bars = 400 μm).   
 
Objective 
used 
Image size 2560 x 1920 
Known Distance in μm/ 
pixel =  
Image size 1280 x 960 
Known Distance in μm/ 
pixel =  
4x 0.86  1.72 
10x 0.34 0.68 
20x 0.17 0.34 
 
Table 1.5 Image size μm/pixel measurements reference table to calculate lengths μm 
lengths and average EB sizes. 
 
2.4.3 DNA Quantification  
 
DNA quantification was used as an indirect measure of the total cell numbers in 
adherent and orbital shaken cultures for later cultures which were difficult to digest 
into live single cell suspensions.  The Quant-iT PicoGreen dsDNA assay (Invitrogen) 
enabled more accurate calculation of the cell numbers by measuring the total quantity 
of DNA from disrupted cells as an end point assay.  Following the manufacturer’s 
instructions, a standard curve for DNA concentration was created using serial dilutions 
of IPS cells in a range between 25^105 and 3^106 cells.  Cells were suspended in 1x TE 
buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5) and added to 100µl of the aqueous 
working solution of Quant-iT PicoGreen Reagent before making up to a final volume 
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of 200µl with TE buffer as required.  The samples were subsequently incubated at 
room temperature in the dark for 5 minutes before fluorescence was measured using a 
Tecan Saffire fluorescence microplate reader (Tecan).  Following the same procedure 
for unknown samples form retinal EBs, the fluorescence readings were analysed 
against the standard curve to attain relative cell numbers per sample. 
 
2.4.4 Lactate Dehydrogenase (LDH) Colorimetric Assay  
 
The oxidoreductase lactate dehydrogenase reduces NAD present in the medium to 
NADH which interacts with a fluorescent probe to emit light (λmax = 450 nm).  LDH 
content in spent supernatant from culture samples were measured using the LDH 
Assay (Abcam) according to the manufacturer’s instructions.  LDH measurements 
were taken as an indication of the presence of cell damage and toxicity within the 
differentiating cultures.  The stability of the LDH enzyme facilitates its use with frozen 
sample which were kept from medium changes for retinal differentiation cultures up to 
21 days before analysis together on the same day.   
Samples (50µl) each were plated into clear bottom 96 well plates (Nunc) in triplicate 
wells alongside a 1:9 serial dilution of the NADH positive control assay buffer.  After 
addition of ‘Reaction Mix’ (50µl) per sample, fluorescence readings were taken using 
a Tecan Saffire fluorescence microplate reader at T0 and after 30 minutes of 
incubation at 370C.  Following the manufacturer’s instructions fluorescence readings 
were used to create a standard curve from the positive control serial dilutions against 
which sample measurements were compared for a measurement of LDH Activity with 
time and plotted for each sample.   
 
2.4.5 Aggregate freezing protocol for cryosectioning 
 
EBs harvested for cryosectioning were first incubated in 4% paraformaldehyde (PFA) 
for 20 minutes at room temperature.  The 4% PFA solution was replaced with a 30% 
sucrose PBS buffer solution and incubated overnight at 4ºC.  The following day the 
dehydrated cell aggregates had settled to the bottom of the vial.  After aspirating and 
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removing most of the sucrose solution, the final volume was aspirated with low 
attachment 200ul pipette tips (Starlabs), cut at the middle to allow for larger aggregates 
to pass and deposited into cryosection moulds.  Using absorbent paper excess sucrose 
solution was removed before adding embedding medium OCT (Tissue-Tek) to cover 
the aggregates and fill the mould.  These OCT blocks were finally frozen at -80ºC and 
later sectioned using a Thermo Scientific™ Cryotome™ FSE Cryostat into 10μm 
slices. 
 
2.4.6 Cryosectioning aggregates 
 
Frozen blocks of aggregates in OCT embedded within their moulds were allowed to 
thaw for less than a minute in order to facilitate the removal of the mould before 
placing the blocks within the cooled chamber of the Cryostat (-250C).  The blocks were 
fixed onto a mounting stage using more OCT and finally sectioned into 10um slices.  
The slices were picked up using Microslide Superfrost Plus White (VWR) glass slides, 
allowed to dry at room temperature for at least an hour and then either stored at -80oC 
or used immediately for immunohistochemistry. 
Cut sections removed from frozen storage are allowed to acclimatise to room 
temperature before the containers are opened to reduce condensation.  The sections 
were dried for up to two hours under a fan or on the bench overnight before 
commencing the immunohistochemistry protocol.  
 
 
2.5 Immunocytochemistry  
 
Cells grown in 24-well tissue culture plates were fixed in 4% PFA for 20min at room 
temperature. The PFA was removed and cells were washed with PBS.  Each well was 
then treated with blocking buffer (0.3% Triton and 5% goat serum (Invitrogen) in 
PBS) for 1 hour at room temperature.  After incubation in blocking buffer, cells were 
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incubated overnight at 40C with primary antibody diluted between 1:200 (Table 2.1) 
and 1:300 for secondary antibodies (Table 2.2) in blocking buffer. 
Following incubation with primary antibodies the next day, cells were washed 3 times 
in PBS for 5mins each on a shaking platform at room temperature.  Post washing, cells 
were incubated at room temperature for up to 1 hour with the appropriate secondary 
antibodies, pre-diluted in blocking buffer at a ratio of 1:300 – 1:400.  Isotype control 
staining to show the secondary antibodies were specific to their corresponding primary 
antibody species were carried out alongside each staining process by including wells 
which were only incubated with secondary antibodies specific for each species of 
primary antibody used.  
After incubation with secondary antibodies cells were washed thrice with PBS as 
before with 5 minutes per wash, and stained with DAPI before being mounted in PBS 
and stored at 40C.  The Nikon epifluorescence Eclipse 2000 inverted microscope was 
used to image the cell markers and analysis was performed using the NIS-elements 
software (version 3.0).   
 
2.6 Gene expression analyses  
 
2.6.1 RNA extraction 
 
RNA samples were harvested from cells using the RNeasy mini-kit (Qiagen) according 
to the manufacturer’s instructions including an in-column DNAse step to digest any 
potentially contaminating genomic DNA.  Adherent cells were harvested by scraping 
and cells in suspension were pelleted before excess medium was aspirated and the 
samples used or frozen at -80oC.  Pellets were first re-suspended in RLT Buffer 
(Qiagen) before being homogenised in Qiashredder Columns (Qiagen) according to the 
manufacturer’s instructions.  Harvested RNA samples were eluted in 40μl RNAse free 
water and quantified to ng/μl by measuring 260/280nm absorbance ratios on a 
spectrophotometer (NanoDrop ND-1000, Thermo Scientific).  
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2.6.2 Reverse transcriptase polymerase chain reaction (RTPCR) 
 
Synthesis of complementary deoxyribonucleic acid (cDNA) and removal of genomic 
DNA was performed using the Qiagen RTPCR kit following the manufacturer’s 
instructions.  Genomic DNA was eliminated using gDNA Wipeout Buffer (Qiagen) 
with up to 1μg template RNA and RNAse free water in a total reaction volume of 14μl 
which was incubated at 42oC for 2 minutes in a thermocycler.  The entire 14μl reaction 
volume was subsequently mixed with a mastermix, containing template RNAs, RT 
Primer Mix Quantiscript RT Buffer and Quantiscript Reverse Transcriptase (all 
Qiagen) in a total volume of 20μl.  The reaction volume was incubated at 42oC for 15 
minutes, then 3 minutes at 95oC to inactivate the reverse transcriptase.  The 
synthesised first strand cDNA scripts from the reverse transcription reactions were 
stored at -20oC and thawed on ice before QPCR analyses. 
 
2.6.3 Quantitative (real time) PCR (qPCR) 
 
The QPCR reactions were performed in Biorad Hard-Shell Low Profile Thin-Wall 96 
Well Skirted PCR plates on the Biorad CFX 96 Connect Real-Time PCR System using 
the Quantitect SYBR Green PCR Kits (Qiagen) according to the manufacturer’s 
instructions.  For each reaction Quantitect Mastermix Buffer, Quantitect pre-validated 
primer assay (Table 2.3), water and cDNA were combined to make final reaction 
volumes of 25μl.  On each 96 well plate samples were analysed in triplicate with 2 
internal reference genes GAPDH and βActin and standard controls NoRT (No reverse 
transcriptase control) and NTCs (no template control) to check for contaminations 
which may have occurred during cDNA synthesis or final mastermix preparation.   
The real-time PCR results were analysed using the Biorad CFX Manager 3.0 to 
calculate normalized relative expression (ΔΔCq) of target genes normalized to relative 
expression levels of the reference genes β Actin and GAPDH, using the Pfaffl method 
(Pfaffl, 2001).  The equations used with the Biorad CFX Manager 3.0 software to 
measure normalized expression relative to reference target genes (Equation 1) and 
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standard errors of the mean (Equation 2) are given below.  All error bars on QPCR 
graphs were standard errors of the mean calculated according to equation 2. 
 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛𝑠𝑎𝑚𝑝𝑙𝑒 (𝐺𝑂𝐼)
=
𝑅𝑄𝑠𝑎𝑚𝑝𝑙𝑒 (𝐺𝑂𝐼)
(𝑅𝑄𝑠𝑎𝑚𝑝𝑙𝑒 (𝑅𝑒𝑓1) × 𝑅𝑄𝑠𝑎𝑚𝑝𝑙𝑒 (𝑅𝑒𝑓1) × …× 𝑅𝑄𝑠𝑎𝑚𝑝𝑙𝑒 (𝑅𝑒𝑓𝑛) )
1
𝑛 
 
 
 RQ = Relative Quantity of a sample 
 Ref = Reference target in a run that includes one or more reference targets in each 
sample 
 GOI = Gene of interest (one target) 
Equation 1:  Formula for normalized expression used to calculate gene expression 
comparisons across multiple plates for QPCR (Biorad CFX Manager 3.0). 
 
𝑆𝐸 𝐺𝑂𝐼𝑛 = 𝐺𝑂𝐼𝑛 𝑋 √(
𝑆𝐸 𝑁𝐹𝑛 
𝑁𝐹𝑛
)
2
+ (
𝑆𝐸 𝐺𝑂𝐼 
𝐺𝑂𝐼
)
2
 
 SE = Standard error 
 GOI = Gene of interest (one target) 
 NF = Normalization factor 
 n = Number of reference targets 
Equation 2:  Formula used to calculate standard errors for normalized expression of genes of 
interest (Biorad CFX Manager 3.0). 
 
2.7 Mycoplasma Testing and Karyotyping 
 
Both the MSU001 and the BJ IPS cell lines were tested for mycoplasma (Surrey 
Diagnostics, Cranleigh, UK) and for karyotypic abnormalities after extensive 
passaging by The Doctor’s Laboratory (TDL 60 Whitfield Street, London).  The 
samples sent for testing were subjected to G banding and up to 20 cells were used in 
the analyses (Figure 2.2). 
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Figure 2.2 Karyotypic Analysis of MSU001 and BJ hiPSC lines.  Standard G banding 
karyotypic analyses were routinely performed on hiPSC lines (TDL Genetics, Whitfield Street, 
London).  (A) Typical G banded chromosomes for MSU001 at passage 62.  The majority of 
analyses for MSU001 resulted in normal 46 XK karyotype. (B) Typical G banded BJ IPS 
chromosomes at passage 51.  The majority of BJ IPS cells showed a modal karyotype 46 XX.  
In an anomalous result one cell showed a chromosome loss 45, XY. 
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Primary Antibody Source Host Isotype Dilution 
Pluripotency Markers         
Oct3/4  Santa Cruz Mouse IgG2b 1:200 
Tra-160 Millipore Mouse IgG 1:200 
SSEA4: Mab4304 Millipore Mouse IgG3 1:200 
Tra-181 
P. Andrews, 
Sheffield University Mouse IgM 1:200 
SSEA 1 
P. Andrews, 
Sheffield University Mouse IgM 1:200 
SSEA3 
P. Andrews, 
Sheffield University Mouse IgG 1:200 
Retinal 
Differentiation 
Markers         
Rax: WH0030062M1 Sigma Mouse IgG 1:200 
Rax: Ab3729 Millipore Rabbit Poly 1:200 
Pax6: Mab5552 Millipore Mouse IgG 1:200 
Otx2: AJ1560a Abgent Rabbit IgG 1:200 
Otx2: Ab9566 Millipore Rabbit Poly 1:200 
Crx: Sc377207 Santa Cruz Mouse IgG2 1:200 
Crx: WH0001406M1 Sigma Mouse IgG1a 1:200 
Rhodopsin: R5403 Sigma Mouse 1D4 1:200 
Opsin: 
04886/051m597 Sigma Mouse IgG1 1:200 
Six3: AT3893a Abgent Mouse IgG2ak 1:200 
Chx10(N): Ab9016 Millipore  Sheep Poly 1:200 
 
Table 2.1 Primary antibodies used for immunocytochemistry to assess pluripotency and retinal 
differentiation.  
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Secondary Antibody Source Dilution 
Alexa Fluor 488 Goat Anti-Mouse 
IgG Invitrogen 1:300 
Alexa Fluor 488 Goat Anti-Rabbit 
IgG Invitrogen 1:300 
Alexa Fluor 555 Goat Anti-Mouse 
IgG Invitrogen 1:300 
Alexa Fluor 555 Goat Anti-Rabbit 
IgG Invitrogen 1:300 
Alexa Fluor 488 Goat Anti-Mouse 
IgM Invitrogen 1:300 
Alexa Fluor 555 Goat Anti-Mouse 
IgM Invitrogen 1:300 
 
Table 2.2 Secondary antibodies used against the primary antibodies in assessing pluripotency 
and differentiation marker expression. 
 
Description Quantitect Primer Assay 
Qiagen 
Reference  
Reference 
  
Beta Actin QT01680476 
GAPDH QT01192646 
Pluripotency P0U5F1 QT00210840 
Early eye 
field 
  
  
  
PAX6  
(Paired box 6) QT00071169 
RAX  
(Retina and anterior neural 
fold homeobox) QT00212667 
OTX2  
(Orthodenticle homeobox 2) QT00213129 
SIX3 (Six homeobox 3) QT00211897 
Photoreceptor 
specific 
  
  
CRX  
(Cone-rod homeobox) QT01192632 
NRL  
(Neural retina leucine 
zipper) QT01005165 
RHO  
(Rhodopsin) QT00035700 
 
Table 2.3 List of primers used to quantify the level of expression of key markers of retinal 
differentiation. 
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3. Stem Cell Aggregation Efficiency and EB Size Control 
3.1 Introduction 
 
Manual scraping produces heterogeneous EB sizes and results in large cell losses, yet 
is still a frequently used technique for their production, despite the availability of more 
controlled methods for EB formation (Heng et al. 2007).  The ability to efficiently 
aggregate stem cells to form uniform sized EBs is important for maximising the yield 
of desired cell types from differentiation protocols dependent on EB stage 
transgression (Bauwens et al. 2008).  When considering the potential of differentiation 
protocols for scale up into industrial manufacturing production bioprocesses; the 
efficiency of EB formation and consistency in size will affect production costs and  the 
ability to direct differentiation in to desired cell types reproducibly (Ungrin et al. 
2008).  In this chapter two EB production techniques are characterised to assess the 
efficiency of aggregation and reproducibility of EB sizes in each.  The first method 
evaluated is the conventional manual scraping technique as used in the Lamba 2006 
protocol for retinal differentiation.  The efficiency of aggregation and uniformity of 
EBs produced from manual scraping will be compared to the same outputs from a 
popular, commercially available method for forming EBs by forced aggregation 
(Aggrewell plates from StemCell Technologies) selected for its reputed ability to 
produce uniform sized EBs.  Comparing the efficiency of aggregation and EB size 
uniformity for scraped and forced aggregation will allow an assessment of the 
suitability of the Aggrewell technique for reproducible and scalable production of EBs 
for retinal differentiation.   
EB formation by manual scraping and spontaneous differentiation is both labour 
intensive and inefficient.  Manual scraping requires highly trained operators to first 
identify good quality compact and undifferentiated stem cell colonies.  Second, these 
colonies need to be manually excised by scraping into as uniform sized clumps as 
possible, with a sterile plastic Pasteur pipet.  These stem cell clumps are subsequently 
cultured in suspension in low attachment culture dishes, where they spontaneously 
differentiate into EBs.  Following EB formation, the micro-environment must provide 
appropriate nutrients in the medium and specific signalling cues from soluble factors to 
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support differentiation along the retinal developmental pathway, a topic discussed in 
more detail in chapter 4. 
Manual scraping can cause cell death through mechanical force but also leaves many 
cells attached to the tissue culture plastic surface which are not subjected to the 
differentiation protocol (Heng et al. 2007).  Manual scraping aims to dislodge stem 
cells from colonies as clumps, but a population of cells which are not scraped off as 
clumps are dissociated into single cell suspension.  Without the addition of Rho Kinase 
Inhibitor (Y-27638) the stem cells in suspension are more likely to undergo apoptosis 
causing another source of waste in the differentiation protocol (Watanabe et al. 2007).   
Cells not incorporated into EBs due to apoptosis or due to being suspended as single 
cells are responsible for the inefficiencies in the aggregation process and are 
characterized in this chapter.  We report higher cell deaths, lower aggregation levels 
and higher numbers of unincorporated cells left to float away in the medium from 
manual scraping methods for EB production compared to forced aggregation.   
The exclusion of large populations of stem cells from incorporation into EBs and 
therefore the differentiation process will necessarily impact negatively on the 
production yields of therapeutic cell types dependent on EB stage facilitated 
differentiation.  The efficiency of the aggregation technique is therefore of interest to 
all EB stage dependent differentiation protocol developers, aiming for robust and 
consistent cell therapy manufacturing techniques.    
The variable reproducibility of reported cell derivation and differentiation efficiencies 
from published protocols using scraped EBs, requires an analysis based on 
fundamental principles.  Consequently in this chapter, mass balance calculations were 
employed to investigate the efficiency of the process of stem cell aggregation into EBs.  
The total number of initial cells available for aggregation, versus the numbers of cells 
left in suspension or dead following aggregation after 24 hours were calculated to 
illustrate advantages and disadvantages of both scraped and forced aggregation 
systems.  Comparing the total number of cells available from the beginning with the 
total number of differentiated cells at the end of a given differentiation protocol should 
provide an indication of the efficiency of the method used and therefore provide a 
more robust and detailed depiction of the impact of aggregation efficiency on the 
bioprocesses in manufacturing therapeutic cells from pluripotent stem cells.  Knowing 
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the efficiencies of the differentiation protocol should have valuable implications for 
development of leaner bioprocesses at industrial manufacturing scales. 
 
3.1.1 Chapter aims and objectives 
 
The aim of this section was to characterise different EB formation techniques and 
determine the most efficient EB formation platform.  This is an important first step in 
establishing a scalable differentiation protocol for stem cell derived products which 
need to differentiate through an EB like stage such as retinal photoreceptor precursor 
cells, the example differentiation protocol throughout this thesis. The specific 
objectives were:  
• To compare the traditional scraped EB formation technique with forced 
aggregation using the Aggrewell technology. 
• To measure the levels of cell losses and determine the cell yields associated 
with each technique. 
• To calculate the impact of the aggregation technique on aggregation efficiency. 
• To characterise both techniques in terms of their impact on EB size variability, 
pluripotency and differentiation. 
 
3.2 Characterisation of EB Formation 
3.2.1 Forced aggregation is more efficient than scraped spontaneous 
aggregation.   
 
Forming EBs by manually scraping stem cell colonies led to the evaluation of 
Aggrewell plates (StemCell Technologies) a recent commercially available innovation 
for scalable aggregation of precise numbers of stem cells into EBs.  The Aggrewell 
plates formed of PDMS microwells can be either 400µm or 800µm in diameter 
depending on the desired EB sizes to be manufactured.  The company claims higher 
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reproducibility of EB sizes but at the time of print they made no claims as the impact 
of this aggregation technique on cell viability or on the efficiency of the process.  
When comparing EBs made by manual scraping or using forced aggregation in 
Aggrewell plates, there is a stark difference in the resultant EBs.   
By visual inspection EBs formed by manual scraping appear more heterogeneous in 
size and shape whilst those formed by forced aggregation are more homogenous as 
shown in the micrographs of EBs at 24 hours post aggregation in Figure 3.1a & b.  In 
addition to the observed differences in EB uniformity between techniques there also 
appeared to be more single cells or visible cell debris in scraped EB cultures compared 
to their forced aggregate counterparts.  Quantification of these visually observed initial 
findings for both methods involved calculating numbers of whole EBs produced from 
equal numbers of input cells in each technique to appreciate the yield of EBs from each 
technique.  Cell numbers from digested EBs as well as live and dead cell counts from 
suspended cells in the medium surrounding EBs 24 hours post formation were also 
measured to calculate the efficiencies of each aggregation technique.    
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5K                      10K                            15K                             20K 
C 
Figure 3.1 Micrographs show stem cell aggregates at 24 hours. (A) Shows the aggregates 
formed by scraping or (B) by forced aggregation. (C) Shows how similar different 
numbers of stem cells appear in Aggrewells of 800um diameters at day 0, for 5K cells/ 
well, 10K cells/ well, 15K cells/ well and 20K cells/ well.  
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3.2.2 The impact of aggregation technique on cell yield 
 
The efficiency of aggregation is usually calculated solely from the percentage of live 
cells incorporated into EBs.  This measure does not take into account the number of 
cells available for aggregation at the beginning or the cells which are lost during the 
process of aggregation.  In order to account for these losses, cell yields after 24 hours 
for both techniques were used to calculate the level of cell death and therefore waste 
associated with either spontaneous aggregation by manual scraping or forced 
aggregation.  Figure 3.2 shows calculating the total percentage of live cells 
incorporated into EBs after 24 hours as a percentage of the number of cells available 
for EB formation at the start of the protocol provided a measure of viable cells 
available to continue differentiating within EBs.  Figure 3.2 also shows more viable 
cells were found within aggregates from forced aggregation.  In terms of cell yields 
alone, forced aggregation was found to be significantly more efficient than scraping by 
an order of over 3-fold (p<0.05). 
 
3.2.3 Aggregation efficiency 
 
Samples of EBs in suspension at t=24 hrs from the start of the aggregation stage and 
unincorporated single cells leftover from the aggregation process were analysed using 
a ViCell cell counter (Beckman Coulter) to determine numbers of live and dead cells 
per sample by the trypan blue dye exclusion method (see section 2.4.1).  In order to 
calculate aggregation efficiency, the numbers of live and dead cells from samples of 
digested EBs and suspended unincorporated cells leftover after EB formation, were 
calculated as percentages of the starting population of input pluripotent stem cells.   
To determine aggregate formation efficiency, aggregate formation protocols for 
scraped and forced aggregation were initiated with all iPSCs harvested from a single 
T25 flask of the same passage number each per experiment.  The T25 flasks of each 
passage were derived from a single confluent T25 flask of hiPSCs split 1:3 every 4 
days on reaching 70% confluency and cultured in parallel.  In these experiments, this 
consistent passaging ratio allowed an assumption that differences in starting hiPSC cell 
84 
 
numbers were negligible between T25 flasks of the same passage number.  This 
assumption was necessary because it was not possible to dissociate the hiPSC colonies 
required for scraped aggregation before scraping them into EBs.   
A motivating factor for investigating aggregation efficiency and the use of forced 
aggregation to control aggregate size, was to try to reduce the variability introduced in 
stem cell differentiation cultures by the unknown numbers of cells per EB in scraped 
EB formation.  To illustrate, if cell numbers making up individual EBs are ignored and 
only population level cell numbers are used, figure 3.2 A shows that average total 
numbers of cells making up EBs then appears misleadingly similar across techniques 
(Scraped: 313 cells/EB Standard deviation SD=72.63; Forced: 357 cells/EB SD=4253 
with no statistically significant differences observed between the average number of 
cells per EB).   
In order to investigate the efficiency of EB formation analysis of the constituent cell 
populations, similar numbers of input hiPSCs per T25 flask in each aggregation 
experiment were assumed to permit an evaluation of the aggregation efficiency 
between scraped and forced aggregation.  Figure 3.3 shows the percentage of 
unincorporated live and dead cells within the medium surrounding EBs and those 
obtained by digesting EBs.  Figure 3.3 shows aggregation efficiency varied 
significantly between techniques in both the MSU001 and BJIPS cell lines (Figure 
3.3A & B).  For example, in the MSU001 cell line, scraping resulted in significantly 
fewer cells incorporated into EBs and many more cells left dead in the medium at 24 
hours.  From forced aggregation the corresponding unincorporated, consisted of almost 
equal numbers of live and dead cells. Overall for the MSU001 hiPSCs, compared to 
scraping forced aggregation resulted in 5 fold (p<0.05) fewer unincorporated dead 
cells in the medium at 24 hours and 3 fold (p<0.05) more live cells within EBs (Figure 
3.3A). 
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Figure 3.2 (A) Average numbers of cells per EB calculated from total numbers 
EBs and total numbers of cells from digested EBs from scraped or forced 
aggregation without considering input cell population counts. Average numbers 
of cells per EB between aggregation techniques appear insignificant as a result.  
Total number of cells from EB digests / number of EBs after 24 hours.  Data are 
means ± Standard deviation, n=3.  (B) Graph shows the percentage of live cells 
after 24 hours as a portion of the input number of pre-aggregation IPS cells for 
scraped and forced aggregation.  Data are from means ± Standard deviation, 
n=3.  Students 2 paired T-test p<0.005. 
 
86 
 
 
 
 
 
 
 
 
Figure 3.3 Live and dead cell counts from aggregation by scraping or by forced 
aggregation for MSU001 IPS (A) and BJ IPS (B) cells.  24 hours post 
aggregation cell numbers of live and dead cells from unincorporated cells in the 
medium and digested EBs were counted using a Vi-cell counter (Beckman 
Coulter). Values are reported as mean ± SD and ANOVA single factor analysis 
performed on data for significant values of *p<0.05 and **p<0.001. 
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3.3 The impact of aggregation technique on EB size 
 
The impact of EB size on differentiation trajectories has been previously investigated 
to size controlled EBs promote biases in development towards specific cell lineages 
(Bauwens et al. 2008; Niebruegge et al. 2009).  To measure the impact of EB 
formation technique on the size of the resulting aggregates, EBs were imaged by light 
microscopy after 3 days in suspension culture.  Average EB diameters were measured 
for both scraped and forced aggregation EBs from the images by taking three length 
measurements as described in section 2.4.2.  The triplicate measurements from each 
EB were averaged to obtain average EB size measurements.  Figure 3.4 shows that as 
expected and in agreement with the manufacturers claims, EBs formed by forced 
aggregation in Aggrewell plates displayed greater control over EB size than those 
formed by the scraping and spontaneous differentiation technique (Figures 3.4 and 
3.5).   
Figures 3.4 and 3.5 show forced aggregation demonstrated consistent control over EB 
size in stark contrast to highly heterogeneous scraped EBs.  EBs formed by manual 
scraping varied greatly in diameter with a broad range between 25- 150µm (mean= 
77.65µm standard deviation (SD) = 48.33) (Figure 1B).  In contrast mean diameters 
for EBs formed by forced aggregation were slightly larger (101.43 µm) and far more 
consistent as reflected by the lower SD of 24.94.  The improved regulation of EB size 
can be directly attributed to the precise starting number of cells in each microwell 
ready to form each EB (Dang et al. 2002). 
After 48 hours EB diameter measurements were taken again for both scraped EBs and 
forced aggregation EBs.  As expected the average EB diameters were larger for both 
techniques scraped EBs had average diameters of 112.45 µm SD=15.57 and forced 
aggregation EBs averaged diameters of 124.06 µm SD=14.31.  The changes in EB 
sizes between t=24hrs and t=48hrs in this experiment can be attributed to growing EBs 
as well as aggregation of smaller sized EBs.  The EB volumes were also calculated for 
both the 24 and 48 hr EB populations. Using the average EB sizes as a proxy for EB 
diameter and assuming EBs to be spherical the average EB volumes for scraped EBs at 
24 hrs was 245,145 μm3 whilst the average volume of forced aggregation EBs was 
546,383 μm3 representing forced aggregate EBs to have larger volumes by 301,239 
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μm3 on average.  The same calculations performed for the 48 hour time points shows 
the average scraped EB volume was 744,520 μm3 against 999,755 μm3 for forced 
aggregation EBs, representing a difference of 255,234 μm3.  The reduced difference in 
EB volumes between 24 and 48 hrs for scarped versus forced aggregation EBs 
(301,239 μm3 vs 255,234 μm3) may indicate differences in growth rates for EBs with 
different starting sizes.  This hypothesis is supported by the greater delta EB volumes 
calculated for scraped EBs between 24 and 48 hours against forced aggregation EBs 
(499,376 μm3 vs 453,372 μm3) however; the assumption that all EBs are spherical is a 
caveat which must be taken into account in drawing any strong conclusions from these 
calculations (Table 3.1). 
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Figure 3.4 Size distribution plots show the variation in size per EB between 
techniques (A) scraped and (B) forced aggregation.  Sizes are taken as averages of 3 
length measurements per EB (transverse, dorso-ventral and diagonal) at 24 hours post 
aggregation.  EBs were cultured from MSU001 IPS cells. 
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Figure 3.5 Size distribution plots show the variation in size per EB between 
techniques (A) scraped and (B) forced aggregation.  Sizes are taken as averages of 3 
length measurements per EB (transverse, dorso-ventral and diagonal) taken at 48 
hours post aggregation.  EBs were cultured from MSU001 IPS cells. 
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Scraped Forced Aggregation 
 
 24 hrs 48 hrs 24 hrs 48 hrs 
EB diameter (μm) 77.65 112.45 101.43 124.06 
Volume V=4/3πr3 
(ml) 2.5^10-8 7.4^10-8 5.5 ^10-8 10.0 ^10-7 
Delta V (ml) 24-
48 hrs  5.0^10-8 4.5 ^10-8 
Delta V (ml) 
Scraped vs Forced 
Aggregation at 24 
hrs 3.0^10-8 
Delta V (ml) 
Scraped vs Forced 
Aggregation at 48 
hrs 2.6^10-8 
 
Table 3.1 EB volume calculations at 24 hrs and 48 hrs.  Calculated using measurements for 
average EB size as a proxy for EB diameter, EBs are assumed to be spherical for the 
calculations. 
 
3.4 Pluripotency and differentiation capacity of EBs 
 
The EBs formed of pluripotent stem cell colonies (Figures 3.6 and 3.7) remain 
pluripotent for longer than the first 24 hours post aggregation.  Newly formed EBs at 
24 hours are not expected to have differentiated and should express pluripotency 
markers (Pekkanen-Mattila et al. 2010).  In order to determine whether the formed EBs 
were still normally pluripotent, 24 hours old EBs were dehydrated in sucrose before 
cryopreservation in cryo-preservant OCT at -80oC.  The EBs were cryosectioned using 
a cryotome before immunochemical labelling to show expression of pluripotency 
markers SSEA4 and Oct4 (Figures 3.8).   
 
3.5 Differentiation capacity of EBs 
 
To assess the differentiation potential of the resulting EBs from each formation 
technique, they were differentiated in pro-retinal conditioned medium for 3 days and 
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analysed for retinal gene expression by QPCR analysis.  Differentiation was carried 
out under typical cell culture conditions (5% CO2 (v/v) incubator at 37 
0C and 90% 
humidity) EBs were left to grow in low attachment dishes (Nunc) with a full medium 
change at day 2.  Figure 3.9 shows that at day 3 of differentiation the EBs were 
harvested and QPCR analysis showed that EBs from both conditions had comparable 
expression profiles of each of the retinal markers investigated.  Consistent with the 
work of Mellough et al both scraped and Aggrewell EBs co-expressed P0u5F1 with 
retinal markers at this early stage (Mellough et al. 2012).   Interestingly we found the 
scraped EBs only out-performed the controlled size EBs for Pax 6 expression (a master 
transcription factor for retinal development) when compared to the smallest sized 1K 
cells/ EBs (Hsieh & Yang 2009; Larsen et al. 2009).   
 
3.6 Summary 
 
In summary, using Aggrewell plates for forming controlled size EBs made it possible 
to increase the efficiency of aggregation and improve the yield of cells incorporated 
into EBs by >3 fold.  Using forced aggregation also afforded greater control over EB 
size.  The increased homogeneity in EB size will be of particular use in attempts to 
synchronize EB development towards retinal cell lineages as discussed in chapter 4.  
We found that the use of forced aggregation did not adversely affect the cells in terms 
of viability nor did it impair their ability to differentiate towards retinal lineages.  The 
finding that scraped EBs displayed higher expression of Pax 6 was particularly 
interesting and prompted investigation into the impact of EB size on retinal 
differentiation, which was the major difference between the scraped and forced 
aggregation EBs.  Together these finding show that using scraped EB formation is 
wasteful and therefore inefficient as a system for future scale-up.  The use of forced 
aggregation addressed the issues of low yields and poor size control associated with 
scraped EB formation but appropriate sizes of EBs need to be selected to improve 
retinal differentiation propensity. 
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Chapter 4 – Establishing an orbitally shaken culture protocol 
to initiate retinal differentiation  
4.1 Introduction & Aims 
 
In this chapter an attempt was made to introduce the potential for scalability to the 
retinal differentiation protocol.  This was done by introducing orbital shaking to the 
suspension cultures of EBs whilst excluding the impact of a potential source of 
variability due to undefined quantities of xenogeneic ingredients found in Matrigel, 
commonly used in standard protocols for retinal differentiation (Table 1.4).   
The need for future-proof manufacturing strategies: Standard techniques for retinal 
differentiation use 2D adherent culture protocols reliant on open and manual 
processing techniques.  Manual processing techniques such as scraping stem cell 
colonies from tissue culture for EB formation are particularly labour-intensive and are 
therefore less amenable to scale up.  The commonly used protocols for retinal 
differentiation frequently include the use of undefined components (Table 1.4).  
Xenogeneic ingredients such as serum and the undefined matrix substrate Matrigel 
incorporated in these protocols leave the systems prone to contamination as well as 
batch quality variability arising from the numerous unquantified components they are 
comprised of (Davie et al. 2012).  As a result such protocols are less suitable to 
manufacturing scales beyond the laboratory research setting.    
Future therapeutic cell production strategies for allogeneic or autologous cell therapies 
will require closed, controlled, scalable and industrialized processes to deliver on the 
promise of the cell therapy industry.  Cell manufacturing processes will need to be 
agile as requirements will vary greatly according to optimal cell dose requirements.  
Annual production requirements could easily reach into trillions as current clinical 
trials explore doses of 100s of millions of cells and above per patient (van den Bos et 
al. 2013).  Translating variable 2D adherent and labour intensive protocols for cell 
differentiation into more controlled 3D suspension culture systems, presents an 
opportunity to improve the potential scalability of laboratory research and provide 
flexibility for future development of manufacturing processes. 
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Practical considerations before setting up orbital shaking experiments:  The 
retinal differentiation protocol used throughout our work already involves a suspension 
phase during the first 3 days post EB formation so, adapting the whole culture protocol 
to a suspension system in light of the work of others seemed plausible.  Orbital shaking 
culture in 24-well microwell plates was expected to provide better mixing of the costly 
nutrients, growth factors, signalling molecules and morphogens supplemented to the 
system and those produced by differentiating EBs within, than static conditions. 
Adaptation from an adherent to a suspension system together with the improved 
mixing expected from orbital shaking could eliminate dependency on the undefined 
matrix substrate Matrigel.  By adapting the process from 2D to a 3D culture, the EBs 
in suspension may no longer require Matrigel as a substrate to adhere to.  Removing 
Matrigel would reduce the impact of many unknown and unquantified factors, since its 
composition is proprietary with over 600 ingredients at undisclosed concentrations 
(Polykandriotis et al. 2008).     
To test the hypothesis that retinal differentiation is possible in an orbital shaken culture 
system we first needed to shortlist potential EB sizes for their capacity to differentiate 
along a retinal trajectory.  Secondly these EBs were ranked according to size and their 
ability to survive and endure orbital shaking culture as intact aggregates for 7 days.  To 
find suitable, controlled size EBs for retinal differentiation we assessed their ability to 
up-regulate expression of early eye field transcription factor genes, after 3 days of 
suspension culture in retinal differentiation medium.  EBs of varying sizes formed by 
forced or scraped aggregation techniques were treated equally and analysed for 
changes in retinal gene expression in parallel by QPCR at the end of the 3 day culture 
period.  
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4.1.1 Chapter Aims and Objectives 
 
In this chapter the aims are to: 
• Establish a range of EB sizes able to withstand orbital shaking conditions 
without being dispersed into the medium as single cells or clumping together to 
be able to establish orbital shaking cultures. 
• Test the hypothesis that retinal differentiation can be initiated with IPS cell 
derived EBs in an orbital shaken culture system without the use of Matrigel. 
• To characterize the impact of EB size on the onset of retinal differentiation in 
suspension culture. 
• To determine and characterize a suitable orbital shaking frequency for EB 
cultures 
 
 
4.2 Establishing a range of viable EB sizes permissive to retinal 
differentiation in suspension culture 
 
In order to identify ideal EB sizes suitable for higher throughput studies, they were 
ranked according to practical considerations.  Ease of EB handling was considered 
important to ensure EBs did not spend too long outside normal tissue culture 
conditions, during transfer from culture plates or whilst medium was changed.  
Consequently, it was important that EBs could easily be seen by eye for rapid counting 
and simple manipulation in assessing their suitability for the higher throughput 
experiments.  Forced aggregation as characterised in chapter 3 provided control over 
input EB size compared to scraped aggregation.  Consequently forced aggregation was 
adopted for subsequent experiments to form uniform sized EBs reproducibly.  Uniform 
sized EBs allow a comparison of different sized EBs for their suitability to tissue 
culture, before being assessed for potential retinal differentiation experiments and 
higher throughput studies to investigate a suitable orbital shaking frequency for retinal 
differentiation.    
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The ideal system for EB manufacture is required to be both practical in an academic 
laboratory setting and efficient, to produce enough EBs for future optimisation 
experiments (discussed in chapter 5) routinely and with minimal waste.  The first EBs 
to be excluded from further experiments were EBs formed of 1000 cells each.  These 
small sized EBs (~100µm diameters) were difficult to see by eye for quick counting 
and therefore not easy to manipulate for higher throughput experiments.  Taking into 
consideration the recent work of Sasai’s group, in which successful suspension culture 
for retinal differentiation was possible with larger EBs made of 9K cells/EB helped 
provide support for focusing experiments on larger EBs (Eiraku et al. 2011).  
Consequently a range of EB sizes: 5K, 10K, 15K and 20K cells/EB is assessed for 
amenability to scalable tissue culture techniques.   
In agreement with the reproducible EB sizes formed by forced aggregation as 
characterised in chapter 3, Figure 4.1 shows IPS cells seeded into Aggrewells at day 0, 
before the 24 hours of incubation required to form EBs after 24 hours (shown 
alongside them)  for  the selected sizes.  The representative images in the micrographs 
illustrate the expected uniformity of EB shape and diameters as assured by the 
manufacturers and characterised in chapter 3.  The suitability of different sized EBs as 
screened by eye for rapid assessment of EB uniformity and size, suggested any of these 
EB sizes could have been appropriate for further experiments.  Another key factor for 
consideration in addition to EB size however, was the practical feasibility of using 
larger EBs, which require more input hiPSC to form.   
The numbers of hiPS cells required to produce different sized EBs were used to 
calculate theoretical cell number requirements per experiment are represented in 
Tables 4.1 and 4.2.  The average number for hiPS cells harvested per T25 flask was 
derived from routine cell number calculations described in chapter 3 which showed an 
average cell yield of 6 x 10e6 cells/T25 flask.  Using the cell number requirements 
provided in the Aggrewell protocol, it was possible to calculate numbers of hiPSC 
required to produce each EB size and use these to calculate total cell numbers required 
to complete one full experiment.  Each experiment required sufficient material for 3 
analytical assays (immunohistochemistry, QPCR and an extra well for contingency 
repeat experiments) for 4 time points (days 3,10,15 and 21) as discussed in Chapter 5.     
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The theoretical calculations helped exclude the 15K and 20K EB sizes from shaking 
speed selection studies due to the impractically large numbers of cells (6.4 x 107 and 
8.6 x 10e7 cells) required to complete a full experiment.  The 5K and 10K sized EBs 
require 1.5 x 10e6 and 3 x 10e6 cells per Aggrewell respectively, numbers sufficient for 
triplicate experiments to be performed from the cells produced by 2 to 3 T25 flasks ) < 
18 x 10e6 cells in total.  Consequently the 5K and 10K EB sizes were found to be the 
most practical candidates for further experiments to determine the feasible shaking 
speeds for orbital shaken culture.  Furthermore the numbers of cells produced and 
required to complete experiments using 5K and 10K cells/EB ensured it was possible 
to produce sufficiently powered data from further differentiation experiments in order 
to assess the influence of size on retinal differentiation in triplicate for 3 time points 
over 21 days of culture.  
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Figure 4.1 Micrographs of IPS cells seeded into Aggrewells at day 0 to form 
EBs made from 5,000, 10,000, 15,000 and 20,000 cells shown beside them to the 
right after 24 hours.  A Nikon phase and fluorescence microscope was used to 
create all images with 4x magnification at day 0 and 10x at 24 hours.  Scale bars 
= 400µm 
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EB Size (no. 
cells per EB) 
Required no. cells 
per well 
Required no. T25 
IPS flasks  
yielding 6x10e^6 
Resulting number 
of EBs 
1000 1.E+06 0.2 1200 
5000 2.E+06 0.25 300 
10000 3.E+06 0.5 300 
15000 5.E+06 0.75 300 
20000 6.E+06 1 300 
No. 
Cells 
per 
EB 
EBs per 
well (24 
well 
plate) 
No. 
EBs 
per 
time 
point 
(n=3) 
Total 
no. EBs  
for 4 
time 
points 
Total no. 
EBs for 3 
assays 
per expt. 
Total 
Aggrewells 
per expt. 
Total no. 
cells per 
expt. 
Total no. 
T25 flasks 
yielding 
6x10e^6 
cells per 
expt. 
1000 40 120 1440 4320 14.4 1.73E+07 2.88 
5000 40 120 1440 4320 14.4 2.16E+07 3.6 
10000 40 120 1440 4320 14.4 4.32E+07 7.2 
15000 40 120 1440 4320 14.4 6.48E+07 10.8 
20000 40 120 1440 4320 14.4 8.64E+07 14.4 
Table 4.1 Total cell numbers required to form different sized EBs using the 
Aggrewell protocol. 
Table 4.2 Total cell numbers required per EB size calculated for numbers of experiments 
taking into account material required for analysis in triplicate at 4 different time points 
with 3 assays (QPCR, immunohistochemistry and cell quantification.  One experiment 
was designated to compose of 4 time points with 3 technical repeats and n=3 (biological 
repeats). 
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4.3 Selection of orbital shaking frequencies for EB culture  
 
To determine orbital shaking speeds which may support EB survival as separate 
entities for longer term cultures, EBs formed of 5K and 10K cells were cultured in 
orbital shaking suspension for up to 7 days.  EBs were assessed daily depending on 
how long it took for them to dissolve into the medium or clump into large aggregates. 
Daily assessment for survival or disaggregation of EBs into the medium was carried 
out rapidly by visual inspection.   
No previous reports describe retinal differentiation from human induced pluripotent 
stem cell derived EBs in orbital shaken cultures.  Consequently there was no directly 
relevant precedent for optimal shaking speeds with our cell culture system.  Therefore 
in order to find a range of shaking speeds for empirical testing, a combination of 
speeds from reports for orbital shaking cultures of murine stem cell cultures were used 
albeit from different vessel geometries.  Sargent et al.2010, reported that between 
orbital shaking speeds of 20 and 60 rpm in 100mm bacterial grade polystyrene Petri 
dishes, average EB area distributions decreased with increasing speed, indicating 
improved homogeneity of the EB sizes at higher speeds in their cultures.  Additionally 
Sargent et al., 2010 report increased cell yields from EBs shaken between 40 and 60 
rpm, providing the rationale to start testing for permissive shaking speeds beyond 50 
rpm the midpoint between 40 and 60 rpm.  In our experiments the search for a 
permissive shaking speed to support hiPSC derived EBs in shaking culture to an upper 
shaking speed of 240 rpm.  This speed selected with reference to another murine stem 
cell differentiation culture using this shaking speed for neural stem cell differentiation 
to oligonendrocytes in T75cm2 tissue culture flasks (Sher et al. 2012). 
The impact of different shaking frequencies on EB morphology were assessed over 7 
days of orbital shaken culture to provide an indication of the potential longevity of the 
EBs in orbital shaking culture.  Slower speeds, such as 50rpm resulted in 
agglomeration of EBs into large clumps while faster speeds, such as 150rpm resulted 
in their dissolution into the medium.  At a speed of 120rpm EBs were able to survive 
as individual entities over the 7 day culture period without showing signs of 
deterioration.  Representative images in Figures 4.2A and 4.2B show variation in EB 
morphology with orbital shaking speed.   
105 
 
Alongside the empirical determination of suitable shaking speeds able to support EB 
cultures by iterative experiments, the influence of shaking speeds on the liquid mixing 
was also theoretically investigated.  Predicted mixing speeds were calculated to 
determine the likely critical shaking speeds which define the transition between 
laminar and turbulent flow regimes under our culture conditions using the previously 
reported formula in (Weheliye et al. 2012b): 
   
ℎ
𝑑𝑖
= 𝑎𝑜  (
𝑑𝑖
𝑑0
)
0.5
𝐹𝑟𝑑𝑜    (1) 
and culture parameters in Table 4.2.  While the calculations supported a narrowing of 
the potential shaking frequencies to between N=115 and 140 rpm, finding the suitable 
shaking speed of 120rpm remained a mostly iterative empirical process.   
 
4.3.1 Determination of the critical shaking speed and flow regime  
 
It was possible to derive a critical Froude number and a range of critical shaking 
speeds (NCr) where flow transition occur at 115rpm and 140rpm for the minimal and 
maximal working volumes respectively (see Table 4.3 for details of dimensions, 
volumes, constants and determined values).  Theoretical calculations using the vessel 
dimensions, shaker diameter, working volume (table 4.3) with equation (1) above from 
(Weheliye et al. 2012a) suggested the empirically determined permissible rotational 
frequency of 120rpm, falls into a turbulent flow regime which should be evidenced by 
visible waves at the surface of the medium in each well (Weheliye et al. 2012a).  
However, it should be noted that it was only possible to calculate approximate values 
due to differences in the inner diameters between the vessels and a do/di > 0.6 in this 
report compared to a do/di between 0.2 and 0.5 in (Weheliye et al. 2012a). 
In the absence phase resolved image velocimetry (PIV) application, the lack of clearly 
visible waves at the medium surface under these conditions suggested that the medium 
and EBs may have been in a transitional flow regime.   During the calculations for 
deriving critical Froude numbers and critical shaking speeds, the constant value for 
viscosity (ao) was the value determined for water 1.4 as recommended in (Weheliye et 
al. 2012a).  Though retinal differentiation medium appears to be very similar to water 
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in its viscosity, the exact viscosity was not determined here and actual differences may 
help account for some of the variation observed.  Additionally the most obvious 
variation would be the addition of EBs in the present system whose volumes may be 
considered insignificant from the values calculated in Table 3.1.  
Differences in the well geometry parameters between our culture vessels and the two 
bioreactors vessels (inner diameters of 10cm and 13cm) used for the calculations in 
Weheliye et al. 2012 could also help explain the variation between the expected and 
observed flow regimes in this report.  In this report observations lacked waves and 
though a flat liquid surface with an elliptical shape during orbital rotation at 120rpm 
may be subjectively visible it is slight and would need confirmation using PIV 
(Appendix1).  Though the images in Appendix 1 are not definitive enough to claim the 
presence of an elliptical shape the result of a 3 minute mixing time and the lack of 
complex waves suggest that the fluid flow was in-phase under these operating 
conditions (Weheliye et al. 2012a). 
To investigate the potential influence of the introduction the additional volume of the 
EBs into the system, expected EB volumes were calculated for EBs made of 5K and 
10K cells per EB by forced aggregation at day 3 of culture.  Day 3 EBs were selected 
as this is the time point shaking is initiated in the retinal differentiation protocol for the 
experiments in this report.  Average EB sizes were used as a proxy for EB diameters to 
calculate EB volumes and surprisingly by day 3 the EB diameters were very similar for 
both the 5K (297.82 μm SD 60.8) and 10K (295.23 μm SD 64.54) EBs as depicted in 
the similar profiles of the size distributions of both 5K and 10K EBs at day 3 in Figure 
4.3.  Consequently expected average volumes calculated according to the formula: 
Volume V=4/3πr3 using the average EB diameters also showed great similarity (V= 
13.8^10-6 ml for 5K EBs and V= 13.4^10-6 ml for 10K EBs).  Importantly the 
relatively small volumes of the EBs are unlikely to account for the absence of expected 
wave forms at the liquid surface from the theoretical calculations and further 
investigations to understand the changes in the liquid viscosity which can alter the 
power required to break the surface tension of the fluid in the wells during the culture 
period would form potential future work (Buchs et al. 2001). 
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Figure 4.2 Micrographs of 7 day old stem cell aggregates cultured in retinal 
differentiation medium in orbitally shaken cultures at different speeds: (A: 50rpm) and 
(A: 150rpm) At speeds above 150 rpm there were no EBs to image after the first 
imaging time point of 24 hours.  (B) shows the improved survival rate of EBs made 
from 10,000 cells at the orbitally shaken speed of 120rpm at different magnifications 4x 
(Bi), 10x (Bii) and 20x (Biii). All images were taken using a Nikon Phase and 
Fluorescence Microscope.  Scale bars = 100µm. 
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Well Geometry and operating conditions Units 
Well inner diameter di 0.0156 m 
Orbital diameter do 0.01 m 
Fluid height hmin 0.00198914 m 
Fluid height hmax 0.00298371 m 
Liquid volume (min) Vl min 0.00000038 m3 
Liquid volume (max) Vl max 0.00000057 m3 
Shaking speed range N 10-500 min-1 
Critical dimensionless ratios 
 
  
hmin/di 0.127509 < (do/di)0.5   
hmax/di 0.191263 < (do/di)0.5   
ao 
1.4 
Water-like 
viscosities   
do/di 0.641026     
(do/di)0.5 0.800641 = h/hcr   
Derivation of Frcr from:   
 
  
h/di=ao(h/ h)cr Frcr hmin/di hmax/di Units 
Frcr 0.072921 0.10938079   
Ncr 1.903677 2.33151883 s-1 
Ncr 114.2206 139.89113 min-1 
  
 
 
 
 
 
 
 
 
 
 
Table 4.3 Parameters used to determine the critical shaking speed NCr for the 
minimal and maximal working volumes of 24 well microwells used for EB culture 
according to equation 6 in Weheliye et al., 2012. 
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Figure 4.3 EB size distribution pots for 5K (A and 10K (B) EBs formed by forced aggregation 
at day 3 of differentiation.  EB diameters are taken as averages of 3 measurements per EB 
(dorso-ventral, horizontal and diagonal).  EBs were cultured with MSU001 IPS cells. 
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4.4 Characterizing the impact of EB size on initiation of retinal 
differentiation in suspension culture 
 
In order to assess the impact of EB size on the onset of retinal differentiation, EBs 
were cultured in retinal induction medium in suspension for 3 days post-formation.  
The EBs were not shaken for the first 3 days of culture to remain consistent with the 
standard protocol and EBs formed by manual scraping were designated as control 
experiments.  Gene expression profiles from all EBs were normalised against internal 
reference genes β Actin and GAPDH before comparison against control scraped EBs 
using one way ANOVA analyses to investigate relative changes in gene expression for 
1K, 5K and 10K cell EBs. 
 
4.4.1 Pluripotency and retinal differentiation marker expression at 
day 3 (Figure 4.4) 
 
Expression of pluripotency marker P0U5F1 
A reduction in pluripotency within cell populations is evidenced by down-regulation of 
master regulators of pluripotency such as P0U5F1 (Oct4) (Hough et al. 2009).  A day 3 
comparison of the relative normalised expression of P0U5F1 with scraped EBs as the 
control showed the smaller 1K cell EBs did not present a statistically significant 
change in P0u5F1 expression (p>0.05), indicating similar levels of pluripotent cells 
persist in both scraped and smaller 1K EBs.  In contrast medium (5K) EBs showed a 
16.55 fold (p<0.05) reduction in P0U5F1 expression and the larger (10K) EBs 
displayed a 6.31 fold reduction (p<0.05) of the same marker.  Reduced P0U5F1 
expression in the 5K and 10K populations may indicate a transgression of pluripotent 
cells to differentiated states as they begin to specify into desired early eye field marker 
expressing cells.   
Expression of early eye field transcription factors: Pax6, Rx, Six3 and Otx2 
Activation of the early eye field transcription factors Pax6, Rx, Six 3 and Otx2 
characterises specification of the anterior neural plate which goes on to form the 
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retinae of developing vertebrate embryos (Bailey et al. 2004). The smaller 1K forced 
aggregation EBs displayed a 5 fold decreased expression of Pax6 (p<0.0005) and no 
significant changes in gene expression of the other retinal markers compared to the 
scraped controls, eliminating them from consideration as suitable for retinal 
differentiation.  In contrast the larger EBs did show increased expression of Pax6, Rx, 
Six3 and Otx2 indicating initiation of retinal differentiation.  The 5K EBs displayed a 
3.52 fold increase in expression of Rx (P<0.01) and a 2 fold up-regulation of Six3 
(P<0.05) compared to scraped controls.  EBs composed of 10K cells also showed 
significant up-regulation of Rx (3.12 fold, p<0.05) and Six3 (5 fold, p<0.001) 
compared to the scraped controls. The data presents a convincing argument for a 
favourable impact of EB size on retinal differentiation which is discussed further in 
Chapter 5. 
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Figure 4.4 Relative normalized expression of early retinal transcription factor genes, Pax6, 
Rx, Six 3 and Otx2 and pluripotency marker P0U5F1 in differentiated EBs at day 3. Samples 
of EBs made from forced aggregation with 1K (Ag1KD3), 5K (Ag5K D3) or 10K (Ag10K 
D3) cells/EB were normalized against expression profiles from scraped EBs.  All EBs were 
produced with MSU001 cells.  One way ANOVA of gene expression levels were performed 
against EBs made by scraping (*p<0.05, **p<0.01, ***p<0.001). 
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4.5 Summary 
 
In this chapter we found 2 EB sizes (5K and 10K cells/EB) which were suitable for 
investigating orbital shaking cultures and appropriate shaking speeds to support EBs to 
initiate retinal differentiation.  EBs composed of 5K and 10K cells each were found to 
be suitable for experiments to test EB survival under different shaking speeds due to 
their ease of manufacture, handling and practically feasible cell number requirements.  
Additionally the impact of EB size variation on the ability to express early markers of 
retinal differentiation Rx, Six3 and Otx2 after 3 days of suspension culture in retinal 
differentiation medium showed 5K and 10K EBs were more suitable for initiating 
retinal differentiation than smaller 1K EBs.  All of the early eye field transcription 
factors were expressed at day 3 for all EB sizes but more pronounced expression of 
retinal markers observed in the larger EBs coincided with their down-regulation of 
pluripotency marker P0U5F1 expression.  The coinciding up-regulation of early eye 
field markers with down-regulation of P0U5F1 suggested that the larger EB 
populations were advancing into retinal differentiation faster than both smaller 1K EBs 
and the scraped EB controls. 
As a result the 5K and 10K EBs were taken forward in experiments to determine the 
suitable shaking speed of 120rpm.  At this orbital shaken speed EBs survived 7 days in 
culture as single entities, without showing signs of deterioration observed at higher 
speeds and the EB agglomeration detected at lower shaking speeds (Figure 4.2).  This 
specified the suitability of EBs formed by forced aggregation from 5K and 10K 
cells/EB, for further studies to investigate progression of retinal differentiation 
discussed in chapter 5.   
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5.0 The impact of size controlled EBs and orbital shaking on 
the progression of retinal differentiation over 21 days in a 
Matrigel-free culture  
 
5.1 Introduction 
 
Current methods to produce retinal photoreceptor-like cells from pluripotent stem cells 
in adherent or static suspension protocols typically involve culture timeframes between 
10 and 126 days with an average culture period of 58 days (Ramsden et al. 2014).  In 
order to assess the suitability of orbital shaking for the differentiation over long culture 
periods, we determined a period of 21 days to measure the impact of orbital shaking 
and initial EB size on the progression of differentiation towards retinal cell fates, as 
evidenced by key retinal gene expression profiles detected by QPCR and 
immunohistochemical analyses.  The 21 day timeframe allowed enough time to detect 
expression of later retinal markers which were also detected in preliminary 
experiments by day 15.    
Within the human retina photoreceptors make up >70% of the final cell population  
(Curcio et al. 1990; Hendrickson et al. 2008).  Consequently up-regulation in the 
expression of markers for retinal differentiation followed by photoreceptor specific 
genes expression in differentiating EB cultures can indicate their level of progression 
through retinal fate specification.  In order to track retinal differentiation the early eye 
field transcription factor Otx2 and the photoreceptor precursor and homeodomain 
transcription factor protein cone-rod homeobox (Crx) indicate earlier retinal 
differentiation states.  The presence of more mature cell types within the differentiating 
EBs are indicated by upregulated expression of the basic motif-leucine Neural Retinal 
Leucine Zipper transcription factor (Nrl) a regulator of photoreceptor development/ 
function and another photoreceptor specific gene for the visual pigment Rhodopsin 
(Rho) (Bailey et al. 2004; Hendrickson et al. 2008; Pan et al. 2011). 
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Previous reports have shown that larger EBs can contain neural enriched cells and an 
EB size of 9K cells/EB has also been found to be optimal for the efficient generation 
of retinal progenitor cells from hESC in another report (Nakano et al. 2012; Bauwens 
et al. 2008). To our knowledge there is no report yet, which combines the impact of 
EB size variation on differentiation towards a retinal lineage with orbital shaking 
culture.  To investigate the influence of changing EB size in adherent and orbital 
shaken cultures during differentiation experiments two EB sizes, 5K and 10K EBs 
were chosen.  The 5K and 10K EBs were picked in favour of smaller 1K or scraped 
uncontrolled EBs from chapter 4 (initiation of retinal differentiation) as they showed 
the highest expression of early retinal differentiation markers compared to static 
adherent controls at day 3 and survived 7 days of orbital shaken culture.  In this 
chapter in order to allow separate analyses of the effects of orbital shaking and those of 
varying EB size, the input EBs used in adherent control samples were also size 
matched to their paralleled orbital shaken cultures. 
The aim of the work in this chapter is firstly to test whether orbital shaking can 
continue to support progression of retinal differentiation beyond 3 days in culture (as 
observed in chapter 4).  We investigate whether the resulting micro-environment is 
conducive to the production of later retinal cell types such as photoreceptor cells, in the 
absence of supplementation with Matrigel through the measurement of total cell yields, 
cell health and the expression of retinal markers.  The influence of EB size on retinal 
differentiation is considered in both the adherent and orbital shaken systems, firstly by 
controlling the input EB sizes and secondly by tracking changes in EB diameters over 
the 21 day culture period.  
 
5.1.1 Aims and Objectives 
 
 To test the hypothesis that progression of retinal differentiation is 
possible in orbital shaken cultures without Matrigel supplementation up 
to 21 days.  
 Investigate changes in EB size with time, in orbital shaken cultures with 
for 2 different EB sizes (5K and 10K cells/EB).  
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 Assess the impact of orbital shaking during retinal differentiation on 
cell health and yields. 
 Characterize the effect of EB size variation and orbital shaking on 
progression through retinal differentiation by gene expression analyses.   
 
 
 
 
5.2 Characterising the impact of orbital shaking culture on retinal 
differentiation 
5.2.1 EB morphology and size variability 
 
Over the of 21 days of orbital shaking culture, light microscopy images of the 
differentiating EBs enables us to observe a close relationship in morphology between 
the 5K and 10K EBs.  The images taken were mostly indistinguishable between the 2 
sizes showing similar responses to orbital shaking throughout the culture period.  
Figure 5.1 shows the 5K and 10K EB cultures as they appeared under a light 
microscope at days 3, 10, 15 and 21 the key sampling time points chosen over the 
duration of the experimental period.  Morphologies were similar in both EB size 
cultures showing a rise in the number of dense, dark centred EBs and hollow bubbly 
EBs, as they progressed along the 21 days of culture.  The edges of EBs also 
frequently appeared to possess secondary structures such as phase dark rings around 
the EB perimeters, occasional invaginations along the edges of EBs as well as optic 
cup like shapes (Figure 5.1 D15), similar to previously reported observations in 
protocols for neural epithelial induction (Nakano et al. 2012; Eiraku et al. 2011; 
Heavner & Pevny 2012). 
The larger 10K EB were sometimes distinguishable from the smaller 5K EBs when 
they appeared denser and larger at later time points.  The densest cores were suspected 
of being necrotic centres which prompted investigation into the cell health with LDH 
assays and assessment of cell yields between the 2 EB size cultures (section 5.2.4).  
Although we did not directly test whether the centres of dense EBs were necrotic there 
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was often an absence of nuclear marker DAPI staining at the centres of EBs.  The 
immunocytochemistry assays of cryosectioned EBs in Figure 5.10(A) together with the 
observed increase in LDH release over time seen in Figure 5.4 (B) may provide 
evidence to support the hypothesis that some larger EBs had necrotic cores.  An 
assessment of the changes in EB sizes over the culture duration was also performed to 
investigate how different EB starting sizes correlated with different EB sizes observed 
throughout the culture period. 
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Figure 5.1 Representative micrographs of MSU001 retinal EBs made from 5000 
or 10,000 cells at days 3, 10, and 21 of retinal differentiation. Scale bar = 400µm 
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5.2.2 EB size variation during retinal differentiation 
 
Aggregate size was specified at EB formation by using forced aggregation as 
demonstrated in chapter 3 but the EBs varied greatly in size over the culture period.  
Creating uniform EB sizes to initiate cultures firstly helped assess the impact of input 
EB size on the onset of retinal differentiation.  Secondly, uniform EB sizes facilitated 
the selection of 2 EB sizes which were subsequently used to investigate the feasibility 
of orbital shaking retinal differentiation culture and the removal of Matrigel from the 
system.  Reducing the impact of initial EB size as a culture variable aimed to facilitate 
the investigation of the impact of the introduction of orbital shaking as a factor, on 
both the onset of and progression through retinal differentiation up to 21 days.   
Instead of observing uniform sized EBs throughout the culture period, EBs varied 
greatly in size.  The EB size variations were characterised by performing EB diameter 
measurements throughout the culture period to create cumulative frequency plots for a 
visual representation of the size distribution of EB populations over the culture period.  
The data show similar patterns in EB size variation over time were observed in EBs 
made from 5K or 10K cells (Figure 5.1A and B).   
 
5.2.3 Characterising size variation over 21 days of retinal 
differentiation 
 
By day 3 of retinal differentiation culture (white bars on Figure 5.2 (A) and (B)) most 
EBs from both 5K and 10K populations measured between 200-600µm in diameter 
with fewer than 20% measuring ≤ 200µm.  At day 10 the majority of EBs remained 
categorized between 200-600 µm for both 5K and 10K EBs which may indicate the 
existence of a potential optimal size for this stage of retinal development in orbital 
shaken culture (Figure 5.2).  By day 15 (dark grey bars on Figure 5.2) a similar pattern 
is again observed for both the 5K and 10K EBs, which by this time in culture span the 
full range of EB diameters in an almost normal distribution (Figure 5.3).  Between 
days 3 and 15 however we observe the majority of EBs (~80%) were split almost 
evenly between the 3 specific size categories.  200-400µm, 401-600 µm and 601-
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800µm (Figure 5.2).  No significant variation was observed in the spread of EBs 
categorised into each of the size ranges in either the 5K or 10K EBs suggesting that 
between days 3 and 15 both cultures behaved similarly in their progression through  
differentiation in terms of EB size. 
The first signs of variation between the EB size distributions of cultures initiated with 
either 5K or 10K EBs was observed at day 21.  By day 21 in orbital shaken culture, 
~40% of the larger 10K EBs measured between 800-1000 µm in diameter, while the 
majority of 5K EBs (~80%) were categorised into a smaller size range between 600-
800 µm, with less than 20% of them achieving EB diameters above 800µm.   
More detailed analyses of these cell populations to provide insight into the nature of 
the differences observed in different EB sizes over time during retinal differentiation 
would be possible with FACS analysis approaches.  FACS analysis would facilitate an 
investigation into the relationship between EB size and retinal differentiation at the 
cellular level to provide constituent retinal cell populations within EBs.  While this 
would form interesting future work, time restraints and challenges with resolving EBs 
into single cell populations made this an unfeasible option for this report.  Instead here, 
we present a correlation between variation in EB size distribution throughout the 
culture period with culture oxygen saturation and culture pH as illustrated in Figures 
5.5 and 5.6.   
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Figure 5.2 Size distribution of retinal EBs formed of (A) 5000 or (B) 10,000 cells per EB 
between days 3 and 21 of culture.  MSU001 retinal EB diameters were measured to 
determine the spread of EB size with time in differentiating EB cultures.  EB diameters 
were measured at each time point (n=100) and average diameters used to determine size 
distribution from absolute percentage frequencies of EBs in each size bracket between ≤ 
200µm and > 1000µm in diameter.  The percentages of EBs populating each size bracket 
are presented above.  EBs were imaged using a phase contrast microscope and images were 
analysed to measure average diameters using Image J software.    
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Figure 5.3 A comparison of the size distribution of MSU001 EBs with different 
starting sizes through differentiation at day 10 (A) and day 15 (B).  Cumulative 
frequency distribution plot was calculated using 3 measurements of diameter per EB 
(n=100) to determine average sizes, which have been allocated to different size 
bands according to frequency.  MSU001 EBs were formed with 5,000 or 10,000 
cells and cultured in retinal differentiation medium for 10 or 15 days. 
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5.2.4 Cell quantification and cytotoxicity analyses 
 
Pico Green Assay for cell quantification from absolute DNA  
The Pico Green absolute DNA quantification assay (Life technologies) helped to 
assess the impact of orbital shaking culture on cell yields.  By plotting a standard curve 
using absolute DNA quantification measurements from known quantities of 
pluripotent cells, it was possible to estimate total cell numbers present in samples of 
EBs in adherent and orbital shaken cultures a using linear regression approach.  A 
further comparison of DNA quantified from cell samples of orbital shaken cultures 
with absolute DNA quantified from control adherent cultures helped measure the 
impact of orbital shaking on cell numbers (Figure 5.4(A)).  For each experiment, in 
both adherent and orbital cultures, 40-50 EBs were plated per well of a 24 well plate 
and medium was changed as necessary (every 2 days up to day 15 then daily up to day 
21).  Interestingly, the relative quantities of cells remained similar across culture 
techniques and between different starting size EB populations under the same culture 
conditions.  The striking similarity between the different culture systems poses the 
question,  whether nutrient availability may have become a limiting factor for 
continued growth of  cells and the possibility  that available nutrients could only 
support a maximum of around 2^106 cells per well for both adherent and orbital shaken 
systems.     
 
LDH Colorimetric Assay for quantification of cell death 
To investigate whether the similarity between total cell quantities observed between 
different cultures was due to an increase in levels of cell death or cell lysis; we 
measured the Lactate Dehydrogenase (LDH) released into the medium using an LDH 
colorimetric assay (Abcam).  The results indicated that LDH release increased over the 
culture period for both EB sizes in orbital shaken cultures.  Figure 5.4(B) shows the 
increase in LDH activity measured from the spent medium of cultures over 21 days 
with 5K and 10K EBs.  The graph in Figure 5.4B shows a rise in levels of LDH up to 
day 16 and then a gradual decrease for the remainder of the culture period.  The 
apparent decrease in LDH activity measured from day 16 to 21 `is actually an artefact 
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of the experiment, wherein the medium exchange regime was changed from every 48 
hours to every 24 hours from day 15 onwards as indicated on graph 5.4(B).   
 
 
 
 
 
Figure 5.4 (A) Cell quantification of retinal EBs Relative cell numbers were obtained 
using the Quant-iT Pico-Green (Invitrogen) DNA quantification method.  Samples of 
5K and 10K adherent EBs at day 10 (Adh D10 5K, Adh D10 10K) and for orbital 
shaken cultured EBs at days 10 and 15 (SD D10 5K, SD D15 5K and SD D10 10K and 
SD D15 10K).  Cell numbers were calculated by reference to an IPS cell DNA standard 
curve.  (B) LDH activity in suspension cultures.  LDH activity of LDH released into 
the supernatant of retinal differentiation cultures from 5K and 10K EBs over 21 days of 
differentiation in orbital shaken culture. 
Medium Δ every 48hrs Medium Δ every 24hrs 
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5.3 Immunocytochemistry analyses show retinal marker expression 
in orbital shaken cultures is comparable to that of static culture  
 
To determine whether EBs in orbital shaken culture were able to differentiate along a 
retinal trajectory, immunocytochemical analyses were performed to test for protein 
level expression of early eye field marker orthodenticle homeobox 2 (Otx2) and the 
later expressed photoreceptor specific transcription factor, the cone-rod homeobox 
(Crx).  The presence of octamer-binding transcription factor 4 (Oct4 or P0U5F1) was 
also detected indicating the persistence of cells maintaining a pluripotent state within 
the cultures. 
Both adherent control (Figures 5.5, 5.6 and 5.7) and orbital shaken (Figures 5.8 and 
5.9) cultures expressed markers for retinal differentiation in the 5K and 10K size EB 
populations (5K and 10K EBs).  Representative immunocytochemistry images showed 
comparable protein level expression of the early field transcription factor Otx2 and the 
later expressed photoreceptor precursor marker Crx in adherent and orbital shaken 
culture systems.  Interestingly, with no major differences in retinal marker expression 
were observed from the immunostain micrographs between the culture systems, or 
amongst different sized EBs, at each time point investigated.  Additionally there 
seemed to be no visibly detectable difference in immunostain intensity between the 
markers of retinal differentiation and P0U5F1 (Figure 5.5) at day 10.  The apparent 
similarity in pluripotency marker P0U5F1 and retinal marker expression may indicate 
that, for day 10 at least, EB size variation between 5k and 10K may not have been 
sufficient to affect the rate of loss of pluripoytency or the rate of acquisition of retinal 
marker expression.  Without observable differences in marker expression between the 
2 EB sizes further investigations to measure the differences were performed using a 
QPCR approach. 
Evidence for the protein level expression of early and later retinal markers by 
immunohistochemistry presented in Figures 5.5 – 5.9 was an important step in 
demonstrating that eye field cells, including photoreceptor precursor cells were likely 
to be present in both the adherent and orbital shaking cultures.  More detailed analyses 
were however necessary to quanitfy changes in the constituent cell populations 
between systems and over time at the genetic level using QPCR.  Real-time 
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quantitative polymerase chain reaction analyses were performed on samples 
throughout the culture period at days 10, 15 and 21.  The QPCR approach enabled 
measurements to be taken to represent changes in the level of expression of eye-field 
transcription factors over the course of the differentiation, in response to differing 
input EB sizes and culture techniques (adherent  vs orbital shaken).    
Figure 5.5 Immunocytochemistry of adherent retinal EBs made from 5K cells at day 10, 
for pluripotency marker P0U5F1, early retinal transcription marker Otx2 and 
photoreceptor precursor marker Crx. Scale bars = 400µm. 
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Figure 5.6 Immunocytochemistry of adherent retinal EBs made from 10K cells at day 10, 
for pluripotency marker P0U5F1, early retinal transcription marker Otx2 and 
photoreceptor precursor marker Crx.  Scale bars = 400µm. 
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Figure 5.7 Immunocytochemistry of adherent retinal EBs made from 5K or 
10K cells at day 15, for early eye field transcription factor Otx2, photoreceptor 
precursor marker Crx, nuclear stain DAPI ad corresponding phase images.  
Scale bars = 400µm. 
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Figure 5.8 Immunocytochemistry of cross-sections of orbital shaken retinal EBs made 
from 5K cells/EB at days 10, 15 and 21 of retinal differentiation culture.  Images show 
early eye field transcription factor Otx2, photoreceptor precursor marker Crx and nuclear 
stain DAPI.  Scale bars = 400µm. 
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Figure 5.9 Immunocytochemistry of cross-sections of orbital shaken retinal EBs made 
from 10K cells/EB at days 10, 15 and 21 of retinal differentiation culture.  Images show 
early eye field transcription factor Otx2, photoreceptor precursor marker Crx and nuclear 
stain DAPI.  Scale bars = 400µm. 
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5.4 QPCR Analyses of retinal differentiation in adherent and orbital 
shaken cultures  
 
Progression through retinal differentiation was quantitatively assessed by QPCR 
analyses of the transcriptiomes extracted from samples of EBs cultured in retinal 
differentiation medium in adherent or orbital shaken cultures. Triplicate samples of 
EBs formed from 3 different hiPSC passages, cultured in both adherent and orbital 
shaken sytems were frozen at -800 C for QPCR analyses at days 10, 15 and 21 of 
differentiation.  Data for the relative expression of eye-field transcription factors and 
pluripotency marker P0U5F1 are presented in graphs in Figures 5.10 to 5.15.  Over the 
course of the differentiation protocol, changes in gene expression for eyefield 
transcription factors Otx2, Crx, Nrl and Rho were compared between adherent and 
orbital shaken cultures.   
The aim was to compare expression levels between each EB size and across culture 
techniques separately for each time point.  Firstly, relative marker expression is 
compared according to EB size, keeping the culture techniques constant so as to 
observe the impact of the culture technique on retinal differentiation at each EB size.  
The second part of each QPCR data set presented, allows a comaprison of the changes 
in gene expression arising from modifying the culture technique from adherent to 
orbital shaken culture for both EB sizes.  This approach was used to simply highlight 
differences in gene expression arising specifically as a result of changing either EB 
size from 5K to 10K cells/EB or the culture technique from adherent to the orbital 
shaking system.    
 
5.4.1 Day 10 QPCR Analyses of EFTFs and P0U5F1 expression  
 
At day 10 all of the eye field transcription factor genes investigated were expressed at 
low levels.  At day 10 no statistically significant variations were observed between 
different sized EBs whether they were cultured in adherent or orbital shaken protocols 
(Figure 5.10A and B).  ANOVA analyses comparing gene expression profiles of 
P0U5F1, Otx2, Crx, Nrl and Rho between size-matched  adherent and orbital shaken 
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samples  also showed no statistically significant differences (p>0.05) (Figure 5.11).  
Together the QPCR data at day 10 show adherent and orbital shaken cultures to be 
equivalent in their expression of the selected markers of differentiation towards retinal 
cell lineages. 
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Figure 5.10 The impact of EB size on differentiation in adherent and orbital shaken culture at 
day 10.  Relative expression of eye field transcription factor genes Otx2, Crx, Nrl, Rho and 
pluripotency marker P0U5F1 in EBs at day 10 for (A) adherent (Adh 5K & Adh 10K) and (B) 
orbital shaken cultures (SD 5K & SD 10K).  Retinal EBs with formation sizes of 5K or 10K 
cells/EB were produced using MSU001 cells.  
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Figure 5.11 The impact of orbital shaken culture on differentiation at day 10.  A day 10 
comparison of gene expression profiles between size-matched EBs of (A) 5K or (B) 10K 
cells cultured in control adherent (Adh 5k & Adh 10K) versus orbital shaken cultures (SD 
5K & SD 10K).  Relative expression of eye field transcription factor genes Otx2, Crx, Nrl, 
Rho and pluripotency marker P0U5F1.  EBs were produced using MSU001 cells.   
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5.5 Day 15: QPCR Analyses of EFTFs and P0U5F1 expression 
5.5.1 The impact of varying EB size at day 15 
The impact of varying input EB size from 5K to 10K cells/EBs on differentiation at 
day 15 was measured by comparing the relative gene expressioin profiles of EBs of the 
same size cultured in either adherent or orbital shaken protocols (Figure 5.12).   
Adherent cultures (Figure 5.12A) 
EBs from matrigel containing adherent cultures at day 15 showed comparable levels of 
expression of the earlier retinal transcription factors Otx2 and Crx regardless of EB 
size by day 15 of retinal differentiation culture.  However, by increasing EB size from 
5K to 10K cells/EB we observed a significantly reduced expression of later 
photoreceptor markers Nrl (1.6 fold p=0.034) and RHO (1.45 fold p=0.023).  In 
adherent cultures, 5K EBs also showed much higher expression of pluripotency marker 
P0U5F1 than 10K EB populations (3.36 fold p=0.0007).  The data seem to suggest that 
5K EBs were better suited to retinal differentiation in orbital shaken culture than larger 
10K EBs. 
Orbital shaken cultures (Figure 5.12B) 
By day 15 EBs with either 5K or 10K starting sizes in orbital shaken cultures still 
showed a closer correlation in their retinal marker and P0U5F1 expression, with the 
exception of one gene (Rho).  The data show that 10K EBs in orbital shaken culture 
showed a 1.69 fold reduction in Rho expression compared to the 5K EB samples.  All 
other genes were expressed at comparable levels, without any statistically significant 
changes observed.  
In summary, the impact of increasing EB size from 5K to 10K EBs on differentiation 
at day 15, seemed to downregulate expression of pluripotency marker P0U5F1 in both 
adherent and orbital shaken cultures.  Interestingly, the downregulation of P0U5F1 in 
larger EBs coincided with a reduction in Rho expression for both adherent and orbital 
shaken cultures.  5K EBs at day 15 therefore contain more pluripotent cells and more 
Rho positive photoreceptors than the 10K EBs.   
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5.5.2 The impact of  orbital shaking culture on retinal marker 
expression in size matched EBs at day 15 of differentiation  
In order to fairly and separately analyse the impact of orbital shaking on progression of 
retinal differentiation at day 15, gene expression profiles from EBs of the same size 
cutured in either adherent or orbital shaken protocols are analysed separately.     
Orbital shaking - 5K EBs (Figure 5.13A) 
A comparison of the gene expression profiles of size-matched (5K) EBs between 
adherent and orbital shaken cultures revealed that at day 15, orbital shaking results in 
comparable levels of early retinal marker Otx2 and photoreceptor precursor marker 
Crx between the culture techniques. For later photoreceptor-specific markers, Nrl 
expression is up-regulated in orbital shaken cultures (2.39 fold, p=0.026), while the 
change in expression of Rho remained negligible.  Interestingly, there was a much 
larger downregulation in expression of pluripotency marker P0U5F1 in orbital shaking 
compared to adherent cultures (8.08 fold, p=0.000015). 
Orbital shaking - 10K EBs (Figure 5.13B) 
In direct comparisons between size matched (10K) EB cultures across adherent and 
orbital shaken systems, at day 15 orbital shaken culture provides a greater impact on 
the expression of retinal markers and P0U5F1 than in adherent cultures than in 5K 
EBs.  For early eye field markers, orbital shaken culture of 10K EBs results in a 5.16 
fold downregulation (p=0.00386) of Otx2 and expression of photoreceptor precursor 
marker Crx is also significantly reduced (6.36 fold p= 0.00049) compared to the 
adherent 10K EB controls.  The photoreceptor marker Nrl however was expressed at 
2.93 fold higher (p=0) levels in orbital shaken cultures than adherent cultures with 10K 
EBs.  Suggesting that 10K EBs cultured in orbital shaken cultures may have conisted 
of more mature retinal cell populations than their adherently cultured counterparts. 
Together with the down-regulation (3.6 fold, p= 0.01) of pluripotency marker P0U5F1 
in these cultures the data may indicate that orbital shaking cultures accelrate 
differentiation toward retinal lineages when compared to adherent cultures, without the 
addition of Matrigel. 
Together the QPCR data show that when compared to size matched adherent cultures 
containing Matrigel, orbital shaking culture promoted a decrease in expression of 
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pluripotency marker P0U5F1 whilst upregulating photoreceptor marker Nrl in both 5K 
and 10K EBs.  For the larger 10K EBs, this pattern was accompanied by a coinciding 
reduction in the early markers of retinal differentiation Otx2 and photoreceptor 
precursor marker Crx, further supporting the hypothesis that these cultures contained 
more mature differentiated poplulation of retinal cells.  
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Figure 5.12 The impact of EB size on differentiation in adherent and orbital shaken 
cultures at day 15.  Relative expression of eye field transcription factor genes Otx2, Crx, 
Nrl, Rho and pluripotency marker P0U5F1 in EBs at day 15 for (A) adherent (Adh 5K & 
Adh 10K) and (B) orbital suspension cultures (SD 5K & SD 10K).  Retinal EBs with 
formation sizes of 5K or 10K cells/EB were produced using MSU001 cells. 
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Figure 5.13 The impact of orbital shaken culture on retinal differentiation of EBs made from 
5K or 10K cells/EB at day 15.  A day 15 comparison of gene expression profiles between 
size-matched EBs of (A) 5K or (B) 10K cells cultured in adherent (Adh 5K and Adh 10K) 
versus orbital shaken cultures (SD 5K & SD 10K).  Relative expression of eye field 
transcription factor genes Otx2, Crx, Nrl, Rho and pluripotency marker P0U5F1.  EBs were 
produced using MSU001 cells 
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5.6 Day 21: QPCR Analyses of EFTFs and P0U5F1 expression 
5.6.1 The impact of varying input EB size on retinal differentiation at 
day 21 
 
Adherent culture (Figure 5.14 A) 
After 21 days in culture the gene expression profiles of adherent EBs show that the 
larger 10K EBs express less Nrl (1.28 fold, p=0.0217) than the 5K EBs.  In the 10K 
EBs, the reduced Nrl expression is accompanied by downregulation of P0U5F1 (1.83 
fold, p=0.03127) but no significant changes are observed in gene regulation of the 
other markers of differentiation in response to a change in EB size.   In summary, the 
QPCR data at day 21 shows the impact of increasing EB size from 5K to 10K was to 
cause a reduction in the expression of pluripotency marker P0U5F1, signaling a 
reduction in the presence of pluripotent cells in the cultures.  The reduced expression 
of photreceptor marker Nrl in adherent cultures but not in orbital shaken cultures was 
an interesting finding which warrants further immunohistochemical or FACS analyses 
to try and establish the identitiy of the cultured cells.    
Orbital shaken cultures (Figure 5.14 B) 
21 days in orbital shaken culture resulted in more homogenous gene expression 
profiles between both 5K and 10K EB sizes.  The photreceptor precursor marker Crx 
was the only significantly differentially expressed gene between the 10K and 5K EBs 
with a 1.79 fold (p= 0.04863) reduced expression in larger 10K EBs. The rest of the 
markers for retinal differentiation (Otx2, Nrl and Rho) and marker of pluripotency 
P0U5F1, were expressed at similar levels with no statistically significant differences 
observed between them.  The higher expression reduced expression of Crx in larger 
EBs in orbital shaken culture, once again may support the idea that the cell populations 
within these 10K EBs may have differentiated to more mature types 
With only one differentially expressed gene (Crx) between 5K and 10K EBs in orbital 
shaken culture, the data also suggests that by day 21, EBs in orbital shaken cultures 
may be composed of more homogenous cell populations than their adherent culture 
counterparts which showed differential expression in Nrl and P0U5F1.   
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5.6.2 The impact of orbital shaken culture on EBs at day 21  
 
5 K EBs in orbital shaken culture at day 21 (Figure 5.15 A) 
For smaller 5K EBs at day 21, expression of the early eye field transcription factor 
Otx2 and photoreceptor precursor marker Crx were similar, with no statistically 
significant differences detected between adherent and orbital shaken cultures.  
Photoreceptor marker Nrl did show differential expression between the cultures with a 
downregulaton of 1.4 fold (p=0.00188) in orbital shaken cultures compared to adherent 
controls.  No significant differences were observed in the expression of the later 
photoreceptor marker Rho.   
Expression of the pluripotency marker P0U5F1 was  significantly reduced in orbital 
shaken cultures (8.14 fold, p=0.00029).  The large reduction in expression of 
pluripotency marker P0U5F1 may provide some support for the hypothesis that orbial 
shaking can help accelerate differentiation but the coinciding evidence for 
downregulation in expression of Nrl may lie in contradiction.  The reduced Nrl 
expression in 5K EBs in orbital shaken compared to adherent cultures, may suggest 
that orbital shaking may have ceased to support continued differentiation of 
photoreceptors by day 21.  The higher expressionn of Nrl in adherent cultures at day 
21 could also be a result arising from the effects of undefined ingredients present 
within Matrigel which have provided an advantage for Nrl expression at this time 
point.  
10K EBs in orbital shaken culture at day 21(Figure 5.15 B) 
As with the 10K EBs in orbital shaken culture at day 15, larger 10K EBs in orbital 
shaken culture at day 21 also showed a greater down-regulation in  expression of early 
eye field marker Otx2 (3.21 fold, p=0.00336) compared to their adherent controls.  
Also in line with the day 15 gene expression profiles, 10K EBs in orbital shaken 
culture showed significant downregulation in Crx expression (7.95 fold, p=0.00027) 
when compared to their size-matched adherent controls.  Unlike the day 15 10K EBs 
however, at day 21 Nrl expression between adherent and orbital shaken cultures was 
comparable without any statistically significant differential expression between the 
culture systems.  Finally expression of the pluripotency marker P0U5F1 also follows 
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the pattern from day 15 and a significant reduction in expression is observed in the 
10K EBs in orbital shaken culture (4.37 fold, p=0.00032) compared to their adherent 
controls.   
Together the day 21 gene expression profiles of 10K EBs at day 21, also support the 
idea that cultures of larger EBs in the orbital shaken system may have consisted of 
more differentiated cell populations than their adherent counterparts.  The  
downregulation of pluripotency (P0U5F1) and early markers of retinal differentiation 
(Otx2 and Crx) support this claim and the similar expression of Nrl between the 
adherent and orbital shaken cultures for larger 10K EBs may also suggest orbital 
shaken culture supports later differentiation in larger EBs better than for smaller 5K 
EBs.  Alternatively it may have been the case that both orbital shaken and adherent  
culture of 10K EBs at day 21 ceased to support continued differentiation of the EBS or 
that both systems had reached maximal expression of Nrl by this time point.  
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Figure 5.14 Impact of EB size on differentiation in adherent (A) and orbital shaken (B) cultures 
at day 21.  Relative normalized gene expression of eye field transcription factor genes Otx2, 
Crx, Nrl, Rho and pluripotency marker P0U5F1 in EBs at day 21 for (A) adherent and (B) 
orbital suspension cultures.  Retinal EBs with formation sizes of 5K or 10K cells/EB were 
produced using MSU001 cells 
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Figure 5.15 The impact of orbital shaking culture on retinal differentiation at day 21.  
Comparison of relative normalized gene expression profiles at day 21, between size-matched 
EBs of (A) 5K or (B) 10K cells cultured in adherent versus orbital shaken systems.  Relative 
expression of eye field transcription factor genes Otx2, Crx, Nrl, Rho and pluripotency marker 
P0U5F1.  EBs were produced using MSU001 cells 
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5.6.3 Time course analyses of pluripotency and retinal marker 
expression 
 
In order to appreciate the variation in expression of pluripotency marker P0U5F1 and 
the retinal panel marker expression (Otx2, Crx, Nrl and Rho) with time Figure 5.16 
presents the relative normalised expression profiles of the targeted genes in a 
clustergram.  The clustergram allows a broad comparison of differential gene 
expression between adherent and orbital shaken culture techniques as well as between 
both EB sizes for all time points sampled (days 10, 15 and 21).  In Figure 5.16 The 
dendreon bars under the gene targets at the bottom of the clustergram show the shortest 
Dendreon bars are observed between Crx and Otx2 expression indicating their 
expression profiles are the most closely related.  The expression profile P0U5F1 is the 
next most closely linked to the early retinal marker expression profiles, a pattern seen 
in most samples regardless of input EB size or culture technique.  The longer 
Dendreon bars adjoining P0U5F1 and the grouped early markers of retinal 
differentiation Otx2 and Crx, with later markers Nrl and Rho show the heirachical 
relationship between the expression profiles of these two sets of genes.   
The dendogram shows the relative similarity in gene expression profiles of all the 
target genes across culture techniques and regardless of input EB size at day 10.  
Suggesting that by 10 EBs in all culture environments were propagating almost 
uniformly toward retinal lineages.  Day 15 of retinal differentiation culture seems to be 
an important timepoint for adherent samples, which express high levels of all retinal 
markers except Nrl coinciding with downregulation of P0U5F1 at this time.  In orbital 
shaken cultures day 15 also seems important, as all cultures seem to have switched 
expression from early to later retinal markers which coincides with downregulation of 
P0U5F1.  The improved homogeneity of retinal marker expression between EB sizes 
in orbital shaken culture is also apparent by day 15 and continues through to day 21.  
For adherent cultures at day 21 the gene expression profiles follow the same pattern of 
downregulation of early genes with upregulation of later retinal markers but 
persistence of expression of earlier retinal markers especially Crx shows the more 
heterogeneous nature of these cultures compared to orbital shaken culture.   
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Figure 5.16 Clustergram showing the levels of relative normalized gene expression of 
pluripotency marker P0U5F1 and retinal markers OTX2, CRX, RHO and NRL across 
different EB sizes and culture techniques over days 10, 15 and 21.  Samples are arranged 
according to sample time points on the y axis for days 10, 15 and 21.  From left to right 
the row of squares at each time point shows the intensity of gene expression of 
pluripotency marker P0U5F1, Otx2, Crx, Nrl and Rho.  Sample nomneclature on the y 
axis indicates the culture day (D10), (D15) or (D21), whether the sample was from 
adherent (Adh) or orbital shaken culture (SD) with the input EB size of (5K) or (10K) 
cells/EB.  The colour of each cell indicates the intensity of expression of a marker for each 
condition (green-low, red-high).  Gene expression levels for all samples were normalised 
to internal reference genes Beta Actin and GAPDH.  The samples are clustered by the 
targets to show the hierarchical relationship between these genes with time.  The length of 
Dendreon bars under each target represent their linkage (longer bars for more 
dissimilarity). 
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5.7 Summary  
 
In this chapter we tested the hypothesis that progression of retinal differentiation is 
possible in orbital shaken cultures without Matrigel supplementation up to 21 days. 
Immunohistochemistry was performed to show the presence of retinal cell populations, 
and differential gene expression profiles by QPCR helped to show the different 
impacts of adherent and orbital shaking cultures on EBs with input sizes of 5K or10K 
cells/EB.  We measured culture oxygen consumption rates and pH to understand the 
impact of orbital shaking culture on the microenvironment and performed cell 
quantification and LDH assays to assess the impact of EB size and culture technique 
on cell health and yields.  The approach of using size matched EBs in control adherent 
cultures alongside orbital shaken cultures allowed us to separate the effects of orbital 
shaking from the effects of EB size on retinal differentiation respectively. 
In characterising the effects of orbital shaking, we observed that a doubling in the cell 
numbers of input EBs from 5K to 10K cells/EB was not represented with observable 
differences between immunohistochemistry images or cell quantification experimental 
data, despite the fact that orbital shaken cultures for both EB sizes were subjected to 
the same medium exchange regimes throughout the culture period.  It may therefore be 
possible that the EBs were adapting to the availability of nutrients.  Detailed analysis 
of the medium metabolite profiles throughout the culture period might help future 
optimization experiments to determine ideal medium volumes and nutrient 
concentrations for these cultures.   
Primary evidence for the differentiation and progression of EBs toward retinal 
specification, was provided by the immunostaining of retinal markers at the protein 
level in Figures 5.5 to 5.9.  The retinal identities of constituent cell populations within 
differentiating EBs was also reflected in the QPCR data, summarized in the 
clustergram time course for adherent and orbital shaken cultures from days 10, 15 and 
21 (Figure 5.16).  The overview provided by the clustergram also showed the close fit 
between 5K and 10K EBs in both culture techniques in addition to showing the general 
pattern of changes in retinal marker expression from early to late markers over the 
culture period.  The clustergram also showed downregulation of pluripotency marker 
expression with time, coincides with down-regulation of the early eye field marker 
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OTX2 and up-regulation of the later retinal markers NRL and RHO for both 5K and 
10K EBs in both adherent and orbital shaken cultures.   
If we consider adherent cultures as positive controls, the greater similarity observed in 
the relative normalised gene expression profiles between 5K adherent and 5K orbital 
shaken cultures compared to the same comparisons with larger 10K EBs may suggest, 
5K EBs were better suited to orbital shaken culture than 10K EBs (Figure 5.15).  The 
10K EBs in orbital shaken culture however showed more intense downregulation of 
early retinal markers and P0U5F1 expression when compared to their adherent controls 
suggesting, larger 10K EBs may have differentiated more rapidly in orbital shaken 
than adherent cultures.   
Our data show that changing EB size had greater influence in adherent than orbital 
shaking EB cultures with larger EBs demonstrating higher exprression of later retinal 
differentiation marker NRL and reduced pluripotency marker P0U5F1 expression, than 
smaller 5K EBs (Figure 5.14) in orbital shaking cultures.  The reduced impact of 
varying EB size in orbital shaken cultures is demonstrated by the similarity in retinal 
marker expression profiles for both sized EBs.  The main difference in expression 
profiles between the two sizes under orbital shaken cultures was that larger EBs  
expressed less RHO at day 15 (Figure 5.12) and showed reduced expression of CRX at 
day 21 (Figure 5.14) than their 5K counterparts.  These data could suggest that larger 
EBs consited of later differentiated populations but more detailed FACS analyses 
would be necessary to confirm this hypothesis. 
The broadly similar expression profiles of markers for retinal differentiation show the 
change in expresssion of pluripotency marker P0U5F1 and early martkers of retinal 
differentiation Otx2 and Crx reduces with time; as expression of later retinal markers 
Nrl and Rho are expressed toward the end of the culture period in both EB sizes, across 
culture techniques (Figure 5.16).  The greater similarities in gene expression profiles 
between the 5K and 10K EBs in orbital shaken as opposed to adherent cultures might 
also indicate that orbital shaking cultures were more homogenous than adherent 
cultures.  Appendix 1 and previous reports from this department also provide evidence 
for improved homogeneity of soluble factor gradients throughout the medium in 
orbital shaken cultures (Rodriguez et al. 2014).  The imporved mixing supported by 
orbital shaking may also explain the effect of reducing the impact of changing the 
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starting EB size on differentiating cells in orbital shaking cultures.  Although the 
retinal gene expression profiles were more homogenous between different EB sizes in 
orbital shaken culture, larger EBs in orbital shaken culture deviated more from their 
adherent control retinal gene expression profiles (Figure 5.16).  The greater fidelity 
between the retinal expression profiles of 5K EBs in orbital shaken culture and their 
adherent controls may suggest that 5K EBs were slightly better suited to orbital shaken 
culture than 10K EBs.  Quantiative assessment of this hypothesis would require FACS 
analyses which were not performed in this report but together our data here, supports 
the hypothesis that orbital shaking reduces the impact of variation in differentiation, 
due to changes in starting EB size. 
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6.0 Orbital shaken culture of EBs for retinal differentiation 
with a feeder free cell line  
6.1 Introduction 
We have demonstrated orbital shaking culture in low-attachment 24 microwell plates is 
a successful platform for initiating retinal differentiation of EBs created from human 
IPS cells grown on mouse embryonic fibroblast cells (feeders) with the MSU001 IPS 
cell line in chapters 3 to 5.  The feeder cell dependent nature of MSU001 hiPSC 
provided motivation to test whether orbital shaken culture could support the initiation 
of retinal differentiation in another feeder-free cell line.   
A human foreskin fibroblast derived IPS cell line: BJ IPS (kindly gifted by Dr Amanda 
Carr, UCL, Institute of Ophthalmology) was sourced in an attempt to recapitulate 
differentiation toward retinal cell fates using the orbital shaken system described in 
chapter 5.  The BJ IPS cells were cultured in a fully defined xeno free stem cell culture 
medium E8 (Invitrogen) which  contains 8 components and was used in combination 
with a xeno-free defined substrate vitronectin to coat tissue culture vessels instead of 
animal derived Matrigel, or mouse embryonic fibroblasts.  The only remaining animal 
derived components persisted in the adapted protocol for retinal differentiation from 
the early differentiation medium which contained FBS for the first 3 days of 
differentiation culture.   
The removal of undefined and xenogeneic ingredients is an important step when 
considering potential clinical development as discussed Section 1.4, to improve culture 
purity and the safety of potential therapeutics.  Additional benefits include the potential 
to improve the consistency of cultures, since guaranteeing exact quantities of 
undefined animal derived components is not possible.  Though Matrigel and hiPSC 
cultured on animal feeders are still commonly used in differentiation protocols, it is 
foreseeable that a greater degree of definition and refinement will be important in 
future recommendations from regulatory bodies when governing the production of 
cellular or other biological therapeutics for human use.  Better defined cultures will 
facilitate more accurate characterisation of cell populations.  Ultimately defined 
cultures will also improve process understanding to identify and quantify which factors 
in the microenvironment of stem cell culture and processes, have the greatest impact 
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on differentiation into therapeutic cell types, cell health and cell yields as discussed in 
chapter 5.   
In this chapter the BJ IPS feeder free cell line selected, is used to perform proof of 
principle experiments using one EB size (10K cells/EB) and culture over 15 days of 
retinal differentiation.  Day 15 of culture was determined to be a key stage to assess 
progression to retinal differentiation from the relative gene expression results observed 
with MSU001 EBs in Chapter 5.  By day 15 MSU001 EBs cultured in orbital shaken 
and adherent cultures showed expression of key markers of retinal differentiation with 
coinciding downregulation of pluripotency marker P0U5F1.  The aim of this chapter is 
to recapitulate these findings for the feeder free cell line to show initiation of retinal 
differentiation in orbital shaken culture in a similar system.   
 
6.1.1 Aims and objectives 
 Test the impact of using Aggrewells on the initiation of differentiation toward 
retinal cell fates in a second cell line. 
 To determine whether orbital shaken culture of EBs supports retinal cell fate 
differentiation in a second feeder free IPS cell line. 
 To characterise the impact of orbital shaking on differentiation toward retinal 
cell fates using immunohistochemistry and QPCR analyses. 
 
6.2 Forced aggregation maintains consistent EB formation sizes with 
BJ hiPSC derived EBS which express early retinal markers at day 3 
 
The forced aggregation approach for forming EBs has been characterised for use with 
BJ IPS cells in Chapter 3 which demonstrated BJ IPS cells are also amenable to 
producing uniform controlled sized input EBs using the Aggrewell protocol.  The 
protocol’s suitability for uniform production of larger 10K EBs is shown in Figure 6.1, 
where light microscopy images of EBs formed by forced aggregation were compared 
to EBs formed by scraping (Figure 6.1(i)).  The images demonstrate the expected 
improvements in uniformity of EB size as a result of using the forced aggregation to 
form EBs.  The resulting EBs formed of 10K cells/EB, were cultured in retinal 
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differentiation medium in suspension without shaking for 3 days before further 
analysis.  In keeping with the protocol used throughout this report the 10K BJ EB and 
scraped BJ EBs were also analysed by QPCR at day 3.  The relative normalized gene 
expression profiles of both forced aggregation and scraped EBs show that scraped EBs 
outperformed forced aggregation EBs for the expression of all markers of retinal 
differentiation.  Compared to scraped EBs the forced aggregation 10K EBs showed 
significantly reduced expression of early retinal field transcription factors Pax 6, Rx 
and Six3 (Pax6 2.51 fold, p=.000002, Rx 8.96 fold, p=0 and Six3 1.48 fold, 
p=0.031908).  The only gene expressed at similar levels between the scraped and 
forced aggregation EBs at day 3 was Otx2 which was the only insignificantly 
differentially expressed target between the two conditions (Figure 6.1(ii)).   
 
Comparing scraped EBs against forced aggregation 10K EBs, the controlled sized EBs 
also showed reduced expression of pluripotency marker P0u5F1(3.64 fold, p<0).  The 
reduced expression in P0U5F1 would be consistent with previous findings which 
showed reduced expression of P0U5F1 coinciding with increased expression of retinal 
markers in EBs suspension culture with retinal differentiation medium in Chapter 4.  
The results were also consistent with the theory that differentiated cells downregulate 
P0U5F1 expression.  In light of this information results showing the greater reduction 
in P0U5F1 expression for forced aggregation EBs were initially interpreted as 
indicating a faster differentiation toward retinal lineages for the larger more uniform 
10K aggregates than their scraped BJ EB controls.  However the greatly reduced 
expression of all other markers of retinal differentiation except Otx2 also suggest that 
the homogenous forced aggregate EBs may not have been differentiating as fast as the 
scraped EBs.   
 
The precise molecular mechanisms governing human eye development are still largely 
unknown and the required levels of expression of retinal markers to initiate 
differentiation have not been determined.  Consequently it was difficult to draw precise 
conclusions about the stage of eye development reached by EBs at day 3 of culture, 
based solely on the levels of gene expression detected (Figure 6.1(ii)).  However,  
detection of the early markers of retinal differentiation albeit slight in the forced 
aggregates prompted further analyses to ascertain whether retinal marker expression 
might improve with more time in culture.   
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Figure 6.1 (i) Representative micrograph images of BJ retinal EBs made from 10Kcells 
at day 3 of differentiation.  EBs were formed by scraping (A and B) or forced 
aggregation (C and D).  Scale bars = 1000 µm (A and C) 400µm (B and D).   
 
(ii) Relative expression of early retinal transcription factor genes Pax 6, Rx, Otx2 and 
Six3 with pluripotency marker P0U5F1 in BJ EBs formed by forced (AgD3) or by 
scraped (ScD3) aggregation from 10K cells/EB at day 3.  One way ANOVA analyses of 
gene expression levels in scraped EBs against forced aggregation EBs are shown 
(*p<0.05, **p<0.01, ***p<0.001  
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6.3 Orbital shaken cultures support initiation of retinal differentiation 
in the feeder free cell line BJ IPS derived EBs  
 
EBs of 10K cells/EB formed by forced aggregation were cultured in adherent and 
orbital shaken systems for 15 days with 48 hourly medium exchanges and sampled at 
days 10 and 15 of differentiation.  Microscopy analyses, immunohistochemical assays 
and QPCR assays were performed to assess how the progression of differentiation 
toward retinal cell fate is affected by the feeder free source of the BJ IPS cells and to 
test if a longer culture time could improve the detection of markers for retinal 
differentiation.   
Light microscope images of EBs from days 10 and 15 in adherent and orbital shaken 
cultures were compared for the similarity of their morphological features to those 
observed in the MSU001 EBs (Chapter 5).  Typical spherical shapes of floating EBs 
with the appearance of phase bright rings around dark centres were observed in most 
EBs and interpreted as signs for retinal lineage differentiation (Sridhar et al. 2013).  
Representative images of EBs in adherent and orbital shaken culture at days 10 and 15 
illustrate these typical qualities of EBs differentiating along retinal fates (Figure 6.2). 
In order to confirm the presence of retinal cells, in the differentiating EBs 
immunohistochemical were performed for EBs at day 15 of culture as presented in the 
figures below.   
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Figure 6.2 Representative micrograph images of BJ EBs formed of 10K cells per EB 
grown in adherent or orbital shaken suspension cultures at days 10 and 15.  Images were 
taken on an Evos microscope at 20x magnification scale bars = 1000um for adherent 
EBs and 400um for suspension EBs. 
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6.3.1 Immunohistochemical analyses demonstrate expression of key 
markers of retinal differentiation  
 
Immunofluorescence images of 10K EBs from orbital shaken or adherent control 
cultures confirm protein level expression of pluripotent populations from the low-level 
expression of transcription factor Nanog, another marker for pluripotency in Figure 
6.4.  In support of this observation, albeit with a different marker for pluripotency, the 
gene level expression of the pluripotency marker P0U5F1 from QPCR analyses also 
shows P0U5F1 expression and therefore pluripotent cell states persist at day 15 or 
adherent and orbital shaken culture. 
Immunohistochemical detection of the expression of the early retinal differentiation 
marker Otx2 detected at days 3 and 15 by QPCR (Figure 6.3 and 6.5) provided 
confirmation that retinal cell types were present alongside the pluripotent cells detected 
in orbital shaken cultures.  Furthermore, low expression of the later photoreceptor 
precursor marker Crx was also detected by immunohistochemistry of EBs from both 
adherent and orbital shaken cultures at day 15 of retinal differentiation.  At day 15, the 
later photoreceptor marker Rho was also detected by immunohistochemistry at low 
levels in adherent but not orbital shaken cultures (Figure 6.4).   
Together the images in Figure 6.3 together with findings from the phase contrast 
images (Figure 6.2) which showed typical morphologies of EBs undergoing retinal 
differentiation help support the idea that initiation of retinal differentiation is feasible 
in orbital shaken culture with EBs from the BJ feeder free IPS cell line.   
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6.4 QPCR analyses for retinal differentiation in orbital shaken 
cultures with BJ hiPSC derived EBs 
 
The QPCR analyses lend quantitative support for the immunohistochemical results 
showing evidence of retinal differentiation for EBs cultured under adherent and orbital 
shaken protocols at days 10 and 15.  Orbital shaken EBs from cultures were compared 
for differential gene expression with control adherent cultured EB samples from the 
same time points.  The adherent and orbital shaken samples were compared by the 
Pfaffl method to quantify relative gene expression using the delta delta CT method for 
consistency with the QPCR results in previous chapters.  Relative quantification of 
gene expression of eye-field transcription factors Otx2, Crx, Nrl and Rho along with 
pluripotency marker P0U5F1, from adherent and orbital suspension cultures are 
presented for days 10 and 15 together in Figure 6.5 (A) and (B) respectively.   
 
At day 10 of retinal differentiation a comparison of gene expression profiles between 
adherent and orbital shaken EBs (Figure 6.5 (A)) illustrates that expression of the early 
eye field marker Otx2 in orbital shaken cultures is significantly reduced (p<0.05) 
compared to that of adherent control EBs.  The reduced expression of Otx2 in orbital 
shaken versus adherent controls at day 10 was not observed with MSU001 EBs 
(Figures 5.12), suggesting the BJ IPS cells may be following a different trend or 
timeframe for differentiation.  Another difference between the day 10 expression 
profiles of BJ and MSU001 EBs was a significant downregulation of the photoreceptor 
precursor target Crx in orbital shaken cultures compared to adherent controls 
(p<0.001) for BJ EBs at day 10.  Changes in gene expression of P0U5F1, Rho and Nrl 
between the orbital shaken and adherent cultures may suggest that BJ EB orbital 
shaken culture at day 10 may have supported more mature cell types than in adherent 
control cultures.   
  
At day 15 retinal gene expression profiles between the adherent and orbital shaken 
cultures show only one significantly differentially expressed gene Nrl (Figure 6.5(B)).  
The expression of Nrl is expressed at 1.5 fold (p<0.05) higher levels in orbital shaken 
cultures compared to their adherent controls in 10K BJ EBs.  Evidence of coinciding 
relative downregulation of pluripotency marker P0U5F1 and Otx2 were not observed 
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at day 15 for orbital shaken BJ EBs, showing a deviation from the trend established 
with orbital shaken MSU001 EBs at day 15 (Figure 5.15(B)).  Consequently, 
interpreting the significance of the increased expression of Nrl is challenging.  The 
increased expression of Nrl in orbital shaken EBs at day 15 compared to adherent 
controls suggests the presence of more differentiated cell types in these cultures.   
 
The trend of decreased expression of Otx2 and P0U5F1 with comparatively increased 
expression of Nrl observed at day, in 15 orbital shaken cultures for the MSU001 EBs 
(Figure 5.15(B)) is however still echoed in the day 15 gene expression profiles of the 
feeder free line for orbital shaken cultures in this chapter but without statistical 
significance (Figure 5.16).  The lack of a statistically significant reduction in the 
expression of Otx2 and P0U5F1 in the orbital shaken BJ EBs, may also be indicative 
of the persistence of more pluripotent cells and immature early retinal cell types by day 
15 in BJ EBs compared to orbital shaken MSU001 EBs at day 15 (Figure 5.16(B) and 
6.5 (B)).   
 
The QPCR data together show BJ orbital shaken EBs have a unique time frame and 
pattern of expression of retinal differentiation genes distinct from the trends observed 
in MSU001 EBs.  These results may also indicate the BJ IPS cell line may be less 
suited to orbital shaken culture with 10K EBs than MSU001 EBs.  The observed 
differences in gene expression profiles may be attributable to inherent biases within the 
cell line, the removal of feeders from the cell expansion phase or the use of vitronectin 
instead of Matrigel in the feeder free cultures.   
  
Additionally, the expression profiles of P0U5F1 in the day 10 and 15 cultures were 
unfortunately more variable either due to less accurate detection or technical errors 
during work with the feeder free cell line as indicated by the large error bars (Figure 
6.5(B)).  An alternate explanation may be there was much greater variability in 
P0U5F1 expression between samples but this was not possible to verify during the 
scope of this work.  A future improvement might include flow cytometry analyses of 
the cells in addition to the QPCR analyses, to better verify the observed trends and 
allocate proportions of the cell populations to their respective cell markers.  
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Figure 6.5 Relative expression of early retinal transcription factor gene Otx2, 
photoreceptor precursor marker Crx, rod photoreceptor markers Nrl and Rho and 
pluripotency marker P0U5F1 in differentiated BJ EBs made from 10K cells at day 10 
(A) and 15 (B) for adherent and orbital suspension cultures. One way ANOVA analyses 
of gene expression levels against adherent EBs cultures made from10K cells are 
presented (*p<0.05, **p<0.01, ***p<0.001).   
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6.5 Summary 
 
The aim of this chapter was to ascertain whether orbital shaken culture is a technique 
which can be applied to support retinal differentiation in a feeder free cell line.  It was 
hoped the effects of relatively faster expression of early retinal markers and relatively 
increased expression of later retinal markers would be observed in comparisons with 
adherent control samples as they were in Chapter 5.  Though the retinal gene 
expression patterns differed between orbital shaken MSU001 EBs and BJ EBs, this 
chapter demonstrated that orbital shaken culture is a system which can be utilised 
across different cell lines to observe the initiation of retinal differentiation as evidenced 
by the expression of retinal markers by immunohistochemistry and QPCR.  We 
observed the expression of all the retinal markers investigated in previous chapters but 
with differing expression profiles to those observed in the MSU001 cell line.  The 
inherent propensities of different cell lines and the lineage biases they confer has been 
documented before (Bauwens et al. 2008) and more recently differences in 
differentiation capacities due to changing EB sizes has also been reported (Moon et al. 
2014).  Therefore it may be the case that both EB size and cell line biases were factors 
which need to be independently optimised specifically with retinal differentiation in 
mind. 
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7.0 Conclusions and future work 
7.1 Conclusions 
 
The aim of this thesis was to test whether improving process control in a commonly 
used retinal differentiation protocol can improve the initiation of induced pluripotent 
stem cell differentiation toward retinal lineages.  The experimental work aimed to 
show control over input EB size could be utilised using commercially available 
technology (Aggrewell plates, StemCell technologies) to improve the consistency of 
the initiation of differentiation.  It was also our aim to test whether it was possible to 
adapt a commonly used 2D adherent retinal differentiation protocol to an orbital 
shaken suspension culture system in 24 well microwell plates.  By adaptation of this 
culture technique our goal was to improve the uniformity of the microenvironment and 
test the hypothesis that orbital shaking can accelerate differentiation (Burridge et al., 
2007 ; Carpenedo, Sargent, et McDevitt, 2007).  Orbital shaken culture is known to 
improve mixing which led to the hypothesis such a system may also help eliminate the 
requirement for exogenous factors such as animal derived Matrigel from the culture 
medium.  We monitored the impact of these process changes on the onset of hiPSC 
fate specification toward retinal differentiation using a commonly used protocol for 
retinal differentiation as the model system (Lamba et al. 2006). 
The work in this thesis has shown evidence for successful retinal differentiation of 
control sized IPS derived EBs in orbital shaken culture by adaptation of an established 
adherent process for retinal differentiation (Lamba et al., 2006).  By introducing 
controlled sized EBs (5K and 10K cells/EB) into an orbital shaken process it was 
possible to demonstrate more homogeneous initiation of retinal differentiation 
compared to static adherent cultures through retinal gene expression profiling.  
Furthermore, the results provide evidence that orbital shaken culture is capable of 
supporting retinal differentiation for up to 21 days, at shaking speeds of 120rpm.  
Additionally, by implementing the orbital shaken platform, it has been possible to 
eliminate the requirement for Matrigel supplementation to the culture medium.   
Review of methodology and results: Although methods for uniform EB production 
are available many protocols for retinal differentiation recommend scraping which 
results in the production of variable sized EBs.  Primarily to address the challenge of 
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variable sized EB production associated with scraped EB formation, we achieved 
control over EB formation efficiency and size by characterising a forced aggregation 
protocol for EB formation in chapter 3.  Control over EB formation was achieved 
using forced aggregation and tight control over EB sizes (Figure 3.4 and 3.5).  Forced 
aggregation improved the efficiency of aggregation and therefore the yield of cells 
incorporated for differentiation by >3fold (p<0.05) (Section 3.2, Figure 3.3).  
Comparisons of the levels of expression of markers of pluripotency and early retinal 
differentiation provided evidence that forced aggregation can be beneficial for the 
onset of retinal fate specification in EBs.  Scraped EBs with uncontrolled sizes 
provided control samples to compare against forced aggregation EBs.  The results first 
provided evidence that controlled sized EBs expressed key markers of retinal 
differentiation at comparable levels to their scraped controls (Figure 3.7).  Having 
demonstrated EB size can be successfully determined by using specific numbers of 
cells available for aggregation in Chapter 3, the next aim was to determine if EB size 
impacts initiation of retinal differentiation.   
Controlled size EBs also facilitated the selection of a permissive shaking speed of 
120rpm for orbital shaken EB cultures (Figure 4.2).  Determining a range of EB sizes 
practical for and amenable to orbital shaking culture conditions enabled the 
demonstration of the influence of initial EB size on progression and acceleration to 
retinal lineage specification (Figure 4.3).  To track progression towards retinal 
specification QPCR analysis showed reduced expression of pluripotency markers 
coincided with upregulation of early retinal markers, indicating the initiation of retinal 
differentiation.  Comparing orbital shaken cultures against scraped EB controls, the 
former showed higher expression of early eye field transcription factors Rx and Six3 
(p<0.05) with further reduced expression of the pluripotency marker P0U5F1 (p<0.05) 
(Figure 4.3).  Forced aggregation EBs demonstrated a superior ability to initiate retinal 
differentiation and were consequently taken forward in experiments to select EB sizes 
amenable to retinal differentiation in orbital shaken culture.   
The orbital shaken culture system is not only suitable for initiating retinal 
differentiation but it also eliminates the requirement for supplementing the medium 
with the murine Engelbreth-Holm-Swarm tumour derived substrate, Matrigel 
(discussed in chapter 4).  Matrigel is a commonly used research tool in many stem cell 
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differentiation protocols (see table 1.5).  Its undefined and xenogeneic status however 
make it a subject of controversy which is hotly debated (Polykandriotis et al. 2008). 
The motivation to remove xenogeneic materials becomes important when considering 
developing clinical-grade cells (Sun et al. 2010).  In addition to reducing the risk of 
exposure to animal pathogens, the demonstrated ability to exclude Matrigel from 
cultures helps observe and measure the effect of other changes made to the 
microenvironment, with reduced risk of influence from its undefined ingredients.  In 
this report, simplifying the micro-environment by removing Matrigel helped observe 
and more confidently attribute measured effects to the impact of changing EB size and 
introducing orbital shaking to the culture system.  By reducing or eliminating 
undefined ingredients from cultures the orbital shaken culture system succeeds in 
improving reproducibility, predictability and ultimately increases the potential for 
translation to clinically relevant good manufacturing practices. 
With evidence that orbital shaken culture supports retinal fate specification and 
improve the homogeneity of the microenvironment, through eliminating the 
requirement for Matrigel, the next objective was to apply these findings to wield 
improvements over the process of retinal differentiation.  Combining control over the 
number of cells entering the process, the size of starting aggregates and the 
homogeneity of the microenvironment made it possible to directly compare the impact 
of EB size and culture technique (adherent or orbital shaken) on retinal differentiation 
(Chapter 5).  Comparisons of orbital shaking cultures in 24 SRW microwell plates on 
an orbital shaking platform were conducted with size-matched adherent EB culture 
controls in standard 24 well culture plates.  The 24SRW microwell platform was 
chosen as it has been previously validated for use as a scale-down model for 
translating mammalian cell cultures into pilot and commercial scale bioprocesses(Silk 
et al. 2010). Another important consideration was that the 24SRW platform format 
provided sufficient throughput, to investigate the impact of two EB sizes (5K and 10K 
cells per EB) on retinal differentiation over 3 time-points days 10, 15 and 21 of retinal 
differentiation culture.   
In order to measure the effects of EB size and orbital shaking on differentiation, a key 
challenge faced was, the difficulty in achieving single cell suspensions from 
differentiated EBs.  Using Tryple Xpress (Invitrogen) with manual pipetting in a water 
bath at 370C was sufficient for newly formed EBs as demonstrated in chapter 3.  For 
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later EBs, older than 5 days however, the technique resulted in large quantities of 
fragmented cells and subsequent agglutination of the remainder of the samples into 
large clumps.  This was likely due to increased viscosity from the release of DNA into 
the medium.  Attempts to resolve clumps using DNAse (Sigma) with Tryple 
(Invitrogen) had little impact and persistent clumps prompted new attempts to obtain 
reliable single cell numbers.  Two alternate methods tested were sonication with the 
E450 Sonicator (Covaris) and an Embryoid Body Dissociation Kit and device 
(Miltneyi Biotec).  Both proved to be no better than manual dissociation as neither was 
able to resolve the clumps.  The inconsistent quality of single cell suspensions 
achieved by these methods in our hands disqualified them from inclusion in flow 
cytometry analyses to acquire cell numbers linked to retinal marker expression in order 
to identify and quantify retinal cell populations within the culture.  Future experiments 
to progress the work in this study would benefit from a thorough exploration of other 
available tissue digestion techniques.  Identification and quantification of cell 
populations is a critical step in generating characterized purified cells for basic 
research as well as for potential clinical applications (Davie et al. 2012). 
The potential yields achievable by cell manufacturing processes is another key factor 
in assessing the suitability of methods, to understand if they are fit for purpose and 
determine if novel approaches offer potential for improved cell yields over existing 
platforms.  To assess the impact of orbital shaking and EB size on the yield of cells, 
the Pico-Green Quant-iT assay helped determine relative cell numbers derived from 
total DNA quantification (Figure 5.4A).  The data showed a close correlation between 
total cell quantities of EBs cultured in the 24 SRW microwells for adherent and orbital 
shaken systems (Figure 5.4A).  The close fit between total cell numbers across samples 
irrespective of variation in EB size and culture technique (P>0.05) found using 
ANOVA, also presents an avenue for further enquiry.  A follow-on study might 
investigate if the system exhibited a method of self-regulation in response to nutrient 
availability or whether the doubled difference in EB sizes investigated was insufficient 
to observe a clear effect (discussed in section 5.6).   
Results showing the cell health throughout differentiation in orbital shaken cultures, 
using LDH assays also demonstrated a close fit between the 5K and 10K EB samples 
(Figure 5.4B).  Our data showed no statistical differences of LDH activity for each 
time point between both EB sizes over 21 days of retinal differentiation (p>0.05) for 
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all comparisons made with one way ANOVA).  Together the size distribution data and 
the LDH results show that homogeneity exists between the 5K and 10K EBs and could 
form the basis of establishing optimal ranges of EB sizes from which to initiate retinal 
differentiation in future experiments.   
Evidence for the improved homogeneity of differentiation, achieved by using orbital 
shaking suspension cultures, also draws support from data analyses of the changes in 
size distribution with time of differentiating EBs.  Throughout the culture our findings 
indicate that the majority of orbital shaken EBs (~80%) were evenly distributed across 
3 narrow size ranges by day 15 (200-400µm, 401-600 µm and 601-800µm) with no 
statistically significant differences between the size populations (p>0.05) (Figures 5.2 
and 5.3).  Further investigation of the EBs within the 3 size ranges may reveal 
subpopulations of EBs differentiating at different rates or in slightly different ways and 
which could provide information on the role of EB self-regulation in 
microenvironments with limited resources.   
The well documented conservation of retinal marker expression throughout 
mammalian retinogenesis helped to define the panel of genes used in our approach for 
tracking differentiation (Heavner & Pevny 2012; Hsieh & Yang 2009).  The use of 
conserved genes validated the approach of using immunocytochemistry coupled with 
QPCR analyses to qualitatively and quantitatively demonstrate progression toward 
retinal differentiation in adherent and orbital shaken cultures (chapter 5).  Our data 
showed the impact of both orbital shaking and size variation (between 5K and 10K 
EBs) on progression of retinal differentiation.  Comparing gene expression profiles 
over the 21 day differentiation between adherent and orbital shaken cultures, provided 
evidence that expression patterns for the markers of retinal differentiation were 
conserved across culture techniques and between different EB sizes (Figure 5.16).  The 
results also provide data to show increasing EB size (from 5K to 10K cells/EB) had 
greater influence on increasing later retinal marker expression in adherent cultures than 
in orbital shaken cultures (Figures 5.12 – 5.15).  Orbital shaken cultures demonstrated 
greater homogeneity in retinal gene expression profiles irrespective of starting EB size 
highlighting the utility of the system as a means to reduce variability in retinal 
differentiation cultures.  
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Taken together, the EB size distribution data (Figures 5.2-3) along with evidence of 
earlier down-regulation of pluripotency marker P0U5F1, faster up-regulation of early 
retinal markers Rx and Six 3 at day 3 (Figure 4.3), speedier down-regulation of Otx2 
and the earlier peak expressions of later retinal markers Crx, Nrl and Rho (Figure 
5.16); these results provide evidence that orbital shaken cultures demonstrate 
accelerated and more consistent initiation of retinal differentiation compared to 
adherent controls.  Furthermore, as orbital shaken cultures diminished the requirement 
for Matrigel in the medium composition there is a case for using this platform to 
develop more defined retinal cell manufacturing processes. 
Pioneering orbital shaken stem cell culture studies demonstrated murine ESCs benefit 
from such a system which supports increased cell yields and homogeneity of the 
microenvironment without injurious effects on differentiation (Carpenedo, Sargent, et 
McDevitt, 2007).  In testing the utility of early proof of principle studies the work in 
this report provides supporting evidence for the previous findings, whilst extending 
their applicability to hiPSC derived EB culture and retinal differentiation over 
extended culture periods.  Orbital shaking cultures offer EB derived cell processes a 
system for improving the homogeneity of the microenvironment whilst also reducing 
the requirement for undefined animal components.  Reducing variability in cell 
manufacturing processes by using the orbital shaken platform addresses a key 
requirement for cell therapy manufacture to maximise the potential for consistent and 
reproducible quality products.     
 
7.2 Future work  
 
The ultimate aim of work to develop bioprocesses from regenerative medicine research 
such as in vitro retinal cell generation, is to enable the production of safe, pure, potent, 
effective and stable products in cGMP compliant reproducible processes.  In order to 
test the wider applicability of the orbital shaken culture system, better characterisation 
of the current model would be necessary.  The following discussion includes 
suggestions for future lines of investigation arising from the work in this study to 
address the challenges faced herein as well as those which could arise from advancing 
the work for industrial application. 
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Greater resolution into the impact of EB size and orbital shaking would require the 
implementation of an effective method for resolving differentiated EBs into live single 
cell suspensions.  Readily available single cell suspensions from differentiated EBs 
would enable detailed characterization of the sub-populations arising within the 
cultures and would help quantify the biases for specific retinal cell lineages inferred by 
the QPCR results in Chapters 4 -6 to provide more definitive data for cell 
characterization.  Measuring the impact of microenvironmental changes at the cellular 
level rather than cell population level would also be an important addition to the work 
to identify stage specific markers of differentiation as well as process dependent 
changes to the cells in culture.  Successful evaluation of the distribution of different 
cell populations making up retinal EBs in response to changes to their 
microenvironment due to the orbital shaken system will depend on novel assays to 
determine the quality of the cells in terms of their phenotypic identity as well as 
functionality.  These additions would form an important intermediary step before the 
inclusion of cells produced by orbital shaken culture in further studies intended for 
process development for clinical translation.   
Comprehensive characterisation of cells and processes is often dependent on the 
discovery of more biomarkers to specify identity.  Cells sourced from hiPSC which 
undergo multiple stages of differentiation would benefit from biomarkers for each 
stage.  Correlating biomarkers for the finer stages of differentiation with markers for 
cell health throughout the process could be particularly useful in identifying areas for 
improvement in developing efficient bioprocesses for cell based products.  The 
recently reviewed approach of applying high-throughput methods such as 
transcriptomics to identify transcripts involved in retinal degeneration in age-related 
macular degeneration and glaucoma may also be applied to in vitro hiPSC derived 
retinogenesis to help find biomarkers for stages of differentiation (Tian et al. 2015).  A 
transcriptomic approach combined with a proteome level assessment of retinogenesis 
would be beneficial in assuring protein level expression of key genes (Pripuzova et al. 
2015).  A panel of specific quantifiable biomarkers with causative rather than 
associative relationships to the specific stages of (retinal) differentiation would 
therefore facilitate more accurate measurements of changes to the microenvironment 
and therefore help determine optimal culture conditions for therapeutic cell production. 
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A deeper understanding of the impact of orbital shaking on developing EBs and the 
influence of growing EBs on the fluid dynamics of medium in 24 SRW microwell 
plates, would also benefit from further study to follow on from work in this report and 
that from the work of McDevitt and others (Sargent et al. 2010; Kinney et al. 2012; 
Rodrigues et al. 2011).  Detailed mathematical models using computational fluid 
dynamics programmes should be validated with laboratory experiments to develop 
more accurate models of the fluid dynamics which take into account the presence of 
and changing sizes of EBs over time.  Such a model would be beneficial in helping to 
determine the most suitable adaptive shaking regimes in a predictive and therefore 
more cost-effective manner for novel cell lines and target cell types amenable to orbital 
shaking culture.  Such a model once created, might also ideally be used to develop a 
database correlating EB sizes and shaking regime combinations specific to different 
target cell derivation systems.  This approach could produce a resource that would be 
of great use in accelerating the translation of differentiation protocols for clinical 
relevance.   
The demand for cell manufacture processes in therapeutic scenarios is rising.  
Currently 53 cell therapy clinical trials are underway in the UK of which a majority of 
34 (64%) are patient specific (autologous) treatments (www.clinicaltrials.gov).  
Autologous cell products require manufacturing approaches to produce smaller 
numbers of cells than allogeneic therapies but depending on the indication this range 
varies from thousands to billions of cells per patient (Serra et al. 2012).  The orbital 
shaken culture platform using 24 SRW plates is a manufacturing approach amenable to 
scale-up to 250ml shaken flasks providing sufficient scope to produce cell numbers in 
line with cell therapy requirements (Silk et al. 2010; Barrett et al. 2010).  Additionally 
since the 24 SRW orbital shaken system offers a 30-fold reduction in scale of 
operation and consumable requirements, it represents a cost effective tool for 
developing further scale-up strategies (Barrett et al. 2010).  Furthermore, the simplicity 
of the orbital shaken culture system combined with elimination of animal derived 
Matrigel from retinal cell derivation systems shown in this report suggests it is suitable 
for scalable manufacturing process development for retinal cell production from hiPSC 
derived EBs. 
Our approach of selecting EB sizes amenable to shaking culture and determining 
corresponding shaking speeds to develop cell differentiation systems, is one which 
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could be readily applied to other cell derivation systems, since EBs give rise to all 
three germ layers responsible for the development of all tissues in the body (Thomson 
et al. 1998).  In order to maximise the potential of the system, a recommendation 
would be to start with the EB size range of 5K and 10K cells/EB combined with the 
orbital shaking speed of 120rpm found to be permissive for 21 days of retinal 
differentiation.  Taking advantage of the EB size to orbital shaking combination found 
to work for two hiPSC cell lines in this report could save time and therefore cost in 
applying the platform for the derivation of other cell types.  The potential for 
applicability to other cell types can only be determined experimentally by substituting 
exogenous retinal induction factors for those determined to be appropriate for deriving 
another target cell type.  A subsequent systematic categorisation of EB diameters at 
different stages of differentiation towards the new cell fate should be linked to key 
stage specific biomarkers.  In this way identifying optimal EB sizes to initiate and 
progress through different stages of differentiation along other cell fate specification 
pathways in orbital shaken cultures might also be possible.  The value of such a 
process is in facilitating adaption of adherent differentiation protocols to 3D orbital 
shaken suspension systems and in acting as a method for eliminating Matrigel from 
other differentiation protocols; to help translate cell derivation practices to scalable 
manufacturing processes.   
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Appendix I 
 
  
 
 
 
 
  
Appendix 1 
Representative images of the liquid 
surface in a single well of a 24 well 
microwell plate during measurement of 
mixing times using the dual indicator 
system for mixing time (DISMT) 
(Melton et al. 2002).  With a fill volume 
of 500μl with water like viscosities, at an 
orbital shaking frequency of 120rpm the 
mixing of 50μl of thymol blue 
(Applichem) and 500μl methyl red 
(Fischer Scientific) both in a final 
concentration of 4.3mg/L in deionised 
water provided the colour change 
captured to indicate a visually 
determined mixing time of under 3 
minutes.  The colour of the liquid 
changes initially to blue before 
transitioning to yellow on complete 
mixing from pink to yellow as depicted 
in the images.  Images were taken using 
a high-speed CCD video camera 
mounted on an orbital shaken stage 
This work was carried out with the kind 
aid of Gregorio Rodriguez (UCL, 
Biochemical Engineering.)  
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Appendix II Considerations for industrial uptake of retinal 
differentiation in the Matrigel-free orbital shaken microwell 
platform 
 
Introduction 
The purpose of this chapter is to evaluate the applicability of the process of orbital 
shaken culture for initiating retinal differentiation in hiPSC derived EBs in an 
industrial context.  The objective of the research in this report has been to adapt a 2D 
adherent retinal differentiation protocol for deriving retinal cells to a 3d mixed system.  
Adaption to a mixed system with the orbital shaken 24 microwell platform improved 
homogeneity of differentiation by day 10 and appeared to improve the speed of 
differentiation for later time points with expression of later markers of retinal 
differentiation.  Importantly retinal differentiation was achieved in orbital shaken 
cultures whilst removing reliance on animal derived Matrigel and adding potential 
scalability.   
Improved control over retinal differentiation was achieved in two parts; first by 
introducing specific input EB sizes for initiating retinal differentiation and secondly by 
introducing orbital shaking to the culture system.  Forced aggregation provided 
reproducible EB formation sizes (Chapter 3).  The formation of specific sized EBs, 
facilitated the identification of suitable EB sizes (5K and 10K cells/EB) able to 
improve the initiation of retinal differentiation, compared to heterogeneous sized EBs 
formed by manual scraping techniques (Chapter 4).  The second half of the work 
involved adapting the adherent protocol to a mixed culture system.  The 24 microwell 
orbital shaking platform was selected for this purpose as it had been previously 
validated for scalability of mixing dynamics with mammalian cell cultures to shake 
flasks and stirred tank lateral vessels (Silk et al. 2010; Barrett et al. 2010).   
The utility of the orbital shaken system for improving future scalability was shown not 
only in its ability to improve the homogeneity and speed of retinal differentiation 
cultures, but also in helping to reduce reliance on animal derived raw materials such as 
Matrigel.  Reduction of animal components is key requirement in considering future 
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clinical applications of the work.  Attempts to show broader applicability of the 
Matrigel-free orbital shaken system were made in chapter 6, to show the system could 
initiate retinal differentiation in a different feeder-free hiPSC line.  The different gene 
expression profiles observed in the feeder free cell line brought one of the first key 
challenges for wider applicability into focus: the issue of cell line variability.  The 
objectives of this chapter are to highlight such challenges facing uptake of Matrigel-
free orbital shaking culture for retinal differentiation and consider pragmatic 
approaches to address them. 
 
Reducing reliance on animal derived raw materials 
The reduction of animal derived raw materials from bioproduction processes intended 
for the production of human therapeutics is a regulatory requirement in validating new 
cell products and processes.  The introduction of mixing through orbital shaking 
facilitated the removal of a key potential source of variability in stem cell 
differentiation protocols, arising from the common use of the xenogeneic material 
Matrigel.  Matrigel could be a key source of variability unsuitable for scale up 
procedures due to its undefined status.  Removal of Matrigel was accomplished in 
trying to address challenges associated with static culture.  In particular the increased 
variability of the microenvironment arising from the creation of concentration 
gradients due to a lack of mixing, which make static cultures inherently limited for 
scalability (Côme et al. 2008b).    The implementation of orbital shaken culture in the 
pre-validated 24-microwell shaking platform to improve mixing and show amenability 
to scale up, allowed the complete exclusion of Matrigel from this system.  
Other animal derived ingredients routinely used in stem cell culture, include porcine 
skin derived gelatine, mouse embryonic fibroblasts (MEF) and bovine albumin present 
in knockout serum replacement (KOSR).  These can be eliminated by switching to a 
feeder free cell line as shown in chapter 6.  Eliminating MEFs commonly used as 
feeder cells for hiPSC maintenance and expansion is in compliance with regulatory 
recommendations from the EMA and FDA (PAS 83:2012).  A feeder free hiPSC lines 
derived by transient over-expression of non-integrating episomal reprogramming 
plasmids would also avoid risks of genomic integration associated with viral 
reprogramming techniques.  Using larger panels of feeder free hiPSC lines for 
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differentiation in the orbital shaken platform would be a key improvement to 
understanding the applicability of the system to different cell lines.  Doing so would 
help explore its potential utility for autologous cell therapy manufacturing processes. 
 
Cell-line variability  
The derivation of a pluripotent cell line from a donor, or selection of a commercially 
available pluripotent cell line is the first step in the process of developing a stem cell 
differentiation process.  The importance of variability arising from cell line selection 
draws on the experiences from mammalian cell manufacturing processes and cell line 
development where clonal variations can result in the production of different quantities 
and qualities of proteins such as monoclonal antibodies  (Lai et al., 2013).  Unlike in 
mammalian cell process development, for regenerative medicine, live cells themselves 
are usually the products and variabilities arising from different cell lines can result in 
varying differentiation propensities (Osafune et al. 2008).   
A potential source of increased variability in hiPSC lines can arise from using different 
methods to derive and reprogram the somatic donor cells, as was the case for the 
MSU001 and BJ IPS cell lines used in this report.  The major source of transcriptional 
variation arising  from cell line specific variability is less connected to reprogramming 
method and more a result of the inherent genetic variations in cells, epigenetic memory 
from donor cells has also been found to be an insignificant factor (Rouhani et al. 
2014).  To account for donor to donor genetic cell line specific variability cell 
differentiation processes should conduct studies with much larger numbers of hiPSC 
lines.  Ensuring the use of hiPSC lines derived from multiple donors but sourced from 
the same tissue and reprogrammed by identical techniques, should help account for this 
potential source of variation in developing differentiation processes.   
The effects of potential genetic variation from starting pluripotent cells are 
demonstrated in chapter 6 which showed that cell line variation can result in unique 
differentiation profiles of target cell types.  The different gene expression profiles for 
retinal cell fate specification observed in the feeder free cell line may have been a 
response to the changes in cell culture conditions for expanding and maintaining feeder 
free cells.  The effects of using different matrix substrates such as Vitronectin used to 
176 
 
support pluripotent cell cultures together with the E8 Stem Cell Medium system 
(Invitrogen) should also be characterised for potential effects on retinal differentiation.  
Evaluating a series of different stem cell maintenance systems for their impact on 
retinal differentiation profiles could help to identify a gold standard procedure for 
feeder-free cell culture of hiPSC intended for retinal differentiation.  On establishing a 
standard protocol for pluripotent cell culture it would be possible to compare larger 
numbers of hiPSC lines in parallel in the orbital shaken culture system for retinal 
differentiation to find suitable conditions for a majority of cell lines.  This would be 
important to establish differentiation systems to produce a variety of cells with 
different haplotypes from genetically diverse cell lines to represent large populations 
of patients. 
 
Cell characterisation 
Cell characterisation is required for clinical application of hiPSCs and their 
derivatives.  Characterisation is important to ensure comparability between the cells’ 
identity and character can be demonstrated before and after manufacturing processes 
for starting cell materials and target differentiated cells, to demonstrate control over 
manufacturing processes.  In this report, initial pluripotent cells were characterised for 
expression of markers of pluripotency at the gene and protein expression levels 
(Chapter 3).  As pluripotent cells differentiated toward retinal fates, challenges 
associated with deriving consistent single cell suspensions from cultured EBs limited 
cell characterisation to population level analyses.  Gene expression profiling, LDH 
assays and expression of markers for retinal differentiation by immunohistochemistry 
within EBs were tested in order to achieve this in Chapter 5. 
Characterising target cells at different stages with cellular and population level 
resolution will facilitate specific definition of the critical quality attributes of target 
cells.  Additionally, this would help to identify contaminating cell populations, such as 
pluripotent cells which require removal.  The use of commercially available micro-
array tests and wider transcriptional profiling approaches would help future 
development of robust panels of markers for cell characterisation (Fergus et al. 2014; 
Tian et al. 2015). 
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Ensuring cells have normal karyotypes is also important for characterisation and to 
minimise associated risks of tumorigenesis and develop laboratory scale research with 
clinical relevance  (Harrison, et al., 2007).  Karyotypic analyses are particularly 
important for pluripotent cells, which  can undergo random chromosomal 
rearrangements in long term culture (Fazeli et al. 2011).  Frequent karyotypic analyses 
of the hiPSC lines at different stages of differentiation and at different steps of 
processing would form an important addition to cell characterisation efforts.   
 
Identifying target cell populations  
To define the target cell populations for development in the orbital shaken platform for 
retinal differentiation it will be important to establish a rapid method for identifying 
retinal cells at various stages of differentiation and through different stages of 
bioprocessing.  Identification and purification of cell populations rests on the ability to 
separate target cells from mixed populations of differentiating cells in 3D aggregates.  
In this report after 10 days of differentiation in orbital shaken culture target retinal 
cells in EBs were entangled in tough extracellular matrix which made achieving single 
cell suspensions difficult without large losses.  While other reports have shown 
successful isolation of photoreceptors from adherent cultures using trypsin and manual 
pipetting, these techniques were not repeated in our lab where EBs were cultured in a 
suspension system (Lamba et al. 2010).  Optimising cell separation with more specific 
digestive enzymes would be a key improvement required for the development of cell 
therapies from heterogeneous suspension cultures such as the target retinal cells from 
EBs in this report.  On development of appropriate cell separation techniques, the cells 
could be purified by fluorescence activated cell sorting (FACS) or magnetic activated 
cell sorting (MACS) to enrich for target cell populations to demonstrate purity and 
perform toxicity, potency and functionality assays. 
 
Differentiation and purification of desired cell types 
In order to enrich for target cell populations a comprehensive set of cell surface 
biomarkers is an essential requirement for cell therapy development.  The recent 
discovery of a set of 5 cell surface markers for photoreceptor precursor cells conserved 
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between mice and human retinae may provide great promise for the ability to 
efficiently purify targeted retinal cell types from this report (Lakowski et al., 2015).   
The development of similar sets of markers for key stages of differentiation to track 
progress of differentiating cells throughout their time in culture would help to better 
understand and control differentiation processes.  In combination with efficient cell 
quantification techniques such as FACS or MACS to quantify cell populations in 
differentiating EBs, it would may then be possible to select optimal culture conditions 
for different retinal cell types in the culture.  Optimised culture conditions for retinal 
differentiation in the 24 microwell orbital shaken culture would in turn help achieve 
maximal purities of target cells such as photoreceptors.  Photoreceptors intended for 
therapeutic use could then be isolated more to demonstrate purity using the panels of 
markers and separation techniques discussed above.  
The identification of cell surface biomarkers for assessing cell health and degradation 
in retinal differentiation would be another useful development.  These could help 
monitor cellular responses to potential toxic or metabolic insults arising from 
unsuitable, sub-optimal or anomalous culture conditions through different stages of 
differentiation in orbital shaken cultures.  Such markers could be used to determine the 
impacts of differing concentrations/ combinations of exogenous factors, altering EB 
sizes or changing orbital shaking speeds on the identity, purity and health of final 
differentiated cell populations.  Apart from their value in informing process 
development, and optimisation decisions for retinal differentiation in orbital shaken 
cultures, such data would ultimately help enable processes to maintain target product 
quality profiles of target retinal cell based therapeutics manufactured in the orbital 
shaken microwell system. 
 
Scalable process development  
The 24 microwell approach is a pre-validated approach for scale up of mammalian 
cultures to larger vessels (Barrett et al. 2010; Silk et al. 2010).  However, the use of 
this platform for stem cell differentiation protocols is a novel application which would 
benefit from further study to evaluate scale-up approaches to larger vessels.  While the 
fluid dynamics of migrating in scales from 24 microwells to larger vessels (shake 
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flasks and 5L STLVs) have been explored in previous reports, these also do not 
include the potential impact of growing aggregates of differentiating stem cells in these 
cultures (Barrett et al., 2010 ; Weheliye et al., 2012).  Studies to investigate the unique 
hydrodynamic environment of orbital shaking EBs would be required to understand 
the demonstrated applicability of the 24 microwells shaking platform to a system 
incorporating differentiating EBs.  Better understanding and characterisation of the 
hydrodynamic environment at the small 24 microwell scale with operating conditions 
relevant to EB differentiation protocols would facilitate a smoother transition to larger 
scales and help identify scale dependent variables to highlight opportunities for 
improvement. 
The integration of the orbital shaken microwell platform into an automation platform 
would also help improve potential scalability of the system.  In this report changing the 
medium in 24 microwells every 48 hours for the first 15 days and then every 24 hours 
for the remaining 6 days of culture in laminar flow tissue culture hoods was prone to 
operator variability and associated risks of culture contaminations.  Previously 
demonstrated culture of stem cells in an automated platform provides within a sterile 
system provide the proof of principle for this approach (Hussain et al. 2013). 
Integrating the orbital shaken system with an automated platform would reduce risks 
of contamination involved with manual handling and improve reproducibility by 
eliminating operator bias.  If incorporated with a temperature and CO2 regulated sterile 
chamber an automation platform could minimise the time cells spend outside optimal 
culture conditions, to avoid potentially detrimental fluctuations in pH and oxygen 
consumption that are inevitable during medium exchanges (Veraitch et al. 2008).   
 
Conclusion 
Advances in laboratory scale culture techniques are required as retinal cell therapy 
research and development approach clinical translation with difficult to culture cell 
types such as photoreceptors (MacLaren et al. 2006; West et al. 2012; Lamba et al. 
2010; Reichman et al. 2014).  Derivation of retinal cell types currently rely on complex 
and lengthy protocols in mostly adherent systems and some static suspension systems 
(Table 1.4).  Clinical trials using live human retinal progenitor cells are currently 
underway and recruiting patients for phase II studies (Clinicaltrials.gov ref: 
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NCT02320812).  If this and similar studies are successful there is likely to be an 
increase in demand for processes to differentiate retinal cells in systems with improved 
reproducibility, reduced reliance on animal derived ingredients and with potential for 
scalability.   
The results chapters in this report demonstrate adaption of an adherent culture system 
for retinal differentiation to an orbital shaken 24 well microwell approach.  The 
adaption has resulted in improved potential for scalability, elimination of animal 
derived Matrigel from the differentiation process and improved speed of 
differentiation.  In order to consider the use of this platform for the manufacture of 
clinically relevant material a cGMP compliant method to separate cells from 3D 
aggregates and a comprehensive set of biomarkers to characterise target retinal cell 
types would need to be established.  Overcoming this hurdle will help identify and 
purify target populations and aid removal of contaminant cell populations.  The orbital 
shaken system could then provide a high-throughput, rapid and accessible approach 
with low product costs to assess several different factors affecting stem cell 
differentiation toward retinal fates in parallel.  Doing so could help establish a 
universally applicable system for retinal differentiation from hiPSCs, which could be 
used to develop larger scale manufacturing processes for therapeutic retinal cell types. 
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